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Development Of Methods For The Analysis Of Deep Sequencing Data;  
Applications To The Discovery Of Targets Of RNA-binding Proteins 
 
by 
 
Biter Bilen 
 
With the recent advances in nucleotide sequencing technologies, it became easy to 
generate tens of millions of reads with genome- or transcriptome-wide distribution with 
reduced cost and high accuracy. One of the applications of deep sequencing is the 
determination of the repertoire of targets of RNA-binding proteins. The method, called 
CLIP (for UV crosslinking and immune-precipitation) is now widely used to characterize 
a variety of proteins with regulatory as well as enzymatic functions. Here we focus on the 
statistical analysis of data obtained through a variant of CLIP, called PAR-CLIP 
(Photoactivatable-Ribonucleoside-Enhanced CLIP), which was applied to three different 
RNA binding proteins whose function was previously not well characterized: PAPD5 
(PAP associated domain containing 5), DIS3L2 (DIS3 mitotic control homolog (S. 
cerevisiae)-like 2), and EWSR1 (Ewing sarcoma breakpoint region 1). Our computational 
analysis was instrumental for the definition of the main in vivo substrates of these 
proteins, which were confirmed by additional experiments. In the analysis, we also used 
extensively publicly available high-throughput data sets that enabled us make inferences 
about the function of the proteins. The main results of biological significance were as 
follows. We determined ribosomal RNAs are the main targets of PAPD5 and that the 
main substrates of the DIS3L2 nuclease are tRNAs and found that the tRNA-derived 
fragments processed by DIS3L2 could be loaded in the RNA silencing complex and be 
 3 
involved in gene silencing. Finally, we determined that EWSR1preferentially binds to 
RNAs that originate from instability-prone regions like sub-telomeres, known to be 
hotspots of genomic rearrangements, as well as other genes located in internal regions of 
chromosomes, that have been implicated in genomic translocations. These include 
EWSR1’s own pre-mRNA. All together this dissertation illustrates the point that when  
coupled with proper statistical analysis, CLIP is able to reveal targets of RNA-binding 
proteins that were difficult to study with other methods and that and integration of public 
domain datasets is very powerful in deciphering complex RNA-protein and regulatory 
RNA networks implicated in post-transcriptional gene regulation. 
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Chapter 1:  Introduction 
1.1 RECENT ADVANCES IN SEQUENCING TECHNOLOGIES AND THEIR APPLICATIONS 
12 years after the completion of the draft of the human genome in (Venter et al., 
2001), a myriad of applications for sequencing-based high–throughput methods have 
been found. The ability to detect variations, yet unknown transcripts, high throughput and 
accuracy and reduced cost play a big role in this revolution. At the time writing this 
thesis, the Ensembl database contained ~70 fully sequenced vertebrate genomes 
(http://www.ensembl.org/info/about/species.html). The target is currently moving 
towards delineating variations in genomes of individuals of the same species and the 
1000 Genomes Project (www.1000genomes.org) is a good example; it was launched in 
2008 to decipher human genetic variations (Consortium, 2010). In parallel to the whole 
genome sequencing efforts, measurements of transcriptomes are also taking place. 
Sequencing has also all but rapidly replaced microarray-based expression profiling. 
Furthermore, the ENCODE (ENCyclopedia Of DNA Elements) 
(http://genome.ucsc.edu/ENCODE/) project is set up to define all functional elements in 
the human genome and to catalogue the transcriptomes of several human cell lines 
(2004). modENCODE (http://www.modencode.org/) is a variant of the initial ENCODE 
project and aims to identify functional elements in selected model organisms, specifically 
Drosophila melanogaster and Caenorhabditis elegans; model organisms are of great 
value, permitting experimental validation of findings in a manner that would not be 
possible in humans (Consortium et al., 2010). Although very exciting, these advances 
brought with them computational challenges. Optimal data structures, some of which 
highly distributed, are being developed to store the massive amounts of generated data 
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and novel algorithms with extremely good performance are needed to operate on these 
data.  
1.2 TRANSCRIPTOME-WIDE SEQUENCING METHODS 
Sequencing can be used to quantify gene expression transcriptome-wide. Among 
the most widely used methods is mRNAseq (mature RNA sequencing), which aims to 
profile all polyadenylated RNA species and is extensively applied to measure the gene 
expression levels (Mortazavi et al., 2008). Other methods have been developed to 
quantify not only transcript levels but also alternative splice form, alternative promoter 
and polyA site usage in different cells (Guttman et al., 2011, Trapnell et al., 2010). 
Quantification of individual transcripts levels is a non-trivial problem. Surprisingly, quite 
substantial differences can be found by applying different methods to one data set, 
reflecting different assumptions and heuristics of the programs (Katz et al., 2010). High-
throughput sequencing has also been integrated recently into methods for determination 
of binding sites of RNA-binding proteins. For example, CLIP (Crosslinking and 
Immunoprecipitation) is a recently developed method that relies on ultraviolet light-
induced crosslinking, followed by immunoprecipitation of the protein of interest with a 
specific antibody and sequencing of the associated RNAs. CLIP was initially applied in 
low throughput to identify mRNA targets of a neuron specific splicing factor, Nova (Ule 
et al., 2003). Integration of high-throughput sequencing lead to development of the HITS-
CLIP (High Throughput Sequencing CLIP) variant, which was first applied to a rather 
challenging problem, namely determination of microRNA targets transcriptome-wide 
(Chi et al., 2009). Our group contributed to the development of the PAR-CLIP 
(Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation) 
approach. PAR-CLIP is an alternative to HITS-CLIP, conceived to increase the 
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efficiency of crosslinking through the use of a photo-reactive nucleoside variant that also 
allows reduction of the UV light-induced damage because the energies that are employed 
are typically lower. PAR-CLIP was applied initially to the determination of targets of 
several RNA binding proteins including Argonaute (Chi et al., 2009). iCLIP (individual-
nucleotide resolution CLIP) is the most recent variant of CLIP that aims to exploit what 
is in fact a problem in the previous CLIP approaches. This is the fact that crosslinking 
positions are usually an obstacle for the reverse transcriptase that dissociates at these 
positions, leading to the loss of the majority of templates at the stage of reverse 
transcription; iCLIP was applied to decipher among others, the role of heterogeneous 
nuclear ribonucleoprotein C in splicing regulation (Konig et al., 2011). Comparisons of 
the efficiency and accuracy of these methods have also started to emerge (Kishore et al., 
2011, Sugimoto et al., 2012). A study from our group determined that the type of 
nuclease and the intensity of digestion could considerably bias the set of identified RNA 
targets (Kishore et al., 2011). Similar to CLIP, ribosome profiling is a method that takes 
advantage of ribosome binding to RNAs to determine actively translated regions 
protected by ribosome along the mRNA and to measure translation rates (Ingolia et al., 
2009). 
1.3 INITIAL PROCESSING OF THE SEQUENCING DATA 
The product of a high-throughput transcriptome-wide sequencing is typically 10s 
of millions of 25-100 nucleotide-long sequence-reads. When a reference genome 
assembly is available, the first step of the analysis is to align these reads to the reference 
genome, which may be in the order of several giga-bases long. To find all occurrences of 
a read in the reference genome, one needs to exhaustively scan each read against the 
reference. Initially, hash based methods (either for the reference genome or the reads) 
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were used to reduce the search space (surveyed in (Fonseca et al., 2012)). The huge 
amount of data that is obtained today already makes this process too time-consuming. 
The fact that the reads don’t have perfect complementarity to the reference exponentially 
increases the search space. The use of algorithms from the computer science field for file 
compression has essentially solved this problem (Burrows and Wheeler, 1994). 
Currently, it is possible to map several millions of varying length reads length reads 
within hours. 
1.4 FUNCTIONAL ANNOTATION OF THE SEQUENCE READS 
Functional annotation of the short reads, similar to expressed sequence tags 
(ESTs) and mRNAs before, is usually done on the basis of previously known elements 
that collocate with the read in the same genomic locus. It has become apparent however, 
that gene structures in mammalian genomes are quite complex, with multiple genomic 
elements frequently originating from the same genomic locus. Additionally, RNAs can be 
extensively modified or nucleotides could be added at the ends of the RNAs post-
transcriptionally (Thornton et al., 2012, Trippe et al., 2003, Betat et al., 2010). The first 
complication causes redundant annotation of reads, while the latter might hinder accurate 
mapping of the reads. In our group, in the CLIPZ web server that we maintain for 
annotation of various types of samples (Trippe et al., 2003), we deal with the first issue 
by setting an annotation hierarchy based on the relative abundance of RNA species 
within cells.  We handle the second issue by allowing increased error rates in the short 
read-to-genome alignments (typically 1 error in 10 nucleotides) and trimming non-
template nucleotides that we know are added to specific transcripts (e.g. CCA for tRNAs) 
prior to mapping the reads to the reference. More sophisticated methods could be applied 
depending on the problem setting but this method performs well for common settings.  
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 1.5 STATISTICAL ANALYSIS OF MRNASEQ DATA FOR (DIFFERENTIAL) GENE 
EXPRESSION ESTIMATION 
Only a fraction of mRNA genes are expressed in a cellular state or conditions. 
This is also reflected in the estimation of mRNA expression based on mRNA-seq 
experiments; the normalized expression values appear to be well described by a mixture 
of two components, one corresponding to clearly expressed mRNA species, and the other 
to very rare mRNAs or to spurious mappings of reads to genomic loci that are not those 
from which the reads originated (Hebenstreit et al., 2011). The noise in the estimated 
expression values is higher for low-expressed genes, hence it is important to first 
determine the expressed genes before carrying out differential expression analysis.  
Following this, one can simply calculate the expression fold changes in between two 
different treatments and identify those genes with highest absolute fold change as the 
differentially expressed genes. Depending on the inherent noise in the data (i.e. whether 
or not the biological replicates for the same condition behave consistently), one can apply 
more sophisticated, model based approaches, and call the genes as differentially 
expressed only when they have a lower variance in the same condition than across 
different conditions (Hardcastle and Kelly, 2010). 
1.6 STATISTICAL ANALYSIS OF CLIP DATA 
Initial CLIP methods developed in the Darnell lab used the enrichment of reads 
obtained in CLIP with respect to the reads obtained by in silico dicing of transcripts 
assumed to be expressed at a level given by measurements obtained with microarrays,, 
for the identification of the targets of the RNA binding proteins (Chi et al., 2009, 
Hebenstreit et al., 2011). It is unclear though how to best model the biases introduced in 
the various steps of CLIP. PAR-CLIP and to some extent CLIP introduce however 
mutations that are indicative of crosslinking. Using more sophisticated, model-based 
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scoring methods that take advantage of crosslink-diagnostic mutations, one can 
accurately identify the targets of RNA binding proteins (Jaskiewicz et al., 2012), without 
the need of an mRNA-sequencing sample from which to estimate the relative expression 
of putative RNA targets. 
1.7 APPLICATIONS 
In this thesis I describe the methods (Chapter 2) that we developed and the 
analyses that we carried out to identify targets of various RNA binding proteins. We 
applied PAR-CLIP to identify RNA targets of PAPD5 (PAP associated domain 
containing 5), DIS3L2 (DIS3 mitotic control homolog (S. cerevisiae)-like 2), and 
EWSR1 (Ewing sarcoma breakpoint region 1) as described in Chapter 3-5, respectively.  
PAP domain is found in poly(A) polymerases and has been shown to have 
polynucleotide adenylyltransferase activity in yeast (Motamedi et al., 2004). PAPD5 is 
the human homolog of yeast Trf4; however, in vivo function of it was not known at the 
time when we initiated the studies described in Chapter 3. We identified rRNAs as the 
main in vivo targets of PAPD5.  
 Our second application of PAR-CLIP was to DIS3L2, one of the three human 
homologs of exosome complex exonuclease Dis3 (Astuti et al., 2012, Hebenstreit et al., 
2011). Among the Dis3 homologs, DIS3L2 was one of the least characterized. Through 
computational analysis of DIS3L2-CLIP data, we identified tRNAs as the main DIS3L2 
substrates. Additional experiments then suggested that DIS3L2 might be the main 
exonuclease involved in the biogenesis of tRNA-derived small RNAs, which are 
subsequently loaded in the RNA silencing complex and function in gene regulation.  
Our most recent study aimed to characterize the function of EWSR1, an RNA-
binding protein best known for the frequent translocations that its locus shows in specific 
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cancers (revieved in (Kovar, 2011)). SR1 RNA binding domain is usually lost in the 
fusion proteins, presumably leading to a loss of function phenotypes in sarcomas. We 
therefore applied PAR-CLIP to assess the importance of the EWSR1 RNA binding 
domain. We have additionally integrated analysis of several different dataset to finally 
establish that EWSR1 binds RNAs originating from instability prone regions including its 
own pre-mRNA, which is involved in translocations.  
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2.1 SUMMARY 
microRNAs are important regulators of gene expression that guide translational 
repression and degradation of target mRNAs. Only relatively few miRNA targets have 
been characterized, and computational prediction is hampered by the relatively small 
number of nucleotides that seem to be involved in target recognition. Argonaute (Ago) 
crosslinking and immunoprecipitation (CLIP) in combination with next-generation 
sequencing proved to be a successful method for identifying targets of endogenous 
cellular miRNAs on a transcriptome-wide scale. Here we review various approaches to 
Ago CLIP, describe in detail the PAR-CLIP method and provide an outline of the 
necessary computational analysis for identification of in vivo miRNA binding sites. 
2.2. OVERVIEW OF CLIP METHODS 
The rapid development of high throughput technologies during the last decade 
made it possible to investigate cellular processes on a global scale. Crosslinking and 
immunoprecipitation (CLIP) became a method of choice for identifying target sites of 
individual RNA-binding proteins. Initially employing classical sequencing, CLIP has 
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been recently combined with next-generation sequencing to generate comprehensive 
catalogues of binding sites. Several variants are currently in use, most notable being high-
throughput sequencing of RNA isolated by crosslinking immunoprecipitation (HITS-
CLIP) (Licatalosi et al., 2008), Photoactivatable-Ribonucleoside-Enhanced Crosslinking 
and Immunoprecipitation (PAR-CLIP) (Hafner et al., 2010) and individual-nucleotide 
resolution UV crosslinking and immunoprecipitation (iCLIP) (Konig et al., 2010). 
Although initially applied to the problem of identifying direct RNA-binding protein 
(RBP)-RNA interactions, recent studies (Hafner et al., 2010, Chi et al., 2009) 
demonstrated that CLIP can be used in more complex situations, as for example 
identification of mRNA targets of microRNAs (miRNAs). These target sites are part of 
ternary complexes (RISC for RNA-induced silencing complex) that contain, beside the 
mRNA, an Argonaute (Ago) protein and a guiding miRNA. 
Elucidation of miRNA targets had been a challenge since the discovery of these 
regulatory molecules. Although it quickly became apparent, particularly from 
computational analyses, that a single miRNA has hundreds of targets (Grimson et al., 
2007), experimental studies typically focus on a single or at best several targets of a given 
miRNA. Because the interaction between a miRNA and its target can involve as few as 7-
8 nucleotides (Bartel, 2009), it is difficult to accurately predict miRNA targets 
transcriptome-wide with computational methods. To circumvent this problem and obtain 
extensive sets of miRNA targets from which additional specificity determinants can be 
inferred, a number of groups applied Ago-CLIP and identified miRNA/Argonaute targets 
in mouse tissues and cells (Chi et al., 2009, Leung et al., 2011), human cells (Hafner et 
al., 2010, Gottwein et al., 2011, Kishore et al., 2011, Stark et al., 2012), and in the worm 
Caenorhabditis elegans (Zisoulis et al., 2010) in close-to-physiological conditions. 
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A typical CLIP protocol is quite complex. It involves the UV-induced crosslink 
formation, cell lysis, immunoprecipitation of the protein of interest along with the 
crosslinked RNA, ribonuclease (RNase) treatment in order to reduce the RNA targets to 
approximately the protein binding sites, RNA isolation, adaptor ligation, reverse 
transcription and library generation by PCR and finally, deep sequencing. It has been 
argued (Hafner et al., 2010, Kishore et al., 2011) that the resulting libraries yield 
quantitative information about the miRNAs present in the cell as well as the sequences of 
their target sites. Recently, we have performed a quantitative analysis of variants of CLIP 
and PAR-CLIP protocols and determined that the RNase fragmentation step used during 
sample preparation can introduce a substantial bias in the set of isolated RNAs, while the 
use of photoactivatable nucleotide analogue moderately improves the CLIP performance 
(Hafner et al., 2010). 
Here we outline a typical Ago CLIP or PAR-CLIP experiment aiming at the 
isolation and analysis of miRNAs and their targets in vivo and discuss the computational 
analysis of the resulting sequence data (Figure 1). 
2.3 DETAILED CLIP PROTOCOL 
2.3.1 Incorporation of photoactivatable nucleotide analog and UV crosslinking 
Incorporation of modified, photoreactive nucleotides like 4-thiouridine (4SU) or 
6-thioguanosine (6SG) is mandatory for PAR-CLIP and can result in higher crosslinking 
efficiency (Hafner et al., 2010, Kishore et al., 2011). Furthermore, the crosslinked 
modified nucleotides lead to the introduction of characteristic mutations (T-to-C for 4SU 
and G-to-A for 6SG, (Hafner et al., 2010)) during reverse transcription, providing a 
means to pinpoint the exact nucleotide that was contacted by the protein (Hafner et al., 
2010, Kishore et al., 2011). Subsequent studies demonstrated that classical crosslinking at 
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254 nm in the absence of a modified nucleotide as in HITS-CLIP also leads to specific 
mutations that can be exploited in the same way as the T-to-C or G-to-A mutations in 
PAR-CLIP to pinpoint the binding sites (Kishore et al., 2011, Zhang and Darnell, 2011), 
although the frequency of these mutations is substantially lower than in PAR-CLIP. 
While both PAR-CLIP and HITS-CLIP achieve nucleotide resolution through diagnostic 
mutations that are introduced as the reverse transcriptase (RT) transcribes over a 
crosslinked nucleotide, the propensity of RT to actually stop transcribing at these 
nucleotides has been exploited in another CLIP method called iCLIP (Konig et al., 2010). 
Adherent or suspension cells can be grown in presence of the modified 
nucleoside. Concentrations of 100 µM 4SU or 10-100 µM 6SG are typically used, and 
labeling times are usually 12 – 14 hours. Afterward, the cells are crosslinked with 365 nm 
UV light (typically with 150 mJ/cm2), pelleted by centrifugation, flash frozen in liquid 
nitrogen and stored at -80 °C until use. 
2.3.2 Cell lysis and immunoprecipitation 
Depending on the experimental design, cytoplasmic, nuclear or whole cell extract 
can be prepared.  The antibody selection is critical for an efficient and accurate CLIP 
experiment. For human Ago2 CLIP and PAR-CLIP we successfully used the 11A9 
monoclonal antibody (Rudel et al., 2008), while for mouse Ago2 2A8 monoclonal 
(Nelson et al., 2007) and 2D4 (Wako) were reported to work in HITS-CLIP (Chi et al., 
2009, Leung et al., 2011). If specific antibodies are not available, an alternative strategy 
is to express a FLAG-tagged version of the protein and perform the immunoprecipitation 
with anti-FLAG antibodies. The latter approach has been employed to determine the 
targets of all four Ago proteins in human cells (Hafner et al., 2010). 
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2.3.3 Nuclease treatment 
RNase treatment is an essential step in CLIP library preparation. The type, 
amount and time of RNase digestion must be carefully optimized to yield RNA fragments 
whose length distribution is in a range that enables their unambiguous assignment to 
appropriate genomic loci and that are minimally affected by the sequence bias of the 
nuclease. In CLIP/HITS-CLIP/iCLIP experiments either a mixture of RNase A and 
RNase T1 (Chi et al., 2009, Ule et al., 2005) or bacterial RNase I are used (Wang et al., 
2009), while in PAR-CLIP extensive RNase T1 digestion has been employed (Hafner et 
al., 2010, Kishore et al., 2011). The high specificity of RNase T1 of cleaving after 
guanosine residues, coupled with a high efficiency of this nuclease can lead to isolation 
of RNA fragments that are essentially devoid of G nucleotides. This bias can be 
diminished substantially by titrating the amount of nuclease in the experiment (Kishore et 
al., 2011). Alternatively, a nuclease of the complementary specificity can be used, like 
micrococcal nuclease (MNase) that exhibits preference for A and U nucleotides (Kishore 
et al., 2011, Zisoulis et al., 2010). 
In a typical Ago2 CLIP experiment we use 5 U/ml of RNase T1 in the extract 
prior to immunoprecipitation and 20 U/µl on the beads for 15 min at 22 °C in or 0.2 gel 
U/µl of MNase for 5 min at 37 °C (Kishore et al., 2011). In these conditions RNA is 
partially digested into 20-100 nucleotide fragments (Jaskiewicz, Kishore and Zavolan, 
unpublished). 
2.3.4 SDS-PAGE and recovery of the immunoprecipitated RNA 
The fragmented RNA that is still covalently linked to the protein is then 
dephoshorylated by alkaline phosphatase and radioactively labeled using 32P-γ-ATP and 
T4 polynucleotide kinase. This step allows the identification of the immunoprecipitated 
protein-RNA complexes after SDS-PAGE. It is worth noting that the protein is not in a 
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denatured state during the phosphorylation reaction, so the nature of the protein-RNA 
interaction can influence the yield of radiolabeled RNA. miRNAs are bound by Ago in a 
specific fashion: their 5’ phosphate is positioned within the protein binding pocket (Wang 
et al., 2008) thereby being partially inaccessible for enzymatic reactions, in particular 
ligation to the 5’ adaptor (Jaskiewicz, Kishore and Zavolan, unpublished data), which can 
be important when the adaptor ligation is performed on the beads prior to SDS-PAGE. 
After labeling, protein-RNA complexes are eluted from the antibodies with SDS-
loading buffer and subjected to SDS-PAGE. The gel is subsequently visualized by 
autoradiography and the sections that correspond to the RNA-bound fragments are 
excised and further processed. In the PAR-CLIP protocol the recovered sections of the 
gel are subjected to electroelution, proteinase K treatment to remove proteins, phenol-
chlorophorm extraction and RNA precipitation. Studies with the CLIP protocol (Ule et 
al., 2005) found that the transfer from the SDS-PAGE to a nitrocellulose membrane 
significantly improves the signal:noise ratio by eliminating free RNA fragments that 
happen to migrate at the same apparent size as immunoprecipitated protein-RNA 
complexes. The isolated RNA-protein complexes can also be visualized by 
autoradiography, and the membrane can be similarly subjected to excision of the relevant 
sections, proteinase K treatment to liberate immunoprecipitated RNA fragments, phenol-
chlorophorm extraction and precipitation of the RNA. 
2.3.5 Ligation of adaptors 
As with most other steps, adaptor ligation has also been performed in variety of 
scenarios in the various CLIP protocols. The original CLIP (Ule et al., 2005) called for 
ligation of one of the adaptors prior to SDS-PAGE, allowing an easier separation of 
ligated and unligated adaptor-RNA products. Care must be taken however that only 
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fragments that are above the position at which the protein is expected to migrate on the 
gel are recovered. In addition, as detailed in the previous paragraph, the conformation of 
the protein-RNA complex might negatively influence the efficiency of the ligation. For 
these reasons the PAR-CLIP protocol calls for ligation of the protein-free RNA fragments 
after gel electrophoresis (or after gel transfer). To minimize the fraction adaptor-adaptor 
ligation products, sequential ligation of adaptors is recommended. The 3’ preadenylated 
adaptor is ligated first with truncated T4 RNA ligase 2 K227Q (New England Biolabs) 
and ATP-free buffer, maximizing the efficiency of RNA-adaptor ligation and preventing 
concatenation of RNA fragments (Hafner et al., 2008). After 3’ adaptor ligation the RNA 
is resolved by denaturing 15% urea-PAGE, and the ligated fragments are excised, eluted, 
precipitated and ligated to the 5’ adaptor using T4 RNA ligase 1 in ATP-containing 
buffer. The ligation reaction is then resolved by 12% urea-PAGE, eluted and precipitated. 
2.3.6 Reverse transcription, PCR amplification and introduction of indexes for 
multiplexing 
The nucleotide-level resolution in binding site identification has been achieved by 
exploiting in various ways reverse transcription through crosslinked sites. Reverse 
transcriptase has a tendency to terminate at the position of crosslink (Urlaub et al., 2002), 
although the frequency with which this happens in the conditions of the CLIP experiment 
is unknown. The iCLIP protocol (Konig et al., 2010) has been developed based on this 
premise yielding sequence reads whose 5’ ends should map immediately downstream of 
crosslinks. HITS-CLIP and PAR-CLIP protocols on the other hand rely precisely on the 
reads that are generated when the RT does transcribe through a crosslinked site. It 
appears that nucleotide misincorporation occurs frequently at such sites, especially in 
PAR-CLIP, leading to diagnostic mutations and nucleotide-level resolution in the 
identification of binding sites. 
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The cDNA resulting from reverse transcription is PCR-amplified, generating a 
library which is then submitted to next-generation sequencing. Because extensive PCR 
amplification is known to bias the composition of the library (Pinard et al., 2006, Dohm 
et al., 2008), various CLIP protocols take precautions to minimize such effects. We opt 
for minimizing the number of PCR cycles used in the library amplification. Libraries 
generated with Ago2 PAR-CLIP require typically 14-18 amplification cycles to yield 
sufficient material for sequencing. This does not appear to introduce strong biases 
because the sites derived by taking into account the actual copy number of the reads that 
are derived from unique fragments are similar in the frequency of expected protein-
specific sequence motifs (Kishore et al., 2011). In HITS-CLIP and iCLIP, the PCR 
amplification is more extensive (25-35 cycles), but the introduction of random barcodes 
before amplification allows one to identify sequences that originated from the same RNA 
fragment (Konig et al., 2010, Chi et al., 2009). These will be collapsed to a single 
sequence during annotation leading to appropriate quantification of reads. 
Current sequencing depth allows for sample multiplexing without sacrificing the 
library complexity. We typically multiplex 4-6 samples in a sequencing lane of a HiSeq 
2000 instrument. Different reverse primer sequences need to be used, as per Illumina 
indexing protocol. 
The step-by-step Ago2 CLIP protocol is provided in Extended Methods. 
2.4 SITE DEFINITION AND EXTRACTION BASED ON ENRICHMENT RELATIVE TO MRNA-
SEQ 
Reads obtained from deep sequencing need to be annotated and used for the 
extraction of individual Ago binding sites. For this purpose we use an automated 
procedure which we implemented in the CLIPZ server (www.clipz.unibas.ch (Khorshid 
et al., 2011)). For each of the steps of this procedure various solutions have been 
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proposed and implemented, but they have not been so far bundled in stand-alone analysis 
packages that can be readily used on the raw sequence data. After discarding low-quality 
sequences (based on the number of nucleotides that could not be unambiguously called) 
we use an in-house implementation of an ends-free alignment algorithm to identify 3’ 
adaptor fragments that are present in the reads and remove them. Reads that are at least 
15 nucleotides in length after adaptor removal are then mapped to the genome assembly 
using a short read alignment program. Recently, the Burrows-Wheeler transform has 
been used to develop very efficient short read alignment programs (Langmead et al., 
2009, Li and Durbin, 2009). In our analyses we use the Burrows-Wheeler Aligner (BWA) 
(Li and Durbin, 2009), which allows us to find not only ungapped but also gapped 
alignments, which in the case of reads derived from CLIP experiments are quite common 
due to nucleotide deletions that are introduced in the cDNAs as the RT transcribes over a 
nucleotide that was crosslinked (Kishore et al., 2011). We then assign the reads with 
equal probability to the possible genomic loci, but for most analyses focus on the subset 
of reads that map uniquely to the genome.  
Typical CLIP experiments yield a large number of reads that appear to originate 
in many different types of RNAs. Initial studies, including ours (Hafner et al., 2010, 
Kishore et al., 2011) have focused on mRNA-derived reads. Furthermore, to be able to 
quantify and compare the relative abundance of various sites in CLIP data, we typically 
select one representative mRNA for every gene, defined as the longest mRNA in the 
Refseq database (Pruitt et al., 2009) that has annotated 5' UTR, coding domain and 3' 
UTR. The mappings of CLIP reads to these representative mRNAs serve as the basis for 
the binding site identification described below. 
Binding sites are identified as peaks in the read density profile along transcripts. 
A number of variants of this procedure have been proposed (Chi et al., 2009, Kishore et 
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al., 2011, Corcoran et al., 2011). Our approach was to identify non-overlapping regions 
of identical length (we typically used 40 nucleotides-long regions) with high coverage by 
reads. In a given transcript we start with the region with highest coverage by reads, then 
identify the window with the next-highest coverage that is not overlapping with the first, 
etc. 
Different binding sites presumably have different affinities to Ago. The high 
affinity binding sites, in the vicinity of which Ago is present a large fraction of the time, 
should have the highest propensity to crosslink with Ago during the CLIP experiment and 
should subsequently yield a large number of CLIP reads. One could thus argue that 
ranking binding sites by the number of reads would allow one to discover the highest 
affinity and perhaps most relevant binding sites. However, the number of CLIP reads 
mapping to a given binding site depends on other factors, among which the abundance of 
the mRNA in which the site resides. If two sites s! and s! of equal affinity to Ago are 
located on different mRNAs m! and m!, the abundance of m! being much higher than 
that of  m!, more sequences of type m! will be available for crosslinking than sequences 
of type m! resulting into more CLIP reads of type s! than of type s!. A few approaches 
have again been used to remove the confounding effect of mRNA abundance in the 
ranking of biding sites. Chi et al. (Chi et al., 2009) use an in silico fragmentation 
procedure to estimate the relative abundance of mRNA fragments based on mRNA 
expression data obtained through microarray experiments. We used mRNA-seq data 
obtained from the same cell line in which the CLIP experiments were performed to the 
same end (Kishore et al., 2011). 
Namely, by computing the ratio between the number of CLIP reads mapping to a 
putative binding site and the number of reads that would be expected to map to that site if 
there was no specific selection of RNA fragments by the Ago CLIP, we can obtain an 
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estimate of the affinity of the site for the RISC complex. Ranking sites by this ratio is 
also not entirely problem-free. For instance, the enrichment ratio for CLIP sites located 
on mRNAs that were not captured in mRNA-seq is infinity, irrespective of the number of 
reads obtained from this site in CLIP. To deal with this issue and obtain meaningful 
estimates of enrichment, we currently use a Bayesian probabilistic model in which the 
fraction p! of CLIP reads expected to map to site i given mRNA abundance alone can be 
written as  
 !! = !! ! + 1!!(!) !!(!)!!!! !!!!!  (1) 
where µμ(i) denotes the mRNA that carries site i, n! !  is the number of mRNA-seq reads 
that map to the mRNA on which site i is located, l!(!) is the length of that mRNA and c is 
the total number of CLIP sites. Consequently, if r! out of a total of r CLIP reads map to 
site i, the enrichment ratio for site i is !!!!!. Based on the enrichment ratio p!, one can rank 
CLIP sites located on mRNAs of widely different abundances in a consistent fashion, 
using a single metric. To further reflect our expectation that at equal enrichment ratios we 
would be more confident in the estimate of enrichment for the site supported by more 
reads, we compute the posterior probability P H! r!, r   that a given site is enriched 
compared to what would be expected from the abundance of the corresponding mRNA 
alone. This probability is given in terms of the reverse cumulative of a beta distribution as 
 ! !! !! , ! = Γ ! + 2Γ r! + 1 Γ r − r! + 1!!! !!!(1 − !)!!!!!" (2) 
where p! is the fraction of CLIP reads expected to map to site i (see Equation 1) and r is 
the total number of CLIP reads, r! of which map to the CLIP site i (Hausser and Zavolan, 
unpublished).  
The tests that we carried out with various measures for ranking CLIP sites of Ago 
and HuR proteins indicate that the probability ! !! !! , !  of a site being enriched over 
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what is expected from mRNA abundance is most accurate. It is also an intuitive, general 
method that can be applied equally to PAR-CLIP data (Hafner et al., 2010, Kishore et al., 
2011), which typically feature a large number of diagnostic mutations, and to HITS-CLIP 
data (Chi et al., 2009) in which diagnostic mutations are scarcer (Kishore et al., 2011). 
Nonetheless, when mRNA-seq data is not available, bona fide binding sites can still be 
obtained by ranking sites according to the number of CLIP reads mapping to them or by 
the frequency of crosslink-diagnostic mutations. These mutations can also be used a 
posteriori to identify the position on the mRNA where the crosslink occurred with 
nucleotide resolution, as we will examine in the next section. 
2.5 RANKING SITES BASED ON CROSSLINK-INDUCED MUTATIONS 
T-to-C mutations in the cDNAs have been used to identify crosslinked sites since 
the introduction of the PAR-CLIP method (Hafner et al., 2010). Recently, kernel density 
estimates of these events were utilized to identify binding sites (Corcoran et al., 2011). 
Our analyses ((Kishore et al., 2011) and Bilen, Hausser and Zavolan, unpublished) 
indicate that although such mutations do indeed pinpoint binding sites at nucleotide 
resolution, measures of the density of crosslink-diagnostic mutations do not necessarily 
outperform that based on the enrichment in reads. Nonetheless, particularly for situations 
when the binding sites are located in non-protein coding transcripts whose abundance is 
difficult to estimate, we developed a model to estimate the probability that the frequency 
of crosslink-diagnostic mutations in reads originating from a given site is typical for a 
crosslinked site. This is because apparent T-to-C mutations can be also due to sequencing 
errors, mis-mapped reads or to single nucleotide polymorphisms, while crosslink-induced 
mutations in a given sample appear to occur at a characteristic frequency (Figure 2).  
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Formally, let us assume that we observe k T-to-C mutations at a position covered 
by n reads. Under the assumption that the reads were independently sampled and that T-
to-C transitions occur at rate µμ, the number of mutations k can be modeled to follow a 
binomial distribution and thus the probability of the data can be written as 
 ! ! !, ! =    Γ ! + 1Γ ! + 1 Γ ! − ! + 1 !! 1 − ! !!! (3) 
where 0 ≤ µμ ≤ 1 and Γ x = (x− 1)! is the gamma function. Further assuming that the 
unknown probability of T-to-C mutations, µμ, has a prior probability of the form 
 ! !|!, ! = Γ(! + !)Γ(!)Γ(!) !!!!(1 − !)!!! (4) 
where a > 0 and b > 0, we can use Bayes’ theorem to calculate the posterior probability 
distribution of µμ as 
 ! ! !, ! = ! ! !, ! ! ! !! ! !, ! ! ! ! !"!! . (5) 
Substituting P µμ n = P(µμ|a, b) from Eq. 4 leads to 
 ! ! !, !, !, ! = Γ ! + ! + ! + !Γ ! + ! Γ ! + ! !!!!!! 1 − ! !!!!! (6) 
where l = n− k. Finally, as a measure of our confidence that the given position 
represents a crosslink site we compute the probability that the rate of T-to-C transitions µμ, 
is within a certain range defined by the lower and upper bounds µμ! and µμ!:  
 ! ! > !!   !"#  ! < !!|!, !, !, ! = !!!!!!!!!!! 1 − ! !!!!!!"  !!!!!!!! 1 − ! !!!!!!"    (7) 
To be able to estimate the parameters a and b of this distribution as well as the cutoffs µμ! 
and µμ!, we analyzed the distribution of the frequency of T-to-C mutations as a function of 
the coverage of a given nucleotide in the data. We found that nucleotides with a 
reasonably high coverage have a very narrowly distributed frequency of T-to-C mutation 
(around 0.1 in the Ago PAR-CLIP datasets that we obtained, Figure 2). Thus, we use a 
“trusted set” of nucleotides that we believe were crosslinked in the experiment to 
estimate the a and b parameters by maximum likelihood. Defining the set of trusted 
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nucleotides is done on the basis of the data. As lower and upper bounds µμ! and µμ!, we use 
the values that correspond to the 0.001 and 0.999 quantiles of the prior distribution of µμ 
defined by formula (Chi et al., 2009). Finally, we calculate the posterior probability of the 
observed T-to-C mutations being within the boundaries that we expect for a crosslinked 
position with formula (Leung et al., 2011). More specific information can be used to 
further reduce the rate of false positives. For example, single-nucleotide polymorphisms 
can be identified based on RNA-seq data and explicitly excluded from the set of putative 
crossliked positions. Similarly, reads that come from repetitive genomic regions and are 
likely to be mis-mapped can be excluded from the analysis. 
2.6 Identification of miRNA binding sites in Ago-CLIP sites 
The methods described above allow us to identify genomic regions to which the 
Argonaute protein is crosslinked with high probability. They do not immediately reveal 
which miRNA guided the interaction of Argonaute with the mRNA. A trivial solution to 
this problem is to intersect the Ago-binding sites with predicted miRNA-binding sites. 
This approach has of course the limitation that no novel binding sites would be 
discovered. Furthermore, the most accurate target prediction programs enforce the 
requirement that ~7 nucleotides from the 5’ end of miRNA (so-called ‘seed’) are 
perfectly complementary to the target site but many Ago-CLIP sites do not seem to be 
explained by this type of sequence complementarity. In cases when a miRNA is very 
highly and specifically expressed and at the same time has a particular type of non-
canonical (i.e. not a seed-matching) site that occurs with high frequency in the data (Chi 
et al., 2012), de novo motif finding with programs such as MEME (Bailey et al., 2009) 
can reveal the miRNA binding site. Nonetheless, a principled method for identifying the 
guide miRNA associated with each Ago-CLIP site is still to be developed. 
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2.7 CONCLUSIONS 
CLIP approaches are instrumental in the discovery of miRNA target sites and for gaining 
a mechanistic understanding of their interaction with RNA-induced silencing complexes. 
However, the obtained data is complex, and accurate methods, that need not make 
assumptions currently made by miRNA target prediction programs, are needed to identify 
bona fide miRNA binding sites. The large collection of experimentally identified sites 
can then be used to learn more about miRNA-target interactions, because only 40-60% of 
sites can typically be explained through matching to the seed region of abundantly 
expressed miRNAs (Hafner et al., 2010, Kishore et al., 2011). In the very near future, 
these approaches are expected to yield comprehensive catalogs of miRNAs and their 
targets in specific cells, tissues and organisms. 
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Table 1. Comparison of different Ago2 CLIP methods 
 Chi et al., 2008 Hafner et al., 2010 Kishore et al., 2011 
Organism, cell type mouse, brain human, cell line human, cell line 
Immunoprecipitated 
protein 
Endogenous FLAG-tagged, 
overexpressed 
endogenous 
Protocol CLIP (HITS-
CLIP) 
PAR-CLIP PAR-CLIP / CLIP 
Modified 
ribonucleoside 
None 4-thio-uridine 4-thio-uridine/none 
Crosslinking UV 
wavelength 
254 nm 365 nm 365 nm / 254 nm 
Nuclease  RNase A RNase T1 RNase T1, MNase 
Nuclease digestion Limited extensive extensive / limited 
Radioactive labeling 3’ adaptor immunoprecipitated 
RNA 
immunoprecipitated 
RNA 
3’ adaptor ligation on beads, prior to 
SDS-PAGE 
after SDS-PAGE after SDS-PAGE 
Preadenylated 3’ 
adaptor and 
truncated RNA 
ligase 
No yes yes 
Nitrocellulose 
transfer after SDS-
PAGE 
Yes no no 
Crosslink-induced 
mutation analysis for 
site identification 
No yes yes, for both PAR-
CLIP and CLIP 
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Figure 1. Sketch of the CLIP protocol. Incubation with a photoactivatable nucleoside 
analog like 4SU is performed in PAR-CLIP and cells 365 nm UV light. In CLIP the 
incubation with modified nucleoside is omitted and the crosslinking is performed at 254 
nm. Optimization of ribonuclease treatment conditions is recommended in order to avoid 
too extensive RNA digestion which can deplete bona fide binding sites. After 
immunoprecipitation, radioactively labeled RNA–protein complexes are resolved by 
SDS–PAGE and blotted to nitrocellulose membrane. This step reduces the background of 
non-crosslinked RNA fragments. After adaptor ligation and reverse transcription, a pilot 
PCR should be performed to determine the number of amplification cycles in the 
preparative-scale PCR. The number of cycles should be chosen to allow library 
amplification with minimal PCR amplification bias. 
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Fig. 2. Frequency of T-to-C mutations at individual genomic positions that are covered 
by mRNA-annotated reads obtained in an Argonaute2 PAR-CLIP experiment (Kishore et 
al., 2011). The reads obtained in the experiment were annotated with the CLIPZ server 
(www.clipz.unibas.ch). Reads that were annotated as mRNAs were used to identify 
genomic positions at which T-to-C mutations occurred, and to compute the frequency of 
T-to-C mutations (number or reads carrying the T-to-C mutation divided by the total 
number of reads covering the given genomic position). Genomic positions were then 
divided into bins, based on the number of mRNA-annotated reads that covered them. The 
first bin corresponded to [0,5) reads covering an individual genomic position, the second 
bin corresponded to [5,10) reads per position etc. Finally, we constructed box-plots of the 
mutation frequency across all genomic positions in a bin. The box indicates the inter-
quartile range, the circle the median mutation frequency and the crosses show the 
outliers. 
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2.8 EXTENDED METHODS 
2.8.1 Step-by-step Ago2 PAR-CLIP protocol 
• Grow 5x108 – 109 cells. At ~60% confluency, add 4SU to final concentration of 
100 µM and grow for additional 12-14 hours. Wash cells with ice cold PBS and 
crosslink on ice with 365 nm UV at 0.15 J/cm2 in a crosslinker (e.g. Stratalinker 
2400 from Stratagene). Collect cells by centrifugation at 2000 rpm for 5 min at 4 
°C, flash freeze and store at -80 °C until use. 
• Add 3 ml of NP40 lysis buffer per g of cell pellet, incubate 10 min on ice, 
centrifuge 14.000 g at 4 °C and filter supernatant through 0.45 µm filter. 
• Perform initial RNase T1 digestion with 5 U/ml RNase T1 (Fermentas) at 22 °C 
for 15 min. 
• Preincubate protein G magnetic beads (Dynabeads, Life technologies) with Ago2 
antibody (generally 10 µl of beads per ml of cell lysate) with Ago2-specific 
antibody (final concentration 0.25 mg/ml) at 4 °C for 1 hour, wash twice with 1 
ml of citrate phosphate buffer, add to lysate and incubate for 2 hours at 4 °C. 
• Collect beads on ice using magnetic rack, wash 3 times with 1 ml of IP washing 
buffer and resuspend in original amount of IP washing buffer containing 20 U/µl 
of RNase T1 (Fermentas), incubate at 22 °C for 15 min. Alternatively, use MNase 
(NEB) at 0.2 gel U/µl final concentration instead of RNase T1. As MNase activity 
is very sensitive to the salt concentration, MNase digestion should be carried out 
in the buffer supplied with the enzyme and incubated at 37 °C for 5 min. 
• Wash beads 3 times with 1 ml of high salt buffer and resuspend beads in the 
original bead volume of 1x NEB buffer 3 with calf intestinal phosphatase (NEB) 
at a final concentration of 0.5 U/µl and incubate at 37 °C for 10 min with 
intermittent shaking. 
 37 
• Wash beads twice with 1 ml of crosslink washing buffer and twice with 1 ml of 
PNK buffer. 
• Resuspend beads in the original volume of PNK buffer containing 5 mM DTT, 
add γ32P-ATP to a final concentration of 0.5 µCi/µl and T4 PNK (NEB) to a final 
concentration of 1 U/µl and incubate at 37 °C for 30 min with intermittent 
shaking. Next, add ATP to a final concentration of 100 µM and incubate at 37 °C 
for additional 5 min. 
• Wash beads 5 times with PNK buffer without DTT. 
• Resuspend beads in 1x SDS-loading buffer, incubate at 90 °C for 3 min and load 
the supernatant on NuPAGE 4-12% Bis-Tris gel in 1x MOPS running buffer (Life 
technologies), resolve for 1 hour 15 min at 150 mA, 200 V. 
• Incubate gel in 2x NuPAGE transfer buffer for 5 min and transfer to nitrocellulose 
membrane using semi-dry blotter at 20 V, 400 mA for 2 to 3 hours. 
• After transfer rinse the nitrocellulose in 1x PBS, wrap membrane in plastic wrap 
and expose to phosphoimager screen. Depending on the signal expose for 10 min 
to several hours. 
• Excise membrane fragments corresponding to the migration of Ago2-RNA 
complexes (~100-130 kDa), add in proteinase K at final concentration of 1.2 
mg/ml in 1x proteinase K buffer to the membrane fragments and incubate at 55 °C 
for 30 min, spin down and recover the supernatant. 
• Add 1 vol of phenol-chlorophorm-isoamyl alcohol (25:24:1) solution, vortex and 
centrifuge at 14000 g for 15 min at room temperature. Transfer aqueous phase to 
fresh tubes, add 1 vol of chlorophorm, vortex and centrifuge at 14000 g for 15 
min at room temperature. 
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• Recover the aqueous phase into fresh tubes, add 1/10 volume of 3M NaCl, 1 µl of 
GlycoBlue (Ambion) and 3 volumes of absolute ethanol. Precipitate at -80 °C for 
30 min and centrifuge at 14000 g for 30 min at 4 °C. Discard supernatant and 
wash pellets with 70% ethanol. Centrifuge at 10000 g for 10 min at 4 °C, discard 
supernatant and briefly (3-5 min) air-dry pellets at room temperature. 
• Resuspend pellets in 19 µl of 3’-adaptor ligation mixture containing 2.5 µM 
preadenylated adaptor RA3 (Illumina) and 1x RNA ligase buffer without ATP 
(NEB), denature at 90 °C for 30 s, place on ice, add 1 µl of 1 µg/µl T4 RNA 
ligase 2 truncated K227Q (NEB) and incubate for 2-3 hours at 22 °C. As an 
efficiency control, a reaction containing ligation mixture and 19 nt RNA 
oligonucleotide should be separately performed. 
• Add 1 vol of 2x RNA loading buffer (Fermentas), denature by incubating at 90 °C 
for 30 s and resolve on 15% urea-PAGE in 1x TBE. Wrap gel in plastic wrap and 
expose to phosphorimager screen for 20 – 60 min. 
• Excise gel fragments containing bands corresponding to the ligated product size, 
generally between 40 and 70 nt, elute RNA by incubating in 0.4 M NaCl 
overnight at 4 °C on a rotating wheel and precipitate with 3 vol of absolute 
ethanol at -80 °C for 30 min and centrifuge at 14000 g for 30 min at 4 °C. Discard 
supernatant and wash pellets with 70% ethanol. Centrifuge at 10000 g for 10 min 
at 4 °C, discard supernatant and briefly (3-5 min) air-dry pellets at room 
temperature. 
• Resuspend pellets in 18 µl of 5’ ligation mix containing 5 µM 5’ adaptor (RA5, 
Illumina), and 1x RNA ligase buffer with 0.2 mM ATP, denature for at 90 °C for 
30 s , place on ice, add 2 µl of T4 RNA ligase 1 (Fermentas) and incubate at 37 
°C for 1 hour. 
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• Add 1 vol of 2x RNA loading buffer (Fermentas), denature by incubating at 90 °C 
for 30 s and resolve on 12% urea-PAGE in 1x TBE. Wrap gel in plastic wrap and 
expose to phosphorimager screen for 30 – 180 min. 
• Excise gel fragments containing fragments corresponding to the ligated product 
size, generally between 60 and 90 nt, elute RNA by incubating in 0.4 M NaCl 
with 1 µl of 100 µM reverse transcription primer (RTP, Illumina) overnight at 4 
°C on a rotating wheel and precipitate with 3 vol of absolute ethanol at -80 °C for 
30 min and centrifuge at 14000 g for 30 min at 4 °C. Discard supernatant and 
wash pellets with 70% ethanol. Centrifuge at 10000 g for 10 min at 4 °C, discard 
supernatant and briefly (3-5 min) air-dry pellets at room temperature. 
• Dissolve pellets in 5.6 µl of water, denature at 90 °C for 30 s, add 5x first strand 
buffer (Life technologies), dNTPs (final concentration 2.5 mM), DTT to final 
concentration of 10 mM, 0.75 µl Superscript III (Life technologies) reverse 
transcriptase and incubate at 42 °C for 1 hour. 
• Add 2U of RNase H (Fermentas) and incubate at 37 °C for 20 min. Bring the 
volume to 20 µl. 
• Perform a 100 µl pilot PCR with 2 µl of cDNA by collecting 12 µl aliquots of the 
PCR reaction every other cycle, starting at cycle 14. Evaluate the pilot PCR by 
2.5% agarose electrophoresis in 1x TBE and identify the cycle number where the 
product above the band corresponding to adaptor-adaptor starts appearing. 
• Perform a 400 µl large scale PCR reaction with the remaining cDNA, after 
ethanol precipitation resuspend in 1x DNA loading buffer, resolve by 2.5% 
agarose electrophoresis in 1x TBE, extract the PCR product corresponding to the 
ligated product, precipitate and subject to deep sequencing. 
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2.8.2 Buffers used in CLIP protocol 
NP40 lysis buffer: 50 mM HEPES, pH 7.5; 150 mM KCl; 2 mM EDTA; 1 mM NaF; 
0.5% (v/v) NP40; 0.5 mM DTT; protease inhibitor cocktail (Roche) 
citrate phosphate buffer:  4.7 g /l citric acid; 9.32 g/l Na2HPO4; pH 5.0 
IP washing buffer: 50 mM HEPES, pH 7.5; 300 mM KCl; 0.05% (v/v) NP40; 0.5 mM 
DTT; protease inhibitor cocktail (Roche) 
high salt wash buffer: 50 mM HEPES, pH 7.5; 500 mM KCl; 0.05% (v/v) NP40; 0.5mM 
DTT; protease inhibitor cocktail (Roche) 
crosslink washing buffer: 50 mM TrisHCl, pH 7.5; 20 mM EGTA; 0.5% (v/v) NP40 
PNK buffer: 50 mM TrisHCl, pH 7.5; 50 mM NaCl; 10 mM MgCl2; 5 mM DTT 
2x proteinase K buffer: 100 mM TrisHCl, pH 7.5; 150 mM NaCl; 12,5mM EDTA; 20% 
(w/v) SDS 
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3.1 SUMMARY 
PAPD5 is one of the seven members of the family of noncanonical poly(A) 
polymerases in human cells. PAPD5 was shown to polyadenylate aberrant pre-ribosomal 
RNAs in vivo, similar to degradation-mediating polyadenylation by the noncanonical 
poly(A) polymerase Trf4p in yeast. PAPD5 has been reported to be also involved in the 
uridylation-dependent degradation of histone mRNAs. To test whether PAPD5 indeed 
catalyzes adenylation as well as uridylation of RNA substrates, we analyzed the in vitro 
properties of recombinant PAPD5 expressed in mammalian cells as well as in bacteria. 
Our results show that PAPD5 catalyzes the polyadenylation of different types of RNA 
substrates in vitro. Interestingly, PAPD5 is active without a protein cofactor, whereas its 
yeast homolog Trf4p is the catalytic subunit of a bipartite poly(A) polymerase in which a 
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separate RNA- binding subunit is needed for activity. In contrast to the yeast protein, the 
C terminus of PAPD5 contains a stretch of basic amino acids that is involved in binding 
the RNA substrate. 
3.2 INTRODUCTION 
The addition of a poly(A) tail to the 39 end of mRNAs in the nucleus of 
eukaryotic cells is catalyzed by the classical or canonical poly(A) polymerases (PAPs) 
and is an important step during mRNA maturation. The poly(A) tail confers stability to 
the mRNA and allows transport out of the nucleus and efficient translation in the 
cytoplasm. In contrast, the functions of the so-called noncanonical PAPs or Cid1-like 
proteins (after the founding member of the family) are only partially understood. 
Enzymes of this group are involved in cytoplasmic polyadenylation of mRNAs, but also 
in polyadenylation-mediated degradation of RNAs, and some members of the family 
even catalyze the addition of uridyl residues to RNA substrates (Schmidt and Norbury, 
2010). Like the canonical PAPs, Cid1-like proteins belong to the superfamily of 
polymerase b-like nucleotidyl transferases. Canonical and noncanonical PAPs have 
similar catalytic and central domains but differ in their nucleotide- base recognition 
motif. Interestingly, only a few Cid1-like proteins contain an RNA-binding domain 
(Martin and Keller, 2007). 
One well-studied member of the Cid1-like protein family is Trf4p, a PAP 
involved in nuclear RNA surveillance in Saccharomyces cerevisiae. Polyadenylation of 
RNAs by Trf4p facilitates their subsequent degradation by the nuclear exosome, a 39–59 
exonuclease complex (Kadaba et al., 2004, Kadaba et al., 2006, Vanacova et al., 2005), 
or in some cases induces the processing of the RNA by exosome-catalyzed trimming of 
the 39 end (Egecioglu et al., 2006). A stimulatory effect of polyadenylation on the 
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exosome activity was first shown to allow efficient degradation of a hypomodified, 
unstable tRNA (LaCava et al., 2005, Vanacova et al., 2005). Later, rRNAs, snRNAs, and 
snoRNAs, as well as so-called cryptic unstable transcripts (CUTs), spliced-out introns, 
and different mRNAs were identified as substrates of this polyadenylation- mediated 
RNA quality-control mechanism (LaCava et al., 2005, Wyers et al., 2005, Davis and 
Ares, 2006, Dez et al., 2006, Egecioglu et al., 2006, Carneiro et al., 2007, Houseley et al., 
2007, San Paolo et al., 2009, Callahan and Butler, 2010). 
Trf4p lacks an RNA-binding domain and is therefore inactive on its own. In vivo 
it is part of the TRAMP4 complex that contains Trf4p as the catalytic subunit, one of the 
zinc knuckle proteins Air1p or Air2p, thought to confer the RNA-binding function to the 
complex, and the RNA helicase Mtr4p (LaCava et al., 2005, Vanacova et al., 2005). A 
similar complex, SpTRAMP, was identified in fission yeast (Win et al., 2006, Buhler et 
al., 2008). In Drosophila melanogaster, overexpression of a homolog of Trf4p was shown 
to lead to the polyadenylation of snRNAs (Nakamura et al., 2008), whereas the human 
homolog PAPD5 is involved in the polyadenylation-mediated degradation of aberrant 
pre-rRNAs (Shcherbik et al., 2010). 
The human PAPD5 protein was also reported to function in the degradation of 
replication-dependent histone mRNAs. These mRNAs do not have a poly(A) tail but end 
in a stem–loop structure. Here, however, the degradation pathway does not start with 
polyadenylation of the RNA, but with the addition of a short oligo(U) tail, which is 
recognized by the Lsm1-7 complex and subsequently leads to decapping and degradation 
of the mRNAs. A knock- down of either PAPD5 or of the mitochondrial poly(A) 
polymerase results in the stabilization of histone mRNAs (Mullen and Marzluff, 2008). 
However, this effect could not be observed by other investigators (Schmidt and Norbury, 
2010). Instead, the knockdown of the uridyl transferase ZCCHC11, a different member of 
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the human Cid1-like proteins, was shown to strongly reduce the oligouridylation of 
histone mRNAs, leading to their stabilization (Schmidt and Norbury, 2010). It is 
therefore possible that PAPD5, depending on the RNA substrate or the presence of 
different protein cofactors, can catalyze the polyadenylation as well as the 
oligouridylation of RNAs. To better understand the function of PAPD5, we set out to 
investigate the activity of the protein in vitro and to explore its function in mammalian 
cells through cross-linking and immunoprecipitation (CLIP) (Hafner et al., 2010). 
3.3 RESULTS 
3.3.1 PAPD5 is a poly(A) polymerase in vitro 
PAPD5 (UniProt accession number Q8NDF8) is involved in the polyadenylation 
of aberrant ribosomal RNA precursors in mouse (Shcherbik et al., 2010). In addition, it 
may also be responsible for the uridylation-mediated degradation of histone mRNAs 
(Mullen and Marzluff, 2008). However, this function of PAPD5 is controversial (Schmidt 
and Norbury, 2010). To test the activity of PAPD5 in vitro, the coding sequence was 
amplified from cDNA of HeLa cells. The protein was expressed in HEK293 cells as a 
fusion protein with an N-terminal Flag tag and a His8 tag. After cell lysis, the protein was 
bound to anti-Flag agarose, washed, and eluted with Flag peptide. The protein was further 
purified via nickel affinity chromatography (Figure. 1A). 
To test the nucleotidyltransferase activity of PAPD5, the oligoribonucleotide A15 
was incubated with the protein either in the presence of ATP, CTP, GTP, or UTP, or in a 
mixture of all four dNTPs (Figure. 2A). When PAPD5 and A15 were incubated in the 
presence of ATP, the incorporation of several nucleotides into the RNA substrate was 
observed. In contrast, the incorporation of the other three ribonucleotides was low and 
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limited to single residues, showing a strong preference of PAPD5 for ATP. In addition, 
PAPD5 is able to discriminate against dNTPs, as these were not used as substrates. 
3.3.2 PAPD5 does not need a cofactor for polyadenylation in vitro 
To further analyze the properties of PAPD5, the protein was expressed in 
Escherichia coli. To prevent contamination with bacterial poly(A) polymerase, an 
expression strain with a disruption in the gene for poly(A) polymerase was used. Two 
PAPD5 expression constructs were tested: a His6 fusion and a combination of a C-
terminal His6 tag and an N-terminal fusion of a GB1 tag that was shown to increase the 
solubility of recombinant proteins (Zhou et al., 2001). Because the activity of both wild-
type fusion proteins was the same but the yield of the GB1-tagged protein was higher, the 
latter construct was used for further experiments. The purified protein is shown in Figure 
1B. 
Trf4p, the poly(A) polymerase of the TRAMP4 complex in baker’s yeast, was 
previously shown to be inactive on its own. Trf4p contains no obvious RNA-binding 
domain and is believed to rely on the zinc-knuckle proteins Air1p or Air2p as the 
substrate-binding domain of the complex. Indeed, only the combination of Trf4p with 
either Air1p or Air2p has poly(A) polymerase activity (LaCava et al., 2005, Vanacova et 
al., 2005). 
Surprisingly, the bacterially expressed PAPD5 (Figure. 1B) showed the same 
activity as the protein purified from HEK293 cells. When the ribo-oligonucleotide A15 
was incubated with PAPD5 in the presence of different nucleotides, efficient 
incorporation could only be observed with ATP (Figure. 2A). A PAPD5 variant in which 
two aspartate residues (D177, D179) in the catalytic domain were exchanged to alanine 
could not catalyze the addition of nucleotides to the RNA substrate (PAPD5 DADA) 
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(Figure. 2B). Therefore, the observed polyadenylation activity is an intrinsic activity of 
PAPD5, and a protein cofactor is not needed for activity. 
The nucleotide incorporation experiment was repeated with other RNA substrates: 
Ribo-oligonucleotide G2U15 was used to test whether the last nucleotide of the RNA 
primer influences the specificity for the nucleotide substrate (Figure. 2C). In addition, in 
vitro–synthesized tRNAiMet (a known substrate for yeast Trf4p) and an in vitro–
synthesized fragment of the 39 UTR of mouse histone H2a mRNA comprising the stem–
loop structure were tested as substrates (results not shown). Again, only AMP 
incorporation could be observed. Therefore, the specificity for ATP incorporation does 
not depend on the last nucleotide of the RNA primer but results from nucleotide 
specificity of the protein. The specificity for ATP incorporation was also observed when 
a reaction buffer containing manganese instead of magnesium was used (results not 
shown). 
As reported for yeast Trf4p (LaCava et al., 2005), the polyadenylation reaction 
catalyzed by PAPD5 is not processive: In all cases, the reaction products were 
heterogeneous in size, the smallest product usually corresponding to the incorporation of 
a single nucleotide. When DNA oligonucleotides were used as primers, none of the 
nucleotide substrates was incorporated (results not shown), showing that the reaction is 
RNA-specific. 
3.3.3 A C-terminal stretch of basic amino acids is involved in binding of the RNA 
primer 
The amino acid sequence of PAPD5 does not contain any motif known to bind 
nucleic acids. However, the poly- adenylation activity of PAPD5 observed in vitro and in 
the absence of other protein cofactors argues for the presence of a domain in the protein 
that is involved in binding of the RNA substrate. To analyze the RNA binding of PAPD5, 
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electrophoretic mobility shift experiments were performed. PAPD5 was incubated with in 
vitro– synthesized tRNA, and the reaction mixture was resolved on a nondenaturing 
polyacrylamide gel. Indeed, a shift of the RNA band to a band of lower mobility could be 
observed, showing that PAPD5 is able to bind RNA. To determine which part of the 
protein is responsible for RNA binding, protein variants comprising only the N terminus 
including the catalytic domain (amino acids 1–111, PAPD5 N), the central domain 
(amino acids 112–368, PAPD5 M), or the C terminus of PAPD5 (amino acids 369–572, 
PAPD5 C1) were analyzed separately. Of these, only the C-terminal part, PAPD5 C1, 
could shift the tRNA (Figure. 3), indicating the presence of an RNA-binding function in 
the C terminus of PAPD5. 
Inspection of the amino acid sequence showed the C terminus of human PAPD5 
to contain a stretch of basic amino acids (amino acids 557–563), a motif that is conserved 
among higher eukaryotes, but not in the yeast protein Trf4p (Figure. 4). To test the 
influence of the basic motif on the RNA-binding ability of PAPD5, a deletion variant of 
the C-terminal part lacking this motif was used (amino acids 369–551, PAPD5 C2). 
Whereas the C terminus binds to RNA (Figure. 3, PAPD5 C1), the deletion variant 
showed no shift of the RNA in EMSA experiments, even when used in higher 
concentrations than the original C-terminal fragment (Figure. 3, PAPD5 C2). 
Next, we wanted to analyze the influence of this basic amino acid stretch on the 
catalytic activity of PAPD5. Therefore, a protein variant PAPD5DC, comprising amino 
acids 1–551, i.e., lacking only the basic stretch, was constructed and tested for 
polyadenylation activity. In addition, a point mutant of PAPD5 was constructed in which 
a lysine residue in the basic domain was exchanged to glutamate (PAPD5 K560E). The 
variants were expressed in E. coli and purified as the wild-type protein. For both variants, 
the yield of soluble protein was comparable to the wild type. In comparison to the wild-
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type protein, both variants showed a reduced activity when incubated with the A15 
substrate in the presence of ATP, resulting in fewer incorporated nucleotides and 
therefore shorter polyadenylation products (Figure. 5). 
To further examine the influence of the basic stretch of amino acids on the 
polyadenylation activity of PAPD5, the wild-type protein and the variants were incubated 
with different concentrations of either ATP or A15 substrate to determine the kinetic 
parameters of the reaction. To this end, radioactive ATP was used as nucleotide substrate, 
and the radioactively labeled reaction products were separated from nonincorporated 
nucleotides with DE81 filters. The polyadenylation activity was measured as total 
incorporation of nucleotides into the A15 substrate, independent of the length of the 
resulting product. 
When the concentration of the RNA substrate A15 was varied, the maximal 
velocities for the wild-type protein and the variants were similar (data not shown). 
However, the KM of the proteins with changes in the C-terminal basic motif was 
increased by a factor of z3 to 5. In contrast, there was no significant difference in the 
apparent affinity for ATP. The concentration of ATP during A15 titration was in much 
higher excess than the concentration of the RNA primer when ATP was titrated; 
therefore, the kcat values determined by titration of ATP are lower than the values 
observed for the titration of A15. This result con- firms the participation of the stretch of 
basic amino acids in the binding of the RNA substrate by PAPD5. 
3.3.4 Specificity for RNA structure 
The yeast TRAMP complex was shown to specifically polyadenylate unmodified 
initiator tRNA, but not the native and therefore fully modified tRNA (Vanacova et al., 
2005). This is thought to be a result of a more compact tertiary structure of the native 
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tRNA. It was shown recently that a core complex consisting of the central part of Trf4p 
and two out of the five zinc knuckles of Air2p is sufficient to discriminate between the 
two tRNA substrates (Hamill et al., 2010). To test whether PAPD5 shows a similar 
ability, PAPD5 purified from HEK293 cells as well as bacterially expressed PAPD5 were 
incubated with either in vitro–synthesized yeast tRNAiMet or the native tRNA purified 
from yeast cells in the presence of ATP. Interestingly, both enzyme preparations were 
able to polyadenylate the in vitro transcript but not the native tRNA, whereas at the same 
time E. coli poly(A) polymerase polyadenylated both tRNA substrates (Figure. 6; results 
not shown). Therefore, similarly to the yeast Trf4p, PAPD5 seems to be sensitive to the 
structure of the RNA substrate. 
3.3.5 Subcellular localization of PAPD5 
In yeast, Trf4p is part of a RNA surveillance machinery residing in the nucleus. 
To determine the localization of PAPD5, the protein was detected in cells expressing 
Flag- tagged PAPD5 with anti-Flag antibody followed by a secondary antibody 
conjugated to a fluorescent dye (Figure. 7A). In addition, PAPD5 fusion proteins with 
green fluorescent protein (GFP) fused to the N or C terminus were expressed transiently 
(Figure. 7B and 7C). All fusion proteins were detected in the nucleus as shown by 
colocalization of the fluorescence signals with the DAPI stain, no staining of the 
cytoplasm could be observed. The basic stretch of amino acids at the C terminus of 
PAPD5 that is involved in RNA binding does not play a role for localization of PAPD5, 
because a Flag- tagged deletion variant corresponding to PAPD5DC, i.e., lacking the 
basic stretch, is still exclusively located in the nucleus (Figure. 7D). 
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3.3.6 Ribosomal RNAs are in vivo targets of PAPD5 
PAPD5 was able to polyadenylate a variety of RNA substrates in vitro, ranging 
from oligo(A) and oligo(U) to different tRNAs as well as the 39 UTR of histone mRNAs. 
To determine the potential substrate spectrum of PAPD5 in vivo, RNAs bound to the 
protein in HEK293 cells were probed by the PAR-CLIP technique (Hafner et al., 2010). 
Briefly, HEK293 cells expressing Flag-tagged PAPD5 were grown in medium containing 
4-thio-uridine and RNA– protein complexes were UV-cross-linked and 
immunoprecipitated. The covalently bound RNAs were extracted, adapter 
oligonucleotides were ligated to the 59 and 39 ends, and the RNA was reverse-
transcribed. The cDNA was amplified and the sequences determined by deep sequencing. 
We then compared the results obtained in two separate PAPD5 PAR-CLIP experiments 
and those previously obtained for the insulin growth factor 2 binding protein 1 
(IGF2BP1) (Hafner et al., 2010) to identify genomic regions from which PAPD5 targets 
derive. The IGF2BP1 PAR-CLIP sample contained 24,914,594 reads and the PAPD5 
PAR- CLIP samples 4,949,000 and 5,563,677 reads, respectively. The proportion of 
reads mapping with at most one error to the human genome was 45.64% in the case of 
IGF2BP1 and 32.77% and 27.13% for PAPD5 replicates. We normalized the count of 
mapped reads across samples and calculated the number of reads originating in each 100-
nt- long window of the genome, and the variance of these counts in the PAPD5 PAR-
CLIP replicates with the method described by Balwierz et al. (Balwierz et al., 2009). We 
then computed the Z-score indicating the significance of the enrichment or depletion in 
reads in a PAPD5 sample compared to the IGF2BP1 sample. The distributions of the Z-
scores across all genomic regions (Figure. 8) show a much higher similarity of PADP5 
replicates relative to the IGF2BP1 sample. With cut-off values of -5 and 5, at which only 
a very small number of genomic regions will be considered differentially represented 
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between PAPD5 replicates, we obtained 988 regions for the first PAPD5 replicate and 
923 for the second (data not shown) that were differentially expressed relative to 
IGF2BP1. Four hundred thirty-four regions were differentially expressed between both 
PAPD5 replicates and the IGF2BP1 sample. Of these, 358 regions were enriched, 
whereas 76 were depleted in PAPD5 samples. One hundred ninety-two out of the 358 
enriched windows corresponded to repeat elements, 61 of which were rRNA. These latter 
windows were located in genomic regions annotated as rRNA-like in the Genome 
Browser of the University of California Santa Cruz. They contained reads that we also 
annotated as rRNA-derived, based on the fact that they mapped with at most one error to 
the rRNA subunits. In contrast, only two of the 76 regions depleted in PAPD5 binding 
had rRNA annotations (Fisher’s exact test, p < 0.001), indicating that rRNAs could be the 
primary targets of PAPD5 in human cells. 
3.4 DISCUSSION 
PAPD5 belongs to the family of Cid1-like proteins or noncanonical PAPs. In this 
family of nucleotidyltransferases, several members do not contain a recognizable RNA- 
binding domain. For the noncanonical PAP Trf4p from yeast, it was shown that 
nucleotidyltransferase activity can only be observed for the complex of Trf4p and one of 
the two zinc-knuckle proteins Air1p or Air2p, but not for Trf4p alone (LaCava et al., 
2005, Vanacova et al., 2005). Therefore, it is thought that Trf4p is the catalytic subunit of 
this bipartite PAP, whereas the zinc-knuckle proteins confer RNA- binding specificity to 
the complex. Such a modular organization of a catalytic subunit that could even be 
combined with different RNA-binding subunits to result in an active 
nucleotidyltransferase may allow the targeting of different classes of substrates, 
depending on the RNA-binding subunit used. For the TRAMP4 complex in yeast, it was 
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shown that two out of the five zinc knuckles of Air2p are necessary and sufficient for the 
polyadenylation of a short RNA oligonucleotide. How- ever, efficient polyadenylation of 
a tRNA required the most N-terminal zinc knuckle in addition. Although the other two 
zinc knuckles seem to be dispensable for the tRNA substrate, they may be important for 
the recognition of other TRAMP substrates (Hamill et al., 2010). 
Surprisingly, PAPD5, a human Trf4p homolog lacking a recognizable RNA-
binding domain, is able to catalyze the addition of nucleotides to RNA substrates in the 
absence of a protein cofactor. Analysis of the amino acid sequence revealed a stretch of 
basic residues in the C terminus of PAPD5 that is highly conserved among higher 
eukaryotes. When this motif was deleted, the nucleotidyltransferase activity was strongly 
reduced, and both electrophoretic mobility shift experiments and the analysis of the 
activity of a point mutant in this part of the protein showed the stretch of basic amino 
acids to take part in binding of the RNA substrate. PAPD5 was able to incor- porate 
nucleotides to different RNA substrates [oligo(A), oligo(U), tRNA, histone mRNA 39 
end], therefore the RNA-binding function is very likely not sequence-specific, resulting 
in polyadenylation of all RNAs with a free 39-hydroxyl end in vitro. However, like the 
yeast TRAMP complex, PAPD5 discriminates between in vitro–synthesized, unmodified 
and native, fully modified tRNAs. Very likely, this is due to a difference in the stability 
of the RNA structure, resulting in the 39 end of the in vitro transcript being more 
accessible to the poly(A) polymerase. PAPD5 has been shown to be involved in the 
polyadenylation of aberrant ribosomal RNAs: Aberrant pre-rRNAs were found to be 
partially polyadenylated in a murine cell line by reverse transcription with an oligo(dT)-
adapter primer followed by PCR with a forward primer specific for the 59-ETS region of 
pre-rRNA. After knockdown of PAPD5, the amount of polyadenylated pre-rRNAs was 
decreased (Shcherbik et al., 2010). In agreement with this finding, the analysis of RNAs 
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cross-linked to PAPD5 in vivo revealed rRNAs to be potential substrates of PAPD5. 
Ribosomal RNAs were represented in the potential RNA substrates in a high percentage, 
and they were specifically enriched in the PAPD5 samples compared to a control 
IGF2BP1 sample. The same was shown for Trf4p-associated RNAs in yeast: 50% of the 
sequences identified by an in vivo cross-linking approach were mapped to ribosomal 
sequences (Wlotzka et al., 2011). In addition, other classes of noncoding RNAs as well as 
pre-mRNAs and mRNAs were found to be associated with PAPD5. Although in Trf4-
deletion yeast strains as well as in the cross-linking approach the same classes of RNAs 
were found to be enriched, the relative proportions of these transcript types were different 
from that found here for PAPD5 (San Paolo et al., 2009, Wlotzka et al., 2011), and in the 
PAPD5 samples such targets were not robustly enriched. Whereas in yeast only two 
noncanonical poly(A) polymerases are present, human cells contain seven members of 
this protein family. Therefore, other noncanonical poly(A) polymerases may be involved 
in the polyadenylation of other aberrant RNAs. 
The catalytic parameters observed for the wild-type PAPD5 protein (data not 
shown) are similar to the values determined for bacterial poly(A) polymerase, an enzyme 
also involved in RNA degradation (Li et al., 1998, Li et al., 2002). In contrast, canonical 
poly(A) polymerases show higher maximal velocity even under distributive reaction 
conditions, reflecting the function of the two different types of polyadenylation. Whereas 
the canonical poly(A) polymerases add long tails that are immediately bound by poly(A)-
binding proteins and allow protection of the mRNA from degradation, polyadenylation-
mediated degradation is characterized by the addition of short tails as well as distributive 
polyadenylation to allow access of the degradation machinery. 
In the cell, noncoding RNAs as well as mRNAs are bound by proteins during 
processing and reside in RNPs to perform their function. In contrast, aberrant RNAs or 
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processing intermediates that—due to misfolding or misprocessing—cannot form the 
correct interactions to protein partners would be accessible for polyadenylation and 
degradation. Therefore, PAPD5 could act as a kind of scavenger enzyme, similar to the 
TRAMP4 complex in yeast, to polyadenylate RNA 39 ends and thereby tag the 
corresponding RNA for degradation. Like yeast Trf4p, PAPD5 is located in the nucleus 
of the cell and may therefore be part of a nuclear surveillance machinery similar to the 
TRAMP4–exosome system of yeast. In contrast to Trf4p, PAPD5 is able to bind different 
RNAs, and when His-Flag-tagged PAPD5 was purified from mammalian cells, no 
copurifying RNA-binding proteins could be identified by mass spectrometry. However, it 
still remains to be determined whether protein cofactors are necessary for the efficient 
binding of PAPD5 to substrates, as has been shown for TRAMP4. 
When the levels of several of the putative substrates identified by the CLIP 
experiments were analyzed in cells treated with siRNAs directed against PAPD5 or 
control siRNA, no significant change could be observed (results not shown). However, 
mammalian cells contain genes for seven proteins of the Cid1-like family. PAPD7, one of 
these homologs, is very similar to PAPD5. If more than one of these non- canonical PAPs 
are able to target the same RNAs, depletion of the cell of a single PAP may not lead to a 
detectable change in the RNA level. It has been observed for poly(A) and A-rich tails on 
human rRNA that the knockdown of a single noncanonical PAP does not abolish tail 
addition (Slomovic et al., 2010). Therefore, the RNA surveillance system is most likely 
redundant, allowing potentially deleterious aberrant RNAs to be degraded with high 
efficiency. 
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3.5 MATERIALS AND METHODS 
3.5.1 Expression and purification of PAPD5 
The coding sequence of PAPD5 was amplified from HeLa cell cDNA. The ORF 
was cloned into pcDNA5/FRT for expression as a fusion protein with N-terminal His8 
and Flag tags in mammalian cells. For expression, an HEK293 cell line, Flp-In-293 
(Invitrogen), was used. Cells were cultivated in DMEM medium containing 10% fetal 
calf serum, and cell lines expressing PAPD5 were selected according to the 
manufacturer’s instructions. For analysis of the subcellular localization, PAPD5 was 
transiently expressed as an N- or C-terminal GFP fusion protein or with a Flag tag. For 
detection of Flag-tagged protein, cells were permeabilized, and the fusion protein was 
stained with mouse anti-Flag antibody (Sigma) and Cy3-conjugated donkey anti-mouse 
antibody (Dianova). 
For expression in E. coli, the ORF of PAPD5 was cloned into pET30 for 
expression as a fusion protein with an N-terminal GB1 tag and a C-terminal His6 tag 
(Zhou et al.) or into pETDuet (Novagen) for expression as a C-terminal His6-tag fusion 
protein. A BL21 (DE3) strain deficient for E. coli poly(A) polymerase was constructed 
with the TargeTron Gene Knockout System (Sigma-Aldrich). The strain was transformed 
with the corresponding expression plasmids, grown in LB medium at 37°C to an OD600 
of 0.8, and expression of PAPD5 was induced with 1 mM IPTG for 3 h. 
For purification of the protein from mammalian cells, the cells were lysed by 
sonication in buffer containing 50 mM Tris (pH 7.5), 100 mM KCl, 10% glycerol, 0,05% 
NP-40, 1 mM PMSF, 1 mg/L Pepstatin, and 1 mg/L Leupeptin. The cleared lysate was 
incubated with M2 anti-Flag agarose (Sigma-Aldrich). The matrix was washed with lysis 
buffer containing 300 mM KCl, and the protein was eluted with lysis buffer containing 5 
mM Flag peptide. The eluate was adjusted to 5 mM imidazole, bound to Ni-NTA agarose 
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(Sigma- Aldrich), washed with buffer containing 25 mM imidazole, and the protein was 
eluted with buffer containing 250 mM imidazole. 
The protein expressed in E. coli was purified via metal chelating chromatography 
like the protein expressed in mammalian cells, but the cell lysate was adjusted to 25 mM 
imidazole, and the washing buffer contained 500 mM KCl and 50 mM imidazole. 
3.5.2 RNA substrates 
A plasmid ptRNAMet for the in vitro transcription of yeast tRNAiMet was 
obtained from Dr. Bruno Senger (Institut de Biologie Moleculaire et Cellulaire 
Strasbourg). The plasmid was linearized with BstNI and transcribed with T7 RNA 
polymerase. The native yeast tRNAMet was a gift of Dr. Gerard Keith (Institut de 
Biologie Mole ́culaire et Cellulaire Strasbourg). The plasmid pUC19-H2a for in vitro 
transcription of the mouse histone H2a mRNA 39 end with T7 RNA polymerase was 
obtained from Dr. Sophie Jaeger (Biozentrum, University of Basel). In vitro– transcribed 
RNAs were purified on 8.3 M urea/10% polyacrylamide gels. For 59-end labeling, RNAs 
were treated with alkaline phosphatase and labeled with [g-32P]ATP (GE Healthcare) 
and T4 polynucleotide kinase. Labeled RNAs were gel-purified. To allow folding of the 
structured RNAs, pellets were dissolved in RNase-free water and incubated for 1 min at 
65°C, followed by incubation for 10 min on ice after the addition of an equal volume of 
twice-concentrated assay buffer containing 10 mM MgCl2. 
3.5.3 Polyadenylation assays 
Polyadenylation assays were carried out in 20-mL reaction mixtures containing 
0.07–0.7 pmol of affinity-purified protein, 1 pmol of 59-end-labeled RNA, 1 mM ATP, 5 
mM MgCl2, 25 mM Tris-HCl (pH 7.5), 50 mM KCl, 0.01 mM EDTA, 0.1 mg/mL BSA, 
1 mM DTT, and 0.02% NP-40. Reactions were incubated for 30 min at 37°C or the times 
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indicated and stopped by the addition of 25 mM EDTA. The RNA was precipitated by 
addition of 0.1 volume of 3 M ammonium acetate and three volumes of ethanol. Pellets 
were resuspended in formamide loading buffer and separated on denaturing poly- 
acrylamide gels. Radioactivity was scanned with a PhosphorImager, and results were 
analyzed with ImageQuant software (Molecular Dynamics). 
For determination of the kinetic parameters, the activities of PAPD5 variants were 
measured in 20-mL reaction mixtures containing buffer as above with 0.2 mCi of [a-
32P]ATP (3000 Ci/mmol) and 0.7–3.5 pmol (0.035–0.17 mM) recombinant protein. The 
concentration of ATP was varied be- tween 0.01 mM and 1 mM (the concentra- tion of 
A15 was kept constant at 2.5 mM), and the concentration of unlabeled RNA A15 was 
varied between 50 nM and 2.5 mM (ATP was kept constant at 1 mM). The reactions were 
incubated for 20 min at 37°C and stopped by spotting onto DE-81 paper. The filters were 
washed three times for 10 min in 0.3 M ammonium formate/10 mM Na-pyrophosphate, 
and the incorporated radioactivity was measured in a scintillation counter. 
3.5.4 EMSA 
Electrophoretic mobility shift assays (EMSAs) were carried out in 20-mL reaction 
mixtures containing 0.5–20 nM of affinity-purified protein, 1 nM 59-end-labeled RNA, 
10% glycerol, and 1 mg/L total yeast RNA in buffer as above. Reactions were incubated 
for 10 min at room temperature and separated on a native 6% polyacryl- amide gel in 
0.53 TBE. Radioactivity was scanned with a PhosphorImager, and results were analyzed 
with ImageQuant software (Molecular Dynamics). 
3.5.5 PAR-CLIP 
RNAs bound to PAPD5 in vivo were analyzed by the PAR-CLIP technique 
essentially as described in Hafner et al. (Hafner et al.). Flp-In-293 cells expressing His8-
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Flag-PAPD5 were grown in medium containing 100 mM 4-thiouridine, RNA–protein 
complexes were cross- linked by exposure of the cells to UV light (366 nm, 150 
mJ/cm2), and lysed in buffer containing 50 mM HEPES (pH 7.4), 150 mM KCl, 2 mM 
EDTA, 1 mM NaF, 0.5% NP-40, 0.5 mM DTT, 1 mM PMSF, 1 mg/L Pepstatin, and 1 
mg/L Leupeptin. After removal of cell debris by centrifugation, the cleared lysate was 
incubated with RNase T1 to allow bound RNAs to be partially digested to an average size 
of 40 to 60 nt. 
RNA–protein complexes were isolated with M2 anti-Flag an- tibody (Sigma-
Aldrich) coupled to protein G Dynabeads (Invitrogen). The RNA–protein complexes 
were gel-purified, the RNA was isolated, and linkers were ligated to the 59 and 39 ends 
of the RNA (Hafner et al.). After reverse transcription and amplification, the resulting 
DNA library was sequenced by Solexa sequencing. Mapping of short reads to the genome 
(hg18 assembly version from the University of California, Santa Cruz obtained from 
hgdownload.cse.ucsc.edu) following adaptor removal was performed as described 
(Hafner et al.). 
3.5.6 Normalization and multiplicative error model in PAR-CLIP 
To compare the expression of genomic regions across samples, the number of 
reads needs to be normalized across samples. With several types of high-throughput 
expression profiling approaches such as SAGE (serial analysis of gene expression), 
CAGE (cap analysis of gene expression), and chromatin immunoprecipitation (ChIP), it 
has been reported that the number of reads originating from a genomic position or region 
has a power-law distribution (Ueda et al., Zhang et al., Balwierz et al.). We found that the 
same holds for our PAR-CLIP data, which we then analyzed as follows. We split the 
genome into 100-nt-long windows and calculated the number of reads originating in each 
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of these regions in the IGF2BP1 CLIP samples obtained by Hafner et al. (Hafner et al.) 
and in our two PAPD5 replicates. The reverse cumulative distribution of the read count in 
a window (showing the number of windows with a read count at least as high as a given 
value, which is indicated on the x-axis) was power-law-distributed (data not shown). We 
standardized these distributions by transforming them to a reference power law 
distribution with slope -1.25 and a total copy of 1 million reads, as described (Balwierz et 
al.). The resulting normalized reverse cumulative distributions are shown in 
Supplemental Figure S1B. Based on the normalized read counts, we estimated the 
variance in read count per window between the PAPD5 replicates to be 0.41. In contrast, 
the variances between first and second PAPD5 replicates and IGF2BP1 were estimated to 
be 0.91 and 1.03, respectively. 
3.5.7 Enrichment and depletion of reads in genomic regions in PAR-CLIP 
Using the estimated variance above, we calculated the Z-scores for the difference 
in expression between PAPD5 reads and IGF2BP1 reads in 100-nt-long overlapping 
genomic windows as described in Balwierz et al. (Balwierz et al.). Inspecting the 
pairwise Z-score distributions, we chose a cut-off value of 5 and -5 for regions that are 
enriched and depleted, respectively, in the PAPD5 relative to the IGF2BP1 samples. 
3.5.8 Annotation of the sequences 
To determine whether the enriched or depleted regions over- lapped known 
elements of the genome, we intersected the genome coordinates of the regions with those 
of annotated functional elements (UCSC RepeatMasker, mRNA and noncoding RNA 
tracks for hg18 assembly version) (Smit et al., Pruitt et al., Lestrade and Weber, Griffiths-
Jones et al.). If the overlap was at least 20 nt, we transferred the annotation of the 
genomic element to the region that was enriched/depleted in CLIP. 
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Figure 1. PAPD5 preparations used in the analysis. (A) PAPD5 was expressed as fusion 
protein with N-terminal His8 and Flag tag in HEK293 cells and purified via anti-Flag 
agarose (Flag), followed by metal chelating affinity chromatography (Flag + NiNTA). 
PAPD5 is marked by an arrowhead. (B) Bacterially expressed PAPD5 after metal 
chelating affinity chromatography (for details, see Materials and Methods). 
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Figure 2. PAPD5 preferentially adds AMP residues to RNA substrates. (A) PAPD5 
preparations from HEK293 cells (HEK293) or recombinant protein expressed in E. coli 
(rec.) were incubated with ribo-oligonucleotide A15 in the presence of ATP (A), CTP 
(C), GTP (G), UTP (U), or a mixture of all four dNTPs (dN), respectively. (B) PAPD5 
wild-type protein (wt) or catalytic site mutant (DADA) expressed in E. coli were 
incubated with ribo- oligonucleotide A15 in the presence of ATP. (C) PAPD5 expressed 
in E. coli was incubated with ribo-oligonucleotide G2U15 in the presence of ATP (A), 
CTP (C), GTP (G), UTP (U), or a mixture of all four dNTPs (dN), respectively. Lane 1 
always shows the RNA substrate incubated in the absence of protein. 
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Figure 3. The C terminus of PAPD5 is involved in RNA binding. (A) Schematic 
representation of the truncation variants of PAPD5 tested for RNA binding. (B) 
Electropho- retic mobility shift assay of PAPD5 variants. Increasing amounts of PAPD5 
full-length protein or fragments comprising the N terminus, central part, or C terminus of 
the protein were incubated with radioactively labeled in vitro–synthesized human 
tRNAiMet, and the reactions were resolved on a native polyacrylamide gel. Protein 
concentrations between 0.5 and 5 nM were tested for the full-length protein and the 
protein PAPD5 C2, 1–20 nM for the other variants. Lane 1 shows the tRNA after 
incubation in the absence of protein. 
 
 65 
 
Figure 4. The basic motif in the C terminus of PAPD5 is conserved among higher 
eukaryotes. Amino acid sequences of PAPD5 homologs (Ensembl) were aligned with 
ClustalW (Chenna et al.) and refined manually (upper panel). The amino acid sequence 
of the yeast protein Trf4p is shown for comparison (lower panel). Basic amino acids are 
labeled in blue, acidic amino acids in red. 
 
Figure 5. Mutations in the basic motif of PAPD5 lead to loss of activity. PAPD5 wild-
type protein (wt), C-terminal deletion mutant (DC, amino acids 1–551), or a point mutant 
in the basic motif (KE, position 560) expressed in E. coli were incubated with ribo-
oligonu- cleotide A15 in the presence of ATP. 
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Figure 6. PAPD5 adds poly(A) tails to the unmodified in vitro transcript of S. cerevisiae 
tRNAiMet, but not to the native tRNA isolated from yeast. PAPD5 protein expressed in 
E. coli (PAPD5 rec.) or in HEK293 cells was incubated with the different RNA substrates 
in the presence of ATP, and the reactions were stopped after the reaction times indicated 
(0, 10, 20, 40, 60 min). 
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Figure 7. PAPD5 is located in the nucleus. (A) PAPD5 was expressed as a fusion protein 
with N-terminal His8-Flag tag in HEK293 cells. The protein was detected with anti-Flag 
antibody and Cy3-conjugated secondary antibody. Nuclei stained with DAPI (left panel); 
the tagged protein signal (middle); the merged picture (right panel). (B,C) PAPD5 was 
expressed as a fusion protein with green fluorescent protein fused to the N terminus (B) 
or the C terminus (C). Panels as in A. (D) PAPD5DC (amino acids 1–551) was expressed 
as a fusion protein with N-terminal His8-Flag tag in HEK293 cells. The protein was 
detected with anti-Flag antibody and Cy3-conjugated secondary antibody. Panels as in A. 
DAPI stain of the nucleus (blue), Cy3 staining (red), and GFP signal (Smit et al.). 
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Figure 8. Distribution of pairwise Z-scores computed for 100-nt-long windows in pairs of 
samples. The reads obtained in two separate PAPD5 PAR-CLIP experiments as well as 
those previously obtained for the insulin growth factor 2 binding protein 1 (IGF2BP1) 
(Hafner et al.) were mapped to the genome. After normalization, the Z-scores, giving a 
measure of the differential expression of individual 100-nt-long windows in each pair of 
experiments, were calculated. 
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4.1 SUMMARY 
Processing of noncoding RNAs in eukaryotes involves the 3' to 5' 
exoribonucleolytic activity of type II ribonucleases that are part of the exosome complex. 
While in yeast it is known that the catalytic activity resides in Rrp44/Dis3 subunit, the 
functions of the three human Dis3 homologs have not been well characterized. In this 
work we aimed to uncover the physiological RNA targets of DIS3L2, the DIS3 homolog 
whose mutation is at the origin of the Perlman syndrome. We show that DIS3L2 is an 
exosome-independent cytoplasmic exoribonuclease, and through crosslinking and 
immunoprecipitation followed by RNA sequencing, we demonstrate that DIS3L2 is 
involved in the formation of tRNA-derived small RNAs (tRFs). A fraction of DIS3L2 
along with its tRFs associates with ribosomes and DIS3L2 overexpression alters the 
polysome/monosome ratio, suggesting that DIS3L2 is involved in translational 
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regulation. Most importantly, we found that the DIS3L2-dependent tRNA-derived 
fragments associate with Argonaute2 (AGO2) pointing to a crosstalk between the 
DIS3L2-dependent processing of tRNAs and AGO2-dependent regulation of gene 
expression the human cells. 
4.2 INTRODUCTION 
Every minute, living cells produces millions of RNA molecules. This rapid RNA 
production is balanced by equally rapid trimming and degradation, and it is this interplay 
that maintains a proper RNA homeostasis and allows cells to respond to new stimuli. The 
amount of protein that is produced from an mRNA is proportional to the lifetime of the 
mRNA, which is directly related to its turnover rate. Thus, mRNA degradation is a key 
step in gene expression that is subjected to extensive regulation, particularly through 
Argonaute protein-bound miRNAs (reviewed in (Czech and Hannon, 2011, Lee et al., 
1993, Wightman et al., 1993)). miRNAs are only one class of small RNAs that have been 
uncovered in studies employing deep sequencing. Other small RNAs derive from well-
known non-coding RNAs (ncRNAs) such as tRNAs, snoRNAs and/or rRNAs (Cole et 
al., 2009, Lee et al., 2009, Li et al., 2008, Li et al., 2012) 
These small RNAs do not appear to be exclusively unstable degradation 
intermediates. tRNAs in particular, give rise to fragments that are stably present in 
various cell types, and this lead to the emergence of the paradigm of tRNA-derived small 
RNAs having additional biological functions (Jochl et al., 2008, Thompson et al., 2008, 
Thompson and Parker, 2009, Yamasaki et al., 2009, Heyer et al., 2012). In various 
studies and depending on the processing pattern, tRNA fragments have acquired different 
names; the shorter, 20-30 nucleotide (nt) long stable forms originating from 5' or 3' tRNA 
ends or pre-tRNA trailers were called tRFs, or tsRNAs (Lee et al., 2009, Haussecker et 
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al., 2010, Heyer et al., 2012), while the longer, 30-50 nt stress-induced fragments were 
called tiRNAs (Yamasaki et al., 2009, Emara et al., 2010), sitRNAs (Li et al., 2008) and 
tRNA halves (Jochl et al., 2008, Thompson et al., 2008, Fu et al., 2009). Little is known 
however about the physiological significance of this diverse set of tRNA-derived 
fragments. The tiRNAs appear able to displace translation initiation factors eIF4G/eIF4A, 
eIF4F from capped and uncapped mRNAs (Yamasaki et al., 2009, Ivanov et al., 2011), 
thereby inhibiting translation. Some tRNA (but also other non-coding RNA)-derived 
fragments were found to associate with Argonaute 2 (AGO2), the effector protein of the 
RNA-induced Silencing Complex (RISC), indicating that they could have miRNA-like or 
siRNA-like functions (Haussecker et al., 2010, Li et al., 2012). 
Mechanisms responsible for generating short RNA fragments have also started to 
emerge. For example, Angiogenin has been identified as the key enzyme responsible for 
the cleavage of tRNAs (Saxena et al., 1992, Fu et al., 2009) upon the exposure of cells to 
various stress conditions (Thompson et al., 2008, Fu et al., 2009, Li et al., 2012). 
Enzymes such as DICER (Cole et al., 2009), the cytoplasmic form of RNase Z (Takaku et 
al., 2003, Elbarbary et al., 2009a, Elbarbary et al., 2009b, Lee et al., 2009), and RNase A 
(Li et al., 2012) have also been linked to the production of short tRNA-derived 
fragments. Through endonucleolytic cleavage, these enzymes often generate extended 
products that need to be further digested exonucleolytically to yield the tRFs that are 
typically detected through RNA sequencing. 
Processing of non-coding RNAs in eukaryotes involves 3' to 5' exoribonucleolytic 
trimming catalyzed by the exosome complex that contains a type II nuclease (RNase II) 
(Mitchell et al., 1997). In yeast, the exosome consists of ten core subunits, all of which 
are essential. Nine of the subunits are catalytically inactive (Vanacova and Stefl, 2007)) 
and form a barrel-shaped structure, while the tenth subunit, Rrp44 (also known as Dis3), 
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carries the nuclease activity (Liu et al., 2006, Dziembowski et al., 2007, Schneider et al., 
2007). Exosomes operate in both nucleus and cytoplasm, being involved in RNA 
interference, processing, maturation and turnover as well as in RNA surveillance 
pathways that recognize and degrade aberrant RNAs (Houseley and Tollervey, 2009)). In 
the cytoplasm, the exosome is responsible for degradation of unstable mRNAs containing 
AU-rich sequence elements and of defective mRNAs that are detected by quality control 
pathways such as nonsense- or nonstop-mediated mRNA decay (Houseley et al., 2006, 
Houseley and Tollervey, 2009)). The nuclear exosomes of S. cerevisiae additionally 
contain a non-essential 3' to 5' exonuclease, termed Rrp6 (Vanacova and Stefl, 2007). 
The human genome encodes three Rrp44/Dis3 homologs: DIS3, DIS3L and 
DIS3L2, which slightly differ in domain composition (Figure 1A). The DIS3 and DIS3L 
proteins associate with the nuclear and cytoplasmic exosomes, respectively (Staals et al., 
2010, Tomecki et al., 2010) and have been implicated in nuclear rRNA processing, 
degradation of promoter upstream transcripts (PROMPTS) and mRNAs such as c-MYC 
and c-FOS (Tomecki et al., 2010). DIS3L2 is the most distant Rrp44 homolog. Lacking 
the PilT N-terminus (PIN) domain that mediates DIS3 association with the exosome core 
in yeast (Lebreton et al., 2008, Schneider et al., 2009), DIS3L2 may not associate with 
the exosome, but rather act independently or in association with other proteins. Recent 
works have linked DIS3L2 mutations with the Perlman syndrome, a genetic overgrowth 
disorder appearing at birth (Perlman, 1986), and revealed that DIS3L2 plays a role in cell 
cycle regulation and cell division (Neumann et al., 2010, Astuti et al., 2012). 
Interestingly, disruptions of the DIS3L2 gene lead to aneuploidy, mitotic errors and 
changes in expression of mitosis-related proteins such as Aurora-B kinase, Cyclin B1 and 
p21 (Astuti et al., 2012). However, the molecular mechanism of DIS3L2 function 
remained elusive. 
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In this work we aimed to uncover the biochemical properties and physiological 
RNA targets of DIS3L2. By using in vivo crosslinking and immunoprecipitation followed 
by next generation sequencing (CLIP-seq) we show that DIS3L2 is bound to relatively 
short (18-34 nt) 5' tRNA-derived fragments (5' tRFs). Biochemical analyses indicate that 
DIS3L2 is involved in the production of 5' tRFs, and that the generation of stable tRNA-
derived fragments requires both endo- as well as exo-ribonucleolytic activities. Together 
with 5' tRFs, a fraction of DIS3L2 associates with ribosomes and DIS3L2 overexpression 
shifts the polysome/monosome ratio. These results suggest an involvement of DIS3L2 in 
translational regulation. Importantly, we found that some tRFs associate with AGO2 and 
have significant reverse complementarity to mRNAs. These findings point to a role of 
tRFs and DIS3L2 in the regulation of gene expression in human cells via an RNAi-like 
pathway. 
4.3 RESULTS 
4.3.1 DIS3L2 is a cytoplasmic exonuclease that does not interact with the exosome 
core 
DIS3L2 is a member of the RNase II family of enzymes. In contrast to DIS3 and 
DIS3L, DIS3L2 lacks the PIN domain that in yeast mediates the interaction with the core 
exosome (Lebreton et al., 2008, Schneider et al., 2009). To determine whether the 
absence of the PIN domain results in DIS3L2 acting independently of the core exosome, 
we analyzed immunoprecipitated (IPed) FLAG-DIS3L2 samples by western blot with 
antibodies against two core exosome subunits RRP40 and RRP41 (Figure 1B). Each of 
the two positive controls, FLAG-DIS3 and FLAG-DIS3L, coimmunoprecipitated both 
factors, whereas no signal over background was observed in FLAG-DIS3L2 IP samples 
(Figure 1B). We concluded that absence of the PIN domain renders DIS3L2 unable to 
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interact with exosomes in vivo. The two exosome-interacting homologs show distinct 
subcellular localization, with DIS3 being primarily nuclear and DIS3L mainly 
cytoplasmic (Staals et al., 2010, Tomecki et al., 2010). To determine the specific 
localization of DIS3L2, we transiently expressed N- and C-terminal EGFP fusion 
proteins (EGFP-DIS3L2 (data not shown) and DIS3L2-EGFP, Figure 1C and 1D), and 
performed immunolocalization with DIS3L2 specific antibodies (Figure 1C). Both 
approaches revealed that DIS3L2 is a cytoplasmic protein (Figure 1C), in agreement with 
a recent report (Astuti et al., 2012). 
To test whether DIS3L2 has 3' to 5' exoribonucleolytic activity, we expressed and 
purified recombinant DIS3L2 from E. coli and performed in vitro RNA degradation 
assays with unstructured RNA as a substrate. The recombinant protein showed processive 
3' to 5' exonucleolytic activity on U30 RNA whereas a D391N mutation of the predicted 
catalytic residue abolished this activity (Figure 1E). Similar activity was observed with 
FLAG-DIS3L2 purified from HEK293T cells on three different unstructured RNA 
substrates. Furthermore, similarly to Rrp44 (Liu et al., 2006), DIS3L2 is also able to 
digest highly structured RNAs such as tRNA. Finally, akin to yeast and mammalian DIS3 
proteins and to the E. coli RNase II (Frazao et al., 2006, Dziembowski et al., 2007), 
DIS3L2 requires bivalent metal cations for catalysis and its typical end product of 
digestion is 2-4 nucleotides in length. 
Because DIS3L2 does not associate with the cofactors that provide RNA-binding 
specificity and affinity to DIS3 and DIS3L, we tested its ability to directly bind RNA in 
an electromobility shift assay (EMSA). The assay was performed in absence of Mg2++ 
ions, thus abolishing the enzymatic activity but without affecting the RNA binding of 
DIS3L2 (Schneider et al., 2007). Interestingly, DIS3L2 displayed rather high affinity for 
U30 RNA, in the nanomolar range (estimated KD 100-125 nM) (Figure 1F). 
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4.3.2 Identification of DIS3L2 RNA targets by PAR-CLIP 
Having proven that DIS3L2 is a bona fide 3' to 5' cytoplasmic exoribonuclease, 
we applied the PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced Crosslinking and 
Immunoprecipitation) method combined with high-throughput Illumina-based sequencing 
(Ule et al., 2005, Wang et al., 2009, Martin et al., 2012) in a HEK293 cell line 
overexpressing FLAG-tagged DIS3L2 (Figure 2A), to identify its in vivo physiological 
targets. We performed two independent experiments and deposited the sequence data in 
the Gene Expression Omnibus (Edgar et al., 2002) with accession number (GSE42311). 
The experiments resulted in 18,113,339 and 16,151,628 good quality reads, respectively, 
which we mapped to the human genome assembly (hg19 from the 
http://genome.cse.ucsc.edu) (Kent et al., 2002, Rosenbloom et al., 2012) using the CLIPZ 
server (http://www.clipz.unibas.ch/, (Khorshid et al., 2011)). 51% and 21% of the reads, 
respectively, mapped to the genome and the 3,632,533 (20%) and 1,192,858 (6%) reads 
that mapped uniquely to the genome were used for our subsequent analyses. For both 
replicates, more than half of the uniquely mapping reads originated from mRNAs (Figure 
2B). Repeat elements and tRNAs together represented approximately 30% of the reads, 
whereas rRNAs, miscRNA (various other known ncRNAs), and reads mapping to un-
annotated regions accounted for approximately 15% of the reads (Figure 2B). To identify 
the sites that were most significantly crosslinked to DIS3L2, we used a method that takes 
advantage of the T-to-C mutations that are introduced during PAR-CLIP sample 
preparation (Jaskiewicz et al., 2012). We then associated the genomic locations 
corresponding to the most significantly crosslinked nucleotides with genes based on the 
various gene tracks available from the genome browser of the University of California 
Santa Cruz (see Methods). Our two PAR-CLIP samples showed substantial 
reproducibility at the level of crosslinked genes, especially when considering a limited 
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number (1,000) of top most significantly crosslinked positions. These positions mapped 
to 225 and 160 distinct genes, with 106 of the genes being identified in both replicates 
(Fisher's Exact test p-value=1.3e-160, odds-ratio=225). Furthermore, around half of the 
1,000 most significantly crosslinked positions from one sample were within 10 
nucleotides distance from at least one of the 1,000 most significantly crosslinked 
nucleotides in the second sample further showing the reproducibility of the crosslinking 
sites across the replicates. To identify the main in vivo substrates bound by DIS3L2, we 
tested whether specific categories of genes were over-represented among the most 
significantly crosslinked 1,000 positions compared to crosslinked positions recovered 
with much more permissive crosslink score cut-offs (30,318 and 25,811 positions, 
respectively, taking half of the positions that we would consider significantly crosslinked 
if they were supported by only one read that had a T-to-C mutation). We found that 
tRNAs were the most enriched category of genes represented among the most 
significantly crosslinked positions: DIS3L2 bound 109 and 107 distinct tRNA genes in 
the first and second replicates, respectively, 81 being common (Figure 2C). The number 
of significantly crosslinked positions on individual tRNA genes that were crosslinked in 
both replicates had a modest linear correlation (R=0.47) further supporting the 
reproducibility of DIS3L2 preference for these substrates. The most crosslinked tRNAs 
were Leu(CAA), Val(TAC), Arg(CCG), Ser(GCT), Lys(TTT), Val(AAC), SeC(e)(TCA), 
Arg(TCT), and Ala(AGC). Although more than half of the uniquely mapping reads were 
annotated as mRNAs, only a small number of mRNAs (N=7) contained positions with a 
crosslink score in the top 1,000 in both libraries. These transcripts corresponded to 
HSPA1B, MAZ, BIRC5, ACTG1, USP22, and HIST1H4B. Gene Ontology enrichment 
analysis with the Ontologizer software (Bauer et al., 2008), see also Methods) of an 
extended set of 89 mRNA genes that gave rise to significantly crosslinked sites in either 
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of the replicates revealed endoplasmic reticulum (adjusted p-value=0.001, N=21) and the 
endomembrane system (adjusted p-value=0.004, N=24) cellular components. The 
abundantly and ubiquitously expressed (Landgraf et al., 2007) mature miRNAs from the 
miR-17-92 locus (miR-17, mir-18a, mir-20a) were the only miRNAs that were 
crosslinked to DIS3L2. Among rRNA, we obtained crosslinks to RN5S9 and RN5S215 5S 
rRNA transcripts, which are part of the large ribosomal subunit. Although snoRNAs are 
predominantly nuclear and DIS3L2 predominantly cytoplasmic, we identified 35 
snoRNAs, among which U60, U14A, U8, mgU6-77, HBII-99B, U33, and U56 were 
reproducibly identified in both replicates. With the exception of U1 and RNU12, almost 
all crosslinked snRNAs (RNU2-2, RNU2-6P, RNU4-2, RNU5E-1, U2, and RNU11) were 
identified in both replicates. 
To validate the CLIP results, we performed RNA Immunoprecipitation (RIP) 
from the FLAG-DIS3L2 Flp-In HEK293T stable cell line followed by reverse 
transcription with oligo(Landgraf et al., 2007) primer and semi-quantitative PCR with 
oligonucleotides specific for genes encoding crosslinked mRNAs from both replicates 
(Figure 2D). FLAG-DIS3L2 samples showed significant enrichment of most selected 
target mRNAs (ACTG1, BIRC5, HSPA1B, MAZ) over the unspecific binding to FLAG-
matrix detected with extracts from empty HEK293 Flp-In cells (Figure 2D). To test the 
specific binding to tRNAs, we used northern blot analysis of the RIP samples and DNA 
probes specific to the 5' and 3' part of tRNAVal, respectively (Figure 2E). Although the 
mature tRNAVal was detected also in the control sample, the FLAG-DIS3L2 specifically 
immunoprecipitated pre-tRNA (slower migrating band in Figure 2E) and shorter forms 
migrating as 50 nt and 30 nt fragments when probed with a 5'-end probe and migrating as 
50 nt and 20 nt fragments when probed with a 3'-end tRNA probe (Figure 2E). 
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4.3.3 DIS3L2 predominantly crosslinks to tRNA 5' ends 
To further investigate the relevance of DIS3L2 binding to tRNA-derived 
fragments (Figure 2E), we used 44 tRNAs that are precisely 72-nucleotides-long and 
were CLIPed with DIS3L2 to compute the profile of the average crosslink score along the 
tRNAs. We found that the highest binding scores were in the 5' region of the tRNAs 
(Figure 3A and 3B). Importantly, a similar profile was obtained for the set of 39 73-
nucleotide-long tRNAs. This positional preference was not due to preferential loss by our 
processing pipeline of 3' end reads that end in the non-templated CCA tri-nucleotides, 
and was also not dependent on whether we used uniquely or multi-mapping reads in our 
analysis. Because the DIS3L2-crosslinked tRNA fragments resemble most the 5' tRFs 
(Lee et al., 2009, Haussecker et al., 2010), we decided to use this designation for the 
DIS3L2-bound 5' tRNA fragments. 
The specific binding of DIS3L2 was further verified on tRNALeu- and tRNAVal-
derived tRFs (Figure 3C) by semi-quantitative RT-PCR applied to RNA 
immunoprecipitated (RIP) with DIS3L2 (see above). To specifically amplify the 5' tRFs 
and not the full length tRNAs, we applied the method of stem-loop RT-PCR in which 
stem-loop RT primer is hybridized to a 5' tRF molecule and then reverse transcribed with 
a reverse transcriptase. For the cDNA synthesis we used primers aligning specifically to 
the last 6 nucleotides of tRFs identified in CLIP (see methods). Next, the RT products are 
amplified with the combination of a forward tRF-specific primer and a reverse stem-loop-
RT-primer-specific oligonucleotide (Chen et al., 2005, Varkonyi-Gasic et al., 2007). We 
have observed specific coimmunoprecipitation of 5' tRFs with FLAG-DIS3L2 protein 
(Figure 3C). The identity of amplified 5' tRFs was further validated by DNA sequencing 
Unfortunately, the same approach could not be used for the specific amplification of 3' 
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tRFs, because it does not allow for selective amplification at certain 5'-end position of a 
3' tRF. In summary, we conclude that DIS3L2 binds the 5' ends of a subset of tRNAs. 
4.3.4 DIS3L2 is a processing factor of tRNA-derived small RNAs that may have a 
miRNA-like function in mRNA gene silencing 
Having shown that DIS3L2 binds 5' tRNA regions, we next investigated whether 
it is responsible for 5' tRFs turnover or processing. As certain stress conditions are 
responsible for the generation of 5' tRNA halves (Thompson et al., 2008, Fu et al., 2009), 
we first checked, whether DIS3L2 is involved in this process or in the degradation of the 
cleaved fragments. We monitored tRNA cleavage during oxidative shock in HeLa cells 
treated with 5 mM H2O2. Whereas the cleavage of mature tRNAs proceeded with similar 
dynamics in the DIS3L2 and control siRNA-treated cells, the cleaved tRNA fragments 
showed a slightly stronger accumulation in the DIS3L2 knockdown. This could indicate 
that DIS3L2 targets Angiogenin-cleaved tRNAs. Reasoning that DIS3L2 may process 
longer forms of tRNA fragments to tRFs observed in this and other studies, we monitored 
the steady state levels of the 22 and 23 nt long 5' tRFLeu(CAA) in response to modified 
levels of DIS3L2. Whereas DIS3L2 overexpression resulted in 1.5 to 2.5-fold increase of 
the tRFs analyzed (Figure 4A), DIS3L2 downregulation in HeLa cells led to 60% and 
80% reduction of 5' tRFLeu(Neumann et al., 2010) and 5' tRFLeu(CAA), respectively 
(Figure 4C). To find out whether the catalytic activity of DIS3L2 was responsible for the 
changes in tRF expression, we used a stable cell line with inducible expression of the 
catalytically inactive form of FLAG-DIS3L2 (D391N, Figure 4B). Overexpression of the 
D391N mutant resulted in 20 - 40% reduction in 5' tRF levels (Figure 4A), a phenotype 
similar to DIS3L2 down-regulation (Figure 4C). This implies that DIS3L2 catalytic 
activity is responsible for tRF production and that D391N overexpression acts in a 
dominant negative manner. Interestingly, we observed similar changes in the levels of 
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mature miR-30b in HEK293T cells and miR-30b and let-7a in HeLa cells (Figure 4A and 
4C), but the miRNAs did not change as profoundly as the 5' tRFs. Cole et al. 2009 
implicated Dicer1 (DCR1) in the production of certain tRNA fragments (Cole et al., 
2009). To rule out the possibility that DIS3L2 regulates DCR1 expression by targeting 
DCR1 mRNA (which would in turn lead to defects in tRF processing) we investigated 
whether altered levels of DIS3L2 lead to changes in the expression of DCR1 or to defects 
in miRNA processing. Neither over-expression, nor down-regulation of WT DIS3L2 
modified DCR1 expression  and no significant changes were detected in the levels of 
mature or pre-miR-16 or pre-let-7 miRNAs in HEK293T cells. In contrast, ectopic 
expression of LIN28A, a known negative regulator of specific miRNA processing, 
caused pre-miRNA accumulation in control samples. Altogether, we conclude that 
DIS3L2 is directly responsible for the processing of tRNAs into 5' tRFs. To gain insight 
into the possible function of the 5' tRFs, we investigated whether they could function 
within the cytoplasmic RNA silencing machinery. Other categories of non-coding RNAs 
have recently been found to be loaded into AGO and to function in mRNA gene silencing 
(Ender et al., 2008, Li et al., 2012). To this end, we applied our processing pipeline to an 
AGO2 PAR-CLIP library (accession GSM714646 in the GEO database of NCBI) from 
Kishore et al. (Kishore et al., 2011) and used the top 1,000 crosslinked sites as for the 
DIS3L2 libraries. Although most of the significantly crosslinked AGO2-binding sites 
were located in miRNA genes, we also obtained 10 significantly crosslinked tRNAs 
(Val(CAC), Val(AAC), Val(TAC), Leu(CAA), Pro(CGG), Ala(AGC), Asn(GTT), 
Ile(TAT), Ala(CGC)). Interestingly, all of these tRNAs were also crosslinked in the 
DIS3L2 replicates (Fisher's Exact test, p-value=1.7e-07). In contrast to the reads derived 
from miRNAs, that have a sharp peak at 23 nucleotides in both AGO2 and DIS3L2 CLIP 
samples, tRNA-derived fragments have a much broader length distribution (Figure 4D). 
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Moreover, the tRNA-derived fragments that were found crosslinked to AGO2 had a 
length distribution with a wide plateau, starting at 23 nt (Figure 4D). To determine which 
mRNAs these tRNA-derived fragments could target, we applied a method for predicting 
miRNA-binding sites in CLIP data that we recently developed (Khorshid et al., 2013). 
For comparison, we predicted sites for bona fide miRNAs as well as for mono- and di-
nucleotide conserving shuffled variants of both tRNA and miRNA. We found that 
although the best hybrids that were predicted for the tRNA-derived small RNAs had on 
average smaller scores compared to hybrids involving bona fide miRNAs, none of the 
randomized tRNA or miRNA fragments was predicted to target one of the mRNA 
fragments obtained in the AGO2 PAR-CLIP. This suggests that tRNA-derived small 
RNAs may load into AGO2 and function in mRNA gene silencing in a way similar to 
miRNAs (Figure 4E). 
Since tRNAs are not the main AGO2-bound RNAs, it is possible that a more 
permissive crosslink scoring cut-off for AGO2 would reveal more tRNA-derived 
fragments processed by DIS3L2. Indeed, among the top 2,000 crosslinked sites of AGO2 
we obtained 51 tRNA genes out of which 37 were represented among top 1,000 most 
significantly crosslinked DIS3L2 positions (which covered a total of 135 tRNAs, Fisher's 
Exact Test p-value=3.2e-16, odds-ratio=13). Importantly, the tRNA-derived fragments 
identified through small RNA sequencing (Mayr and Bartel, 2009) and in the AGO2 
PAR-CLIP samples also preferentially originated from the tRNA 5' ends (Cole et al., 
2009), just as in the DIS3L2 PAR-CLIP samples. This further supports the hypothesis 
that DIS3L2 is involved in the processing of the majority of tRFs in cytoplasm under 
standard growth conditions. Among the targets that we predicted for tRFs that did not 
match any miRNA with a comparable score, and whose hybrid score was higher than the 
median score of the miRNA-mRNA hybrids (median score = 147.6, see Methods) were 
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mRNAs encoding ACVR1B, ATF7, DNAJB12, HMGA2, HNRNPA2B1, MTHFD2, 
PPIL1, PSMB1, RPA2, SLC19A2, SLC38A2, SRSF6 and TUBB which could be targeted 
by small RNAs derived from tRNAAsn(GTT), tRNAVal(TAC), tRNAVal(AAC), 
tRNALeu(CAA), tRNAAla(CGC) and tRNAPro(CGG). 
4.3.5 DIS3L2 and 5' tRFs associate with active polysomes 
Although we tested whether DIS3L2 directly regulates the stability of top CLIPed 
mRNA targets, we did not observed significant changes neither upon DIS3L2 
knockdown, nor over-expression (data not shown). tRNAs are a fundamental component 
of the translation machinery and tRFs themselves have been shown to interact with 
proteins with a function in translation regulation, such as YB1, TIA1, PABP1 and AGO2 
(Ivanov et al., 2011). We thus reasoned that DIS3L2 and its 5' tRFs could regulate the 
translation rather than the stability of mRNAs. To investigate this hypothesis we sought 
to determine whether DIS3L2 associates with translating ribosomes, and we performed 
polysomal profiling of DIS3L2-overexpressing and control HEK293T cells combined 
with western blot analysis of individual sucrose gradient fractions (Figure 5A). The 
endogenous as well as overexpressed DIS3L2 signal was present along the whole sucrose 
gradient indicating the presence of DIS3L2 in monosomes as well as polysomal fractions 
(Figure 5B). The polysomal profiles showed an increased signal for 80S monosomes in 
FLAG-DIS3L2 overexpressing samples. Comparing the relative abundance of polysome 
and monosome peaks of control and FLAG-DIS3L2 overexpressing cells, we found that 
the monosomal fraction increased three times upon DIS3L2 overexpression (Figure 5C). 
Furthermore, overexpression of the D391N mutant did not result in a similarly strong 
shift towards monosomes indicating that the nuclease activity of DIS3L2 is responsible 
for this phenotype (Figure 5C, last column). This was not due to different levels of 
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expression of the tagged proteins. The changes in translation activity may be one of the 
reasons for growth defects associated with DIS3L2 overexpression (Astuti et al., 2012) In 
agreement with our polysomal profiling results, the overexpression of catalytically 
inactive DIS3L2 did not result in growth retardation. 
Because the yeast Dis3 and the associated exosome are essential for ribosomal 
RNA (rRNA) processing and degradation, we checked whether DIS3L2 overexpression 
leads to changes in the rRNA profile. We did not find however, any accumulation of 
aberrant rRNA species or an imbalance in SSU/LSU rRNA levels in cells with altered 
DIS3L2 expression. Moreover, Astuti et al. ruled out the involvement of DIS3L2 in 5.8S 
rRNA maturation (Astuti et al., 2012). 
Reasoning that 5' tRFs mediate at least some of DIS3L2 activity on ribosomes, we 
isolated RNA from the individual fractions of the sucrose gradient and used it for stem-
loop RT-PCR analysis (see above) with specific primers for two 5' Leu tRFs. We found 
that the tRF signal paralleled DIS3L2 distribution along the whole sucrose gradient, with 
a stronger signal over the 60 and 80S monosomes (Figure 5D), indicating that they may 
have a role during translation initiation. 
4.4 DISCUSSION 
The high-throughput sequencing of various RNA size fractions have led in the 
recent years to the identification of new types of small and long RNAs, some of which 
have functions in the regulation of gene expression. In this work we have established 
DIS3L2 as a factor responsible for the generation of tRNA-derived fragments with 
regulatory potential. DIS3L2 is a human homolog of Dis3, the key exonuclease of yeast 
exosomes. In contrast to its DIS3 yeast and human homologs however, DIS3L2 does not 
associate with exosomes in vivo. 
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To uncover the DIS3L2-specific RNA targets in vivo, we applied photo-
crosslinking followed by DIS3L2 immunoprecipitation and next generation sequencing, 
(DIS3L2 PAR-CLIP) in HEK293 Flp-In cells. Analysis of CLIP data combined with 
further experimental validation uncovered a strong enrichment in binding of DIS3L2 to 
tRNA molecules, particularly to fragments originating from tRNA 5'-ends. We 
designated these molecules tRFs, akin to the tRNA-derived fragments recently reported 
by Haussecker et al. (Haussecker et al., 2010). 
A number of studies reported that tRNA halves are produced in response to 
certain stress stimuli, but also exist stably in cells (Fu et al., 2009, Lee et al., 2009, Li et 
al., 2012). To date, several endonucleases such as DICER1, Angiogenin or RNase Z, 
have been proposed to generate different types of tRNA fragments (Takaku et al., 2003, 
Cole et al., 2009, Lee et al., 2009). In many cases, such cleavage would generate 
fragments longer than those identified by RNA sequencing, which presumably captures 
mature/functional fragments. This suggests that an additional exonuclease activity is 
involved in the processing of tRFs. Because DIS3L2 knockdown leads to a reduction in 5' 
tRF levels and DIS3L2 upregulation increases 5' tRF levels, we propose that DIS3L2 
provides this so-far-unknown activity. 
At the moment, it is unclear whether DIS3L2 targets tRNA halves that result from 
an initial endonucleolytic cleavage or whether it targets full length tRNAs. The fact that 
both 5' and 3' tRNA cleavage products became stabilized in DIS3L2 knockdown cells 
upon H2O2 stress, suggested that DIS3L2 may either be responsible for their decay or 
further processing. On the other hand, the infrequent occurrence of crosslinks to 
fragments derived from tRNA 3' ends under non-stressed conditions and our finding that 
DIS3L2 processively digests both unstructured and structured RNAs in vitro (Figure 1, 
Figure 4) suggest that rapid decay is responsible for the depletion of 3' ends of tRNA 
 88 
fragments in our CLIP data. The fact that some 5' tRFs escape complete degradation 
could indicate that an additional factor controls DIS3L2 activity and sets the boundaries 
of mature 5' tRFs. Previous studies have demonstrated AGO2 binding to tRNA-derived 
fragments in mammals (Cole et al., 2009, Haussecker et al., 2010, Li et al., 2012), 
Tetrahymena (Couvillion et al., 2012), and fission yeast (Buhler et al., 2008). 
Interestingly, Xue et al. have recently reported that Dis3 and the exosome can produce, 
together with Argonaute, mature miRNAs in Neurospora crassa (Xue et al., 2012). Our 
analysis indicated a significant overlap between AGO2 and DIS3L2 binding to tRFs. We 
propose that AGO2 binding to the 5' region of tRFs acts as a molecular ruler (Wang et al., 
2008, Haussecker et al., 2010) controlling DIS3L2 digestion (Figure 6B). 5' tRFs are thus 
protected by AGO2, leaving the 3' ends of the tRNAs or fragments accessible to DIS3L2 
or other nucleases. We have observed that DIS3L2 also copurified extended tRNA 
species (Figure 2E). These may represent pre-tRNAs that for some reason escaped 
nuclear processing and were exported to cytoplasm. It is possible, that pre-tRNAs that 
fail RNaseP and/or RNaseZ processing and therefore also the subsequent aminoacylation 
serve as the cytoplasmic pool for tRF production. This hypothesis could also explain the 
earlier finding of another type of tRNA-derived fragments originating from 3'-end tRNA 
trailers that are found in cytoplasmic fractions (Li et al., 2012). Our results rule out the 
possibility that DIS3L2 affects the stability of the mRNAs corresponding to the 
endonucleases that are already known to be responsible for tRF formation (Babiarz and 
Blelloch, 2008). Particularly, we show that DICER1 levels and miRNA processing are 
not regulated by DIS3L2. Furthermore, Angiogenin-mediated cleavage is not altered 
upon DIS3L2 knockdown, and finally, our northern analyses did not show any 
accumulation of pre-tRNA molecules that would indicate defects in RNAse Z activity. It 
is currently unclear how DIS3L2 selects its targets. Apart from 5' tRFs, DIS3L2 CLIP 
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identified other small RNAs originating from RNA Polymerase III transcripts, such as 5S 
rRNA and a miR-1975 originating from Y-RNA (Canella et al., 2010). We have shown 
that DIS3L2 binds U30 RNA with nanomolar affinity. RNA Pol III transcription 
termination often involves a U-rich stretch that could form a landing platform for initial 
DIS3L2 binding. On the other hand, it is possible that DIS3L2 associates with other 
RNA-binding cofactors that provide RNA substrate specificity. 
The key question is whether DIS3L2-linked tRFs possess any biological function. 
Mostly due to tRF association with Argonaute proteins, some recent studies focused on 
the function of tRFs in the RNAi pathway. It was shown that certain 3' tRFs in 
association with AGO2 are able to induce cleavage of a complementary RNA in vitro (Li 
et al., 2012), yet in vivo their trans-silencing potential was rather small (Haussecker et al., 
2010). On the other hand, in Tetrahymena, nuclear tRNA derived 3' RNAs associate with 
a Piwi-like protein and, in complex with the nuclear 5' to 3' exonuclease Xrn2, are 
responsible for the processing of the ribosomal RNAs (Couvillion et al., 2012). In fission 
yeast, tRNAGlu-derived small 5' tRFGlu represent a highly abundant class of sRNAs that 
have been proposed to interfere with the RNAi pathway (Buhler et al., 2008). Last, but 
not least, in mammalian cells, tRNA fragments have been shown to induce translational 
arrest (Yamasaki et al., 2009). In this context, we show that a fraction of DIS3L2 and the 
respective 5' tRFs associate with ribosomes and that DIS3L2 overexpression changes 
ribosomal profiles towards monosomes, which is generally understood as a sign of 
translational inhibition. The majority of DIS3L2 is not bound to ribosomes. However, 
this also seems to be the case for other proteins that are known to associate with 
ribosomes, e.g. CIRP2 (Matsumoto et al., 2000), S6 kinase 1 (Volarevic and Thomas, 
2001), PRMT3 (Bachand and Silver, 2004) or Gemin3/4 (Nelson et al., 2004). Because 
we detect also the endogenous DIS3L2 in the individual sucrose fractions, it is unlikely 
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that we detect FLAG-DIS3L2 only due to its overexpression. Although it is possible that 
DIS3L2 co-sediments with polysomes due to its association with another high molecular 
complex, the effect of DIS3L2 overexpression on polysome/monosome ratio further 
supports its association with translation machinery. Even though we do not know the 
stoichiometry of DIS3L2 loading to ribosomes we speculate that DIS3L2 associates with 
ribosomes under distinct conditions and dependent on specific subsets of mRNAs. This 
would be consistent with the fact that a few specific types of tRNAs (tRNALeu and 
tRNAVal) were especially enriched in our CLIP data. Interestingly, a recent study in 
yeast pointed to a correlation between the stress-induced general tRNA cleavage, 
protection of tRNALeu(CAA) and translation of mRNAs with a high frequency of 
Leu(CAA) codon occurrence (Chan et al., 2012). Upon stress, yeast cells upregulate 
Trm4-mediated tRNALeu(CAA) methylation (Trm4 is a yeast homolog of the 
mammalian DNA methyltransferase DNMT2), thereby protecting it from endonucleolytic 
cleavage. A subset of ribosomal proteins encoded by mRNAs with a high frequency of 
Leu(CAA) codons is then preferentially translated under stress conditions (Chan et al., 
2012). The set of human genes with a very high frequency of Leu codons is strongly 
enriched in Gene Ontology categories that reflect membrane biosynthetic processes 
(protein lipidation, phospholipid/lipoprotein/glycerolipid biosynthetic process). Whether 
these or other Leu(CAA)-rich factors are regulated in a DIS3L2-dependent manner 
remains to be determined. 
On the other hand, expression of the DIS3L2 may primarily affect protein 
synthesis via small regulatory RNAs. Fragments derived from tRNAs have been 
previously linked to translational inhibition through the association with a translation 
initiation factor (Ivanov et al., 2011). The fact that we detected slightly higher 5' tRF 
LeuCAA levels at 60S and 80S ribosomal fractions, could indicate that they function in 
 91 
translational initiation. However, the overall 5' tRFs distribution over the whole 
polysomal profile points to a more specific role in translational repression. Because it is 
well established that microRNAs inhibit mRNA translation, we sought evidence for 
DIS3L2-linked 5' tRFs acting in a miRNA-like pathway. A computational search for 
putative mRNA targets revealed several mRNAs whose disregulation could explain the 
slow growth and division phenotype observed upon DIS3L2 knockdown or mutation 
(Astuti et al., 2012)), such as DNAJB12, RPA2, or others. Nevertheless, future studies 
will be necessary for clarifying whether 5' tRFs act in a miRNA-like manner on these 
predicted targets. Apart from the predicted mRNA targets for 5' tRFs, our DIS3L2-CLIP 
analyses identified crosslinks to several mRNAs. Interestingly, the most significantly 
crosslinked mRNAs encode proteins linked to cell cycle (HIST1H4B, USP22) and mitosis 
(BIRC5). In agreement with the proposed indirect role of DIS3L2 on gene expression 
regulation, DIS3L2 knockdown or overexpression did not cause stabilization or down-
regulation of these mRNAs, respectively (data not shown). This resembles results of 
Astuti et al. who reported on differences in expression of several proteins involved in 
mitosis upon the knock down of DIS3L2 in HeLa cells, without the change of their 
corresponding mRNA levels (except for one, the TTK) (Astuti et al., 2012). Thus, 
DIS3L2 may regulate these genes only at the level of translation. In summary, here we 
have uncovered the role of a cytoplasmic exonuclease that mediates production of 
potentially functional tRNA-derived fragments. We propose that DIS3L2 and tRFs 
cooperatively regulate gene expression. As different types of tRNA-derived fragments 
exist stably in various cell types, future studies will be needed to assess tRF specific 
functions in vivo. 
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4.5 MATERIAL AND METHODS 
4.5.1 Mammalian cell culture and transfection 
Mammalian cells (HEK Flip In, HEK Flip In FLAG-DIS3L2, HEK293T, HeLa) 
were maintained in Dulbecco's Modified Eagle's Medium (DMEM), supplemented with 
10% fetal calf serum at 37°C in the presence of 5% CO2. Inducible conditions: 10-
50ng/ml of doxycycline. For transient expressions, cells were grown to 70% confluency, 
plasmid DNA was transfected using TURBOFECT (Fermentas) following the 
manufacturer manual. Preparation of stable cell lines 
Plasmids (pcDNA5 FRT/TO FLAG DIS3L2, pcDNA5/FRT FLAG DIS3L2, 
pcDNA5/FRT/TO DIS312 D391N mutant) were transfected to Flp-InTM or to Flp-InTM 
T-RExTM (Invitrogen) cell line with TURBOFECT reagent. The stable inducible cell 
lines overexpressing different versions hDIS3L2 were generated with the use of the 
HEK293 Flp-In™ and Flp-In T-REx™ system (Invitrogen) according to the protocol of 
the manufacturer. 
4.5.2 Polysomal profiling 
The polysomal profiling was performed with minor modifications according to 
(Damgaard and Lykke-Andersen, 2011). For details see supplementary material. 
4.5.3 RNA analysis by RT-PCR. 
Total RNA was isolated with TRIzol (Invitrogen) according to manufacturer 
instructions followed by RNase-free DNase (TURBO DNase, Fermentas) treatment. 1 ug 
of purified RNA was reverse transcribed using random hexamers or oligo dT (as 
indicated) and Superscript III reverse transcriptase (Invitrogen) according to 
manufacturer instructions. Real-time quantitative PCR (RT-qPCR) was performed using 
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FastStart Universal SYBR Green Master (Roche) and gene-specific primer pairs on Q-
PCR Light Cycler 7500 (Applied Biosystems). For details see Supplementary material. 
4.5.4 PAR-CLIP 
PAR-CLIP was performed essentially as described (Bauer et al., 2008). For 
details see supplementary material. 
4.5.5 In silico analysis of high-throughput sequencing data 
We extensively used custom Perl (version 5.8.1) and R (version 2.15.1) scripts as 
well as the BEDTools (version 2.16.1) package (Quinlan and Hall, 2010) for many steps 
of the analysis. Details are indicated in supplementary material. 
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Figure 1. DIS3L2 is a cytoplasmic 3' to 5' exoribonuclease that does not associate with 
the exosome. A. Schematic representation of the domain organization of DIS3L2 
homologues from S. cerevisiae and H. sapiens. The PIN domain is in green, the CSD1 
and CSD2 RNA binding domains are in orange, the RNB ribonuclease domain in blue, 
and the S1 domain in pink. B. DIS3L2 does not interact with core exosome components. 
FLAG-tagged DIS3, DIS3L and DIS3L2 were immunoprecipitated from stable cell lines 
with inducible overexpression of the individual proteins. The composition of IP samples 
was analyzed by western blot analysis with antibodies indicated. C. DIS3L2 is a 
cytoplasmic protein. DIS3L2 C-terminally fused to an EGFP tag was transiently 
expressed in HeLa and HEK293T cells, respectively. Plasmid expressing EGFP alone 
was used for background control. The scale bar corresponding to 10 microM is shown in 
white. D. Relative abundance of endogenous and EGFP-tagged DIS3L2 in HeLa cells 
expressing either only EGFP or EGFP-tagged DIS3L2 were detected with antibodies 
specific to DIS3L2. E. In vitro degradation assays with recombinant DIS3L2 and its 
catalytical mutant (D391N) with U30 RNA as a substrate. The migration of input RNA 
and degradation products are indicated. F. DIS3L2 binds U30 RNA with nanomolar 
affinity. Electromobility shift assay with recombinant DIS3L2 (concentrations indicated 
on top) and 5' end 32P labeled U30 RNA. Migration of free RNA and of protein-RNA 
complexes, respectively are indicated. 
DIS3L2 U30 RNA
 np   
U30 RNA
F
DIS3L2 MERGE
D
IS
3L
2-­
E
G
FP
E
G
FP
EGFP
H
E
K
293
H
eLa
EG
FP
Di
S3
L2
-E
GF
P
DIS3L2-EGFP
DIS3L2
HeLa
C
CT
RL
DI
S3
DI
S3
L2
DI
S3
L
CT
RL
DI
S3
DI
S3
L2
DI
S3
L
Input IP
_-FLAG
_-RRP40
_-RRP41
A
PIN CSD1 CSD2 RNB S1
1 49 137 228 329 775 885
CSD1 CSD2 RNB S1
hDIS3
hDIS3L
hDIS3L2
yRrp44
B
rDIS3L2 WT D391N
U30 RNA
dp
Time, min 5  15 30 5  15  30
np
E
D
0.5 1 30 50 100 125 25
0 500 100
0
150
0
320
0
rDIS3L2
 nM   
30
 95 
 
Figure 2. tRNAs are the main in vivo substrates of DIS3L2. A. Autoradiography of y- P-
labeled RNAs crosslinked to DIS3L2. Each CLIP was split to two halves and loaded into 
two lanes. The squares designate area that was cut from the gel and used for subsequent 
analyses. B. Functional annotation of reads uniquely mapping to the genome in two 
DIS3L2 PAR-CLIP replicates. Categories that accumulate less than 1% of the reads are 
not represented individually, but are grouped in the "other" category and reads mapping 
to genomic regions without a functional annotation are represented as none category. C. 
tRNA genes are enriched among the 1,000 most significantly crosslinked positions. 
Categories shown on the x-axis are in descending order of the number of distinct genes 
represented in the set of the 1,000 most significantly crosslinked positions. Y-axis is p-
value (-log10) of Fisher's Exact test. D. RNA immunoprecipitation with FLAG-DIS3L2 
followed by oligo(Landgraf et al., 2007) cDNA synthesis and semi-quantitative PCR with 
gene specific primers. Empty HEK 293T-Rex cells (empty) were used as a negative 
control for unspecific coimmunoprecipitation of RNAs on FLAG matrix. No RT is a 
control where no reverse transcriptase was used. E. Northern blot analysis of tRNA 
ValAAC immunoprecipitated with FLAG-DIS3L2. RNAs obtained by RIP as in C were 
separated on 10 % denaturing polyacrylamide gel, transferred to nylon membrane and 
hybridized with 5'-end labeled DNA oligos corresponding to 3' and 5' part of Homo 
sapiens chr6.trna136-ValAAC (27,648,885-27,648,957), respectively. 
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Figure 3. DIS3L2 preferentially binds 5' halves of tRNAs. A. Profile of average crosslink 
score (log of the probability that crosslink-diagnostic T-to-C mutations are more frequent 
than expected by chance, see Methods) along the 72-nucleotide long tRNAs that were 
crosslinked in the two replicate samples. The empirical 90% confidence intervals of the 
average crosslink scores obtained by shuffling the crosslinked positions along the T 
positions of the crosslinked tRNA species 2,000 times is shown with dashed lines. The 
crosslink position on specific regions of tRNAs are indicated below the x-axis. B. 
Secondary structure of tRNA AGC as a representative tRNA species of length 72 
(predicted by tRNAscan-SE (Lowe and Eddy, 1997) and rendered by VARNA (Darty et 
al., 2009)). C. 5' fragments of tRNALys and tRNAVal are specifically bound by DIS3L2. 
RIP-RT-PCR analysis of DIS3L2 associated RNAs. The PCR product corresponding to 5' 
tRFs migrates as 60 - 70 bp band. The band migrating as 150 bp fragment corresponds to 
tRNAVal. D. Profile of read lengths of tRNA and miRNA annotated tags from the 
DIS3L2, AGO2, and small RNA-seq libraries. The left panel shows read length of 
miRNAs, where the number of reads at ~22 is highest for AGO2, sRNA and weakly also 
for DIS3L2. The right panel represents read length of tRNAs. 
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Figure 4. DIS3L2 generates 5'-derived tRNA fragments (tRFs) that are bound by AGO2 
and may have miRNA-like function. A. DIS3L2 overexpression increases 5' tRFs levels. 
RT-PCR of mature miRNA30b, 5' tRFLeu TAG and 5' tRFLeu CAA in HEK293T-Rex 
cell lines with or without (empty) overexpression of wild type (WT) and D391N (MUT) 
FLAG-DIS3L2. Results are derived from three independent biological replicates, *) p-
value = 0.03, n=3. **) p-value < 0.015, n=3. B. FLAG-D391N DIS3L2 mutant shows no 
exonucleolytic activity in vitro. Wild type (WT) and D391N (MUT) were 
immunoprecipitated from HEK 293T-Rex cells and incubated with 5'-end labeled pre-let-
7a RNA for 30 minutes. np is a reaction where no protein was added. Reactions were 
stopped with formamide buffer and RNAs were resolved on 20% denaturing 
polyacrylamide gel, dp are degradation products. C. DIS3L2 downregulation decreases 5' 
levels of tRFLeu TAG and tRFLeu CAA in HeLa cells. Q-PCR of total RNA purified 
from control and siRNA treated cells. Results are derived from three independent 
biological replicates, *) p-value = 0.021, n=3. **) p-value < 0.009, n=3. In A and C the 
levels of tRFs and miRNAs were normalized to the expression of RNU44 snoRNA. P-
values estimated by Student's paired t-test, number of replicates is indicated. Error bars 
represent standard deviation. The level of DIS3L2 knockdown (right panel) monitored 
with DIS3L2 specific antibodies. Tubulin is a loading control. D. Some hybrids predicted 
to form between tRNA-derived small RNAs and (AGO2-CLIPed) mRNA sites have 
scores that are comparable to those of miRNA-mRNA hybrids. Black lines indicate the 
median, the box edges the 25th and 75th percentiles, and plus symbols the outliers. 
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Figure 5. DIS3L2 and DIS3L2-derived 5' tRFs associate with translating ribosomes. A. 
Polysomal profiles of sucrose gradients from HEK293T-Rex cells. A polysome-enriched 
fraction of HEK293T was centrifuged through a linear 10-50% (wt/vol) sucrose gradient. 
The top of the gradient is on the left. The peaks corresponding to particular ribosomal 
fractions are indicated above. B. A fraction of DIS3L2 copurifies with HEK293T 
ribosomes on sucrose gradients. The distribution of DIS3L2 and ribosomal protein L8 
(RPL8) in the fractions of the gradient were analyzed by immunoblotting using anti-
DIS3L2 and anti-RPL8 antibodies, respectively. C. Ratio of the polysomes versus 
monosomes extracted from the graphs shown above (panel A). D. 5' tRFs and miR-30 
associate with ribosomal fractions. PCR analysis of cDNAs prepared from RNAs 
associated with individual fractions from the sucrose gradient shown in (A). The RT-PCR 
protocol is designed to amplify 5' tRFs, not full length tRNAs (see methods). No RT is a 
control where no reverse transcriptase was used. 
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Figure 6. Proposed model of DIS3L2 and 5' tRF processing and function. A. Different 
roles of DIS3L2 in mRNA degradation, tRF production and translationalcontrol. B. 
Proposed mechanism of 5' tRF processing. 
4.7 SUPPLEMENTARY MATERIAL 
4.7.1 Dis3L2 constructs 
Constructs for bacterial expression: The coding sequence of human DIS3L2 
protein (isoform 1, 885 aminoacids, NP_689596.4) was cloned into pET28b between 
NheI and BamHI sites allowing expression of N-terminaly fused 6xHis-Smt3 tag. 
DIS3L2 was amplified by PCR in two parts (because of XhoI internal cleavage site) 
using cDNA prepared from HEK293 RNA as a template. First, the 3ʹ′ part of CDS (1664 
– 2658 nt) was amplified with primers (Forward 5ʹ′ 
AGCAGCGAGGAGGTACACCAG3ʹ′, Reverse 5ʹ′ 
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ACCTCGAGTCAGCTGGTGCTTGAGTCCTCG 3ʹ′) and subcloned into pET28b using 
HindIII and XhoI sites, than the 5ʹ′ part (1 – 1663 nt) was amplified with primers 
(Forward 5ʹ′ CGGGATCCATGAGCCATCCTGACTACAG 3ʹ′, Reverse 5ʹ′ 
ATGACATCCTTGAGGCAATCC 3ʹ′) and ligated to the 3ʹ′ end via BamHI and HindIII 
sites. The sequence of the final clone was verified by sequencing.  
Catalytical mutants D391 was designed based on sequence alignments with 
RNase II in which, D391 position in DIS3L2 corresponds to the D209 residue of E. coli 
RNase II that is critical for nuclease activity. D209N mutation within RNB motif allows 
RNA binding but prevents cleavage (Amblar and Arraiano, 2005). The mutation was 
introduced by site-directed mutagenesis using oligos: forward DIS3L2 D391N F, reverse 
DIS3L2 D391N Rv. 
For the expression of the protein in human cells, coding sequence of DIS3L2 was 
cloned in pcDNA5/FRT and pcDNA/FRT/TO.  FLAG DIS3L2 was prepared by 
amplification of DIS3L2 coding sequence using DIS3L2 pcDNA/FRT Not1 Rv and 
DIS3L2pcDNA/FRT Kpn1 Fw. pcDNA5/FRT/TO DIS3l2 was created by 
endonucleolytic cleavage of DIS3L2 coding sequence from pcDNA5/FRT FLAG 
DIS3L2 by KpnI and NotI endonucleases and ligating them to the pcDNA4 FRT/TO 
vector. 
For immunofluorescence, the coding sequence of DIS3L2 was subcloned into 
pEGFP-N1 (GenBank Accession #U55762) and pEGFP-C3 vectors (GenBank Accession 
#: U57607) to obtain N-terminal and C-terminal EGFP fused tags, respectively. 
4.7.2 Preparation of specific DIS3L2 antibodies 
Part of coding sequence of DIS3L2 corresponding to aminoacids 135 – 298 was 
cloned into pET28b vector containing N-terminal fusion 6xHis-SMT3 tag (between NheI 
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and BamHI sites) using primers (forward 5ʹ′ 
CGGGATCCGCTGCGTATGAATCAGATATC 3ʹ′, reverse 5ʹ′ 
TGAAGCTTTTAGGCATAATCTTTAGGCCGTGC 3ʹ′) standard cloning techniques. 
Protein fragment was expressed in E. coli BL21-CodonPlus (DE3)-RIPL strain; cells 
were lysed in 100 mM dihydrogen sodium phosphate, 10 mM Tris-HCl and 8 M urea, pH 
8. Protein was purified by metal affinity chromatography on NiNTA beads (Qiagen) and 
released by low pH. Fractions containing eluted protein were collected together and 
dialysed for 72 hrs to 50 mM Tris, 300 mM NaCl, 5% glycerol, 0.02 % NP-40 and 1 mM 
β-mercaptoethanol. SMT3 tag was removed by Ulp1p cleavage at room temperature for 6 
hrs. After concentration by VIVASPIN 6 MWCO10 000 (Sartorius Stedim Biotech S.A.), 
3 mg of protein were separated from SMT3 tag on 18% SDS-PAGE, coomassie stained 
band corresponding to fragment of Dis3L2 protein was cut out from the gel and sent to 
Moravian-Biotechnology Ltd for rabbit immunization. 
4.7.3 Expression and purification of recombinant wild type and mutant proteins 
Recombinant DIS3L2 was expressed and purified from BL21-DE3 RIPL strain of 
E. coli. Bacterial cells were grown in at 37 °C, protein expression was induced at O.D. 
0.7 with 0.5 M IPTG at 27 °C for 2 hours. Cells were harvested by centrifugation and 
lysed by sonication in buffer containing 50 mM Tris pH 7.9, 500 mM NaCl, 10% 
glycerol, 2 mM 2-mercaptoethanol, and 0.1 % NP-40. Lysate was cleared by 
centrifugation (14000 rpm, 30 minutes, 4 °C). Protein was purified by Ni-NTA 
chromatography. SMT3 tag was removed by proteolysis with Ulp1 protease. Resulting 
recombinant DIS3L2 (rDIS3L2) was further purified by gel filtration on Superdex 200 
column (GE Healthcare) in buffer containing 20 mM Tris pH 7.9, 300 mM NaCl, 10% 
glycerol, 0.01 NP-40, 2 mM 2-mercaptoethanol, 10 mM imidazole. 
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4.7.4 In vitro degradation assay 
In vitro degradation assays were performed in 10 ul reaction volumes containing 
10 mM Tris pH 8.0, 50 mM KCl, 5 mM MgCl2, 10mM DTT (modified from (Staals et 
al., 2010, Tomecki et al., 2010, Lorentzen et al., 2008). Typically, 150 nM of purified 
protein and 20 pmol of 5ʹ′-end labeled RNA substrate, were incubated at 37 °C for the 
times indicated. Reactions were terminated with 1 volume of formamide loading buffer 
(80% formamide, 0.1% bromphenol blue, 0.1% xylene cyanol, 5mM EDTA). Reactions 
were resolved on denaturing 20% polyacrylamide gels containing 8 M urea. The 
radioactivity was exposed to phosphorimaging screen (FUJI) and scanned by 
phosphorimager FLA-9000 (FUJIFILM). 
4.7.5 RNA binding assay 
The binding reactions were performed in 10 µl volume. Recombinant DIS3L2 
was incubated with 5ʹ′-end labeled U30 RNA for 20 minutes at room temperature in 
binding buffer (50 mM KCl, 10 mM Tris pH 8.0, 10 mM DTT, 10% glycerol, 0.1 µg 
BSA). Proteins and RNAs were resolved on native 8% polyacrylamide under 100V for 
approximately 8 hours. Visualized by exposing to phosphorimaging screen (Fuji) and 
scanned by FLA-9000 (FUJIFILM). 
4.7.6 Northern blot analysis 
Total RNA was resolved on 10% denaturing polyacrylamide gel and transferred 
to Hybond-N+ membrane (GE Healthcare) by electroblotting (BioRad). The 
hybridization with radioactively labeled oligonucleotides was performed in ULTRAhyb-
oligo hybridizatioin buffer (Ambion) at 38 °C. Prior adding the labeled probe membrane 
was prehybridized at 42°C for 2 hours. The radioactive signal was monitored by 
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phosphorimager FLA-9000 (FUJIFILM). Quantification of signals was done using Multi 
Gauge software v3.2 (FUJIFILM). 
4.7.7 Purification of FLAG-DIS3L2 from human cells 
Flag-DIS3L2 was purified from stable HEK293 FlipIn cell line expressing the 
fusion protein. Cells were resuspended in 4 ml of ice cold lysis buffer (50 mM Tris pH 
8.0, 150 mM NaCl, 0.5% Triton X100 and Complete Protease Inhibitor Cocktail (Roche) 
and incubated rocking at 4 °C for 15 min. Lysate was cleared by centrifugation (14000 
rpm, 30 minutes, 4 °C). For purification of FLAG DIS3L2, 100 µl of anti-FLAG M2 
beads (Sigma-Aldrich) washed with lysis buffer were incubated with cell extract for 1 
hour in a cold room rotating. Beads were extensively washed with 10 volumes of wash 
buffer (50 mM Tris pH 8.0, 300 mM NaCl, 0.1% Triton X100). Protein elution was done 
with 1 volume of 3x FLAG peptide (Sigma-Aldrich) resuspended in lysis buffer or by 
boiling with SDS loading buffer for 5 min. 
4.7.8 PAR-CLIP  
Human embryonic kidney cells (HEK293 FlpIn, Invitrogen) stably expressing 
human N-terminal FLAG-DIS3L2 fusion protein were grown overnight in a medium 
supplemented with 100 mM 4-thiouracyl (4-SU). Cells were washed with 1xPBS and 
exposed to 150 mJ of 365 nm UV light in a Stratalinker 2400 device  (Stratagene). Cells 
were collected, frozen in liquid nitrogen and stored at -80°C. PAR-CLIP was performed 
essentially as described (Martin et al., 2012). Whole cell lysate was prepared in PNDS 
buffer (1x PBS, 0.5 NP-40, 0.25% deoxycholate, 0.05% SDS supplemented with 1 mM 
DTT, protease inhibitor cocktail (Roche) and RNase inhibitor RNAsin (Promega). 
Lysates were cleared by centrifugation and split in two aliquots. One aliquot was treated 
with 4 Units/ml and the other aliquot with 12 Units/ml of RNase I (Ambion, AM2294) 
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for 10 min at 32°C and pooled on ice. FLAG-tagged DIS3L2 was immunoprecipitated 
using anti-FLAG M2 monoclonal antibody (Sigma) bound to Protein G Dynabeads 
(Invitrogen). Beads were treated with alkaline phosphatase (Fast-AP, Fermentas). 3ʹ′ 
adaptor (P-UCGUAUGCCGUCUUCUGCUUGU-Pur) was ligated to the bound RNA 
with T4 RNA ligase (Fermentas) in buffer containing 25% PEG 8000 at 16°C over night. 
The crosslinked RNAs were radiolabeled with polynucleotide kinase (T4 PNK, NEB) and 
g-32P ATP. Protein-RNA complexes were resolved on a 4-12% gradient SDS-PAGE 
(NuPAGE, Invitrogen), the band corresponding to tagged DIS3L2 was cut out from the 
gel and eluted with proteinase K containing elution buffer (50mM Tris pH 7.5, 50 mM 
NaCl, 10 mM EDTA, 2 M urea, 2 mg/ml proteinase K) at 50°C for 2 hrs. RNAs were 
then ligated to 5ʹ′ adaptor (OH-GUUCAGAGUUCUACAGUCCGACGAUC-OH). RNA 
was size fractionated on 8% polyacrylamide- 8 M urea gel and 70-110 nt long RNA 
fragmets were eluted. Reverse transcription was done with a 3ʹ′ primer (5ʹ′ 
CAAGCAGAAGACGGCATACGA 3ʹ′) and with Superscript III reverse transcriptase 
(Invitrogen). Resulting cDNAs were used as templates for PCR amplification (5ʹ′ Primer: 
5ʹ′ AATGATACGGCGAC-CACCGACAGGTTCAG-AGTTCTACAGTCCGA 3ʹ′ and 
the lowest possible number of PCR cycles were used. The PCR products were sequenced 
on an Illumina Genome Analyzer IIx. 
4.7.9 Growth analysis 
Control HEK293T-Rex cells and cells overexpressing WT and D391N form of 
DIS3L2 were seeded into 24-well format plates at seeding density 0.5 x 105/ml per well. 
At times indicated, cells were collected, stained with 0.2% trypan blue solution (Sigma) 
and counted with LUNATM automated cell counter (Logos Biosystems) according to 
manufacturer instructions. Only live cells were included in the analysis. The resulting 
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growth curves represent the average result of at least tree independent measurements and 
error bars indicate standard deviations. 
4.7.10 siRNA-mediated knock down 
The day before transfections 1,7 x 105 cells were seeded. siRNA were transfected 
using INTERFERin transfecting reagent (Polyplus transfections) following the 
manufacturer instructions. Briefly, 10 – 30 nM of siRNAs were taken, polysomes formed 
by addition the transfecting reagent (8 – 15 µl). After 24 hours cells were re-transfected 
and collected for further experiments the next day. siRNA used in this study were 
obtained: siDIS3L2 (Dharmacon), Non-Targeting Control (Sigma). 
4.7.11 Immunofluorescence and image processing  
Cells expressing GFP-fusion proteins were plated in dishes with coverslips coated 
with 0.2% gelatin. Paraformaldehyde fixed cells were permeabilized with 0.2% Triton-
X100 in PBS in the presence of DAPI to stain the nucleus. Coverslips with FlouroMount 
reagent (Invitrogen) were mount to glass slides and fluorescent images were captured 
with a Leica DM 6000 B microscope. To visualize DAPI and GFP, 405 nm diode and 
Argon 488nm lasers were applied, respectively. 
Transfected HeLa cells were fixed with 3.7% PFA in PBS for 30 min, 
permeabilized with 0.2% Triton X-100 in PBS for 30 min and blocked with 5% horse 
serum in PBS for 1 h. All steps were performed at RT. Samples were incubated with 
primary antibodies (rabbit anti-DIS3L2) diluted 1:200 in the blocking buffer overnight at 
4°C. The next day, fixed cells were washed three times with 0.2% Triton X-100 in PBS 
(5 min) and incubated in the dark with the secondary antibody for 40 min at RT. Cy2-, 
Cy3-, or Cy5-conjugated donkey secondary antibodies (Jackson ImmunoResearch 
Laboratories, West Grove, PA) were used at dilutions of 1:200, 1:2,000, or 1:200 with 
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2.5% horse serum in PBS buffer, respectively. The cells were mounted in FluoroMount 
reagent (SouthernBiotech, Birmingham, AL) and pictures were captured with a confocal 
microscope Leica TSC SP5. 
4.7.12 H2O2 treatment 
Cells were treated with a standardized doze of hydrogen peroxide (5 mM) for 
times indicated and collected for the RNA isolation. 
4.7.13 Sucrose gradient fractionation for polysomal profilling 
Polysomes were isolated from one 15 cm dish of the cell lines HEK293T-Rex 
empty control, HEK293T-Rex Flag-DIS3L2 and HEK293T-Rex Flag-DIS3L2 D391N. 
Cells were cultured in DMEM supplemented with 10% fetal bovine serum without 
antibiotics. When indicated overproduction of both wt and mutant forms of the DIS3L2 
protein was achieved by adding doxycycline (100 ng/ml) directly to media. Actively 
growing cells (confluence around 85-90%) were treated with 10 µg/ml cycloheximide for 
5 minutes at 37°C, all subsequent steps were performed in a cold room. Cells were 
washed twice with cold PBS supplemented with 10 µg/ml cycloheximide and then lysed 
on plate using PB (100 mM KCl, 5 mM MgCl2, 10 mM HEPES pH 7, 10 µg/ml 
cycloheximide, 0.5 % NP-40, 1 mM DTT, 1 mM PMSF, 200 µg/ml Heparin, 100 U/ml 
RNAsin Plus, 2 mM vanadyl ribonucleoside complex, protease and phosphatase 
inhibitors). Lysates were incubated on ice for 15 min. and cleared by centrifugation at 15 
000 g for 15 min. Supernatants (24 Units) were separated in 5-45% sucrose gradients by 
ultracentrifugation (35 000 rpm, 105 min. in Beckman SW41 rotor at 4°C). Polysome 
profiles were fractionated (1 ml fractions) using an ISCO UA-5 gradient analyzer 
connected to a Clarity data acquisition station (DataApex). Proteins from individual 
fractions were ethanol precipitated and separated on 9% SDS-PAGE gels and proteins 
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were transferred and immobilized onto PVDF membranes. Proteins were detected by 
western blot analyses with antibodies indicated (α-DIS3L2 rabbit polyclonal serum 
1:800, and α-RPL8 (Abcam) goat polyclonal serum 1:500, Abcam). Both α-goat (Sigma) 
and α-rabbit (Promega) HRP secondary antibodies were diluted 1:5000.  
The polysome to monosome ratios were acquired using the Image SXM 193 
software (NIH). 
4.7.14 RNA immunoprecipitation 
Empty HEK293T-REX cells and HEK293T-REX FLAG DIS3L2 were grown to 
80% confluence. Washed with ice cold PBS and UV cross-linked   (400mJ, 254nm). 
Cells lysed in buffer containing 150mM NaCl, 50mM Tris pH 7.6, 0.5% Triton X 100, 
supplemented with protease inhibitors (EDTA-free Complete Protease Inhibitor Cocktail, 
Roche), 0.5mM EDTA, 1mM DTT, RNase In (Promega). Lysate cleared by 
centrifugation. Supernatant applied on FLAG M2 Magnetic beads (Sigma) and incubated 
for 60 min. Washed two times with Lysis buffer, two times with Lysis buffer containing 
300mM NaCl. RNA was eluted by treating whole beads with 2mg/ml Protease K (New 
England Biolabs) for 120 min at 37C. RNA was phenol/chlorophorm cleaned and ethanol 
precipitated.  After DNase treatment (Turbo DNase, Fermentas) equal amount of RNA 
was taken for the cDNA synthesis by Superscript III (Invitrogen). Obtained cDNA was 
used for semi quantitative PCR. Reaction resolved on 2% agarose gel. 
4.7.15 RNA isolation, cDNA synthesis and quantitative PCR 
Total RNA was isolated with TRIzol (Invitrogen) according to manufacturer 
instructions followed by RNase-free DNase (TURBO DNase, Fermentas) treatment. The 
RNA concentration was measured in a Beckman Coulter DU 730. 1 ug of purified RNA 
was reverse transcribed using random hexamers or oligo dT (as indicated) and 
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Superscript III reverse transcriptase (Invitrogen) according to manufacturer instructions. 
Real-time quantitative PCR (RT-qPCR) was performed using FastStart Universal SYBR 
Green Master (Roche) and gene-specific primer pairs on Q-PCR Light Cycler 7500 
(Applied Biosystems). Each experiment was performed in triplicate. Transcript 
abundance was calculated by the Delta Ct method. Data were normalized to an internal 
control of the housekeeping gene HPRT mRNA or RNU44 for small RNA detection. 
Results are expressed as means and standard errors of the mean. Statistical analyses were 
performed with a t test; P values < 0.05 were considered significant. 
The RNA for in vitro tests were either prepared by in vitro transcription (tRNA 
Ala) from DNA templates containing T7 promotor and T7 RNA polymerase or purchased 
as synthetic molecules from Dharmacon or Sigma. For the degradation assays and 
EMSA, the RNAs were radioactively labeled at the tRNA 5ʹ′ end by T4 polynucleotide 
kinase (New England Biolabs) and 32P gamma-ATP (company, MGP-Zlin).  
4.7.15 Read-to-genome mapping 
The high-throughput sequencing resulted in an average of 4 x 107 reads per 
sample. After filtering out reads with nucleotides that could not be unambiguously called, 
we mapped the reads to the human genome 19 assembly downloaded from the University 
of California at Santa Cruz (hg19) on the CLIPZ server (www.clipz.unibas.ch and 
(Khorshid et al., 2011). The copy numbers of reads that mapped to multiple locations 
(multi-mappers) were distributed equally among the possible mapping locations. Reads 
that did not map in the first step were processed to remove the intact and truncated CCAs 
at the 3' end and then remapped with the CLIPZ server. We merged the results of these 
two mapping steps and calculated the genome-wide crosslink scores as described in 
(Jaskiewicz et al., 2012). In the calculation of the crosslink score we used only uniquely 
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mapping reads that were not annotated by the CLIPZ server as being of bacterial, fungal, 
vector, marker/adaptor or viral origin.  
4.7.16 Annotation of the genomic crosslinked sites 
We used the RefSeq, snomir, and tRNA gene tracks (Dreszer et al., 2011) and the 
wgEncodeGencodeBasicV12 tracks for snRNA and rRNA genes (Rosenbloom et al., 
2012) from University of California at Santa Cruz (http://genome.cse.ucsc.edu). We 
further annotated the RefSeq genes with their biotype information and used one 
representative transcript from long-noncoding RNAs or mRNAs. The selection of the 
representative transcripts of single-locus genes were done based on a hierarchy of several 
criteria ordered by biotype (mRNA > non-coding RNA), RefSeq gene status (Reviewed > 
Validated > Inferred > Provisional > Predicted), length of genomic locus, and length of 
the exonic region with a higher precedence for the longer loci and transcripts. 
4.7.17 Estimation of expressed RefSeq mRNA genes and long non-coding RNA 
genes 
We used the CLIPZ server (Khorshid et al., 2011) to map the reads from two 
RNA-seq libraries prepared from HEK293 FlpIn cells overexpressing Flag-tagged 
DIS3L2 to the human genome (assembly version hg19) and processed the expression 
levels of the representative RefSeq transcripts to which at least one read longer than 25 nt 
and annotated as either “mRNA” or without a know annotation mapped.  We performed 
the expression estimation by fitting a two-component Gaussian Mixture model with 
unequal variance to the per-nucleotide read densities of the transcripts with the mclust R 
package (Fraley and Raftery, 2002). We used the union of genes belonging to the higher 
expression component of the mixture in the two libraries as the set of “expressed genes” 
and for the annotation of genomic crosslinked positions.  
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4.7.18 Gene set enrichment analysis  
We used the Ontologizer (version 2.0) tool for calculating the enriched Gene 
Ontology (GO) terms considering the expressed RefSeq genes as the total population of 
genes with the following additional parameters: -n -c Parent-Child-Union -m Westfall-
Young-Single-Step -d 0.1 -r 1000. 
4.7.19 Identification of mRNA targets of tRNA derived fragments 
To define the (tRNA/miRNA derived) guide sequences, we used uniquely 
mapping reads in AGO2 PAR-CLIP library that were longer than 20 nt. We identified 
those reads that mapped to tRNA/miRNA loci that contained one of the top 1,000 most 
significantly crosslinked genomic positions in the AGO2 CLIP library. We grouped these 
reads by their genomic start positions and summed up the read counts in each group. We 
then isolated 21-nucleotide-long regions from the start of each group that contained at 
least 100 reads and defined these as potential guide sequences. For each miRNA, we only 
used one guide, the one with the highest read count. For tRNAs, we used those putative 
guides that were at least over ½ of their length located in the 5' half of the tRNA. As 
potential target sequences, we took the top 3,000 mRNA-annotated, 51-nucleotides-long, 
crosslinked-centered regions. Finally, we used the MIRZA model for calculating the 
energy of hybrid structures formed between putative guide RNAs and target mRNAs 
(Khorshid et al., 2013) The MIRZA model is similar to those typically used for predicting 
RNA secondary structure and RNA-RNA interactions, but has an additional set of 
parameters corresponding to energy contributions of individual positions in the miRNA 
to the energy of miRNA-target interaction. Parameters of the model were inferred in 
Khorshid et al. (Khorshid et al., 2013) from the Ago2-CLIP site data of Kishore et al. 
(Kishore et al., 2011). 
 
 111 
4.8 REFERENCES 
AMBLAR, M. & ARRAIANO, C. M. 2005. A single mutation in Escherichia coli 
ribonuclease II inactivates the enzyme without affecting RNA binding. FEBS J, 
272, 363-74. 
ASTUTI, D., MORRIS, M. R., COOPER, W. N., STAALS, R. H., WAKE, N. C., 
FEWS, G. A., GILL, H., GENTLE, D., SHUIB, S., RICKETTS, C. J., COLE, T., 
VAN ESSEN, A. J., VAN LINGEN, R. A., NERI, G., OPITZ, J. M., RUMP, P., 
STOLTE-DIJKSTRA, I., MULLER, F., PRUIJN, G. J., LATIF, F. & MAHER, E. 
R. 2012. Germline mutations in DIS3L2 cause the Perlman syndrome of 
overgrowth and Wilms tumor susceptibility. Nat Genet, 44, 277-84. 
BABIARZ, J. E. & BLELLOCH, R. 2008. Small RNAs - their biogenesis, regulation and 
function in embryonic stem cells. StemBook. Cambridge (MA). 
BACHAND, F. & SILVER, P. A. 2004. PRMT3 is a ribosomal protein methyltransferase 
that affects the cellular levels of ribosomal subunits. EMBO J, 23, 2641-50. 
BAUER, S., GROSSMANN, S., VINGRON, M. & ROBINSON, P. N. 2008. Ontologizer 
2.0--a multifunctional tool for GO term enrichment analysis and data exploration. 
Bioinformatics, 24, 1650-1. 
BUHLER, M., SPIES, N., BARTEL, D. P. & MOAZED, D. 2008. TRAMP-mediated 
RNA surveillance prevents spurious entry of RNAs into the Schizosaccharomyces 
pombe siRNA pathway. Nat Struct Mol Biol, 15, 1015-23. 
CANELLA, D., PRAZ, V., REINA, J. H., COUSIN, P. & HERNANDEZ, N. 2010. 
Defining the RNA polymerase III transcriptome: Genome-wide localization of the 
RNA polymerase III transcription machinery in human cells. Genome Res, 20, 
710-21. 
CHAN, C. T., PANG, Y. L., DENG, W., BABU, I. R., DYAVAIAH, M., BEGLEY, T. J. 
& DEDON, P. C. 2012. Reprogramming of tRNA modifications controls the 
oxidative stress response by codon-biased translation of proteins. Nat Commun, 3, 
937. 
CHEN, C., RIDZON, D. A., BROOMER, A. J., ZHOU, Z., LEE, D. H., NGUYEN, J. T., 
BARBISIN, M., XU, N. L., MAHUVAKAR, V. R., ANDERSEN, M. R., LAO, 
K. Q., LIVAK, K. J. & GUEGLER, K. J. 2005. Real-time quantification of 
microRNAs by stem-loop RT-PCR. Nucleic Acids Res, 33, e179. 
COLE, C., SOBALA, A., LU, C., THATCHER, S. R., BOWMAN, A., BROWN, J. W., 
GREEN, P. J., BARTON, G. J. & HUTVAGNER, G. 2009. Filtering of deep 
sequencing data reveals the existence of abundant Dicer-dependent small RNAs 
derived from tRNAs. RNA, 15, 2147-60. 
COUVILLION, M. T., BOUNOVA, G., PURDOM, E., SPEED, T. P. & COLLINS, K. 
2012. A Tetrahymena Piwi bound to mature tRNA 3' fragments activates the 
exonuclease Xrn2 for RNA processing in the nucleus. Mol Cell, 48, 509-20. 
CZECH, B. & HANNON, G. J. 2011. Small RNA sorting: matchmaking for Argonautes. 
Nat Rev Genet, 12, 19-31. 
DAMGAARD, C. K. & LYKKE-ANDERSEN, J. 2011. Translational coregulation of 
5'TOP mRNAs by TIA-1 and TIAR. Genes Dev, 25, 2057-68. 
 112 
DARTY, K., DENISE, A. & PONTY, Y. 2009. VARNA: Interactive drawing and editing 
of the RNA secondary structure. Bioinformatics, 25, 1974-5. 
DRESZER, T. R., KAROLCHIK, D., ZWEIG, A. S., HINRICHS, A. S., RANEY, B. J., 
KUHN, R. M., MEYER, L. R., WONG, M., SLOAN, C. A., ROSENBLOOM, K. 
R., ROE, G., RHEAD, B., POHL, A., MALLADI, V. S., LI, C. H., LEARNED, 
K., KIRKUP, V., HSU, F., HARTE, R. A., GURUVADOO, L., GOLDMAN, M., 
GIARDINE, B. M., FUJITA, P. A., DIEKHANS, M., CLINE, M. S., 
CLAWSON, H., BARBER, G. P., HAUSSLER, D. & JAMES KENT, W. 2011. 
The UCSC Genome Browser database: extensions and updates 2011. Nucleic 
Acids Res, 40, D918-23. 
DZIEMBOWSKI, A., LORENTZEN, E., CONTI, E. & SERAPHIN, B. 2007. A single 
subunit, Dis3, is essentially responsible for yeast exosome core activity. Nat 
Struct Mol Biol, 14, 15-22. 
EDGAR, R., DOMRACHEV, M. & LASH, A. E. 2002. Gene Expression Omnibus: 
NCBI gene expression and hybridization array data repository. Nucleic Acids Res, 
30, 207-10. 
ELBARBARY, R. A., TAKAKU, H., UCHIUMI, N., TAMIYA, H., ABE, M., 
NISHIDA, H. & NASHIMOTO, M. 2009a. Human cytosolic tRNase ZL can 
downregulate gene expression through miRNA. FEBS Lett, 583, 3241-6. 
ELBARBARY, R. A., TAKAKU, H., UCHIUMI, N., TAMIYA, H., ABE, M., 
TAKAHASHI, M., NISHIDA, H. & NASHIMOTO, M. 2009b. Modulation of 
gene expression by human cytosolic tRNase Z(L) through 5'-half-tRNA. PLoS 
One, 4, e5908. 
EMARA, M. M., IVANOV, P., HICKMAN, T., DAWRA, N., TISDALE, S., 
KEDERSHA, N., HU, G. F. & ANDERSON, P. 2010. Angiogenin-induced 
tRNA-derived stress-induced RNAs promote stress-induced stress granule 
assembly. J Biol Chem, 285, 10959-68. 
ENDER, C., KREK, A., FRIEDLANDER, M. R., BEITZINGER, M., WEINMANN, L., 
CHEN, W., PFEFFER, S., RAJEWSKY, N. & MEISTER, G. 2008. A human 
snoRNA with microRNA-like functions. Mol Cell, 32, 519-28. 
FRALEY, C. & RAFTERY, A. E. 2002. Model-based clustering, discriminant analysis, 
and density estimation. J. Am. Stat. Assoc., 97, 611–631. 
FRAZAO, C., MCVEY, C. E., AMBLAR, M., BARBAS, A., VONRHEIN, C., 
ARRAIANO, C. M. & CARRONDO, M. A. 2006. Unravelling the dynamics of 
RNA degradation by ribonuclease II and its RNA-bound complex. Nature, 443, 
110-4. 
FU, H., FENG, J., LIU, Q., SUN, F., TIE, Y., ZHU, J., XING, R., SUN, Z. & ZHENG, 
X. 2009. Stress induces tRNA cleavage by angiogenin in mammalian cells. FEBS 
Lett, 583, 437-42. 
HAUSSECKER, D., HUANG, Y., LAU, A., PARAMESWARAN, P., FIRE, A. Z. & 
KAY, M. A. 2010. Human tRNA-derived small RNAs in the global regulation of 
RNA silencing. RNA, 16, 673-95. 
 113 
HEYER, R., DORR, M., JELLEN-RITTER, A., SPATH, B., BABSKI, J., JASCHINSKI, 
K., SOPPA, J. & MARCHFELDER, A. 2012. High throughput sequencing 
reveals a plethora of small RNAs including tRNA derived fragments in Haloferax 
volcanii. RNA Biol, 9, 1011-8. 
HOUSELEY, J., LACAVA, J. & TOLLERVEY, D. 2006. RNA-quality control by the 
exosome. Nat Rev Mol Cell Biol, 7, 529-39. 
HOUSELEY, J. & TOLLERVEY, D. 2009. The many pathways of RNA degradation. 
Cell, 136, 763-76. 
IVANOV, P., EMARA, M. M., VILLEN, J., GYGI, S. P. & ANDERSON, P. 2011. 
Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell, 43, 
613-23. 
JASKIEWICZ, L., BILEN, B., HAUSSER, J. & ZAVOLAN, M. 2012. Argonaute CLIP 
- A method to identify in vivo targets of miRNAs. Methods. 
JOCHL, C., REDERSTORFF, M., HERTEL, J., STADLER, P. F., HOFACKER, I. L., 
SCHRETTL, M., HAAS, H. & HUTTENHOFER, A. 2008. Small ncRNA 
transcriptome analysis from Aspergillus fumigatus suggests a novel mechanism 
for regulation of protein synthesis. Nucleic Acids Res, 36, 2677-89. 
KENT, W. J., SUGNET, C. W., FUREY, T. S., ROSKIN, K. M., PRINGLE, T. H., 
ZAHLER, A. M. & HAUSSLER, D. 2002. The human genome browser at UCSC. 
Genome Res, 12, 996-1006. 
KHORSHID, M., HAUSSER, J., ZAVOLAN, M. & VAN NIMWEGEN, E. 2013. A 
biophysical miRNA-mRNA interaction model infers canonical and noncanonical 
targets. Nat Methods, 10, 253-5. 
KHORSHID, M., RODAK, C. & ZAVOLAN, M. 2011. CLIPZ: a database and analysis 
environment for experimentally determined binding sites of RNA-binding 
proteins. Nucleic Acids Res, 39, D245-52. 
KISHORE, S., JASKIEWICZ, L., BURGER, L., HAUSSER, J., KHORSHID, M. & 
ZAVOLAN, M. 2011. A quantitative analysis of CLIP methods for identifying 
binding sites of RNA-binding proteins. Nat Methods, 8, 559-64. 
LANDGRAF, P., RUSU, M., SHERIDAN, R., SEWER, A., IOVINO, N., ARAVIN, A., 
PFEFFER, S., RICE, A., KAMPHORST, A. O., LANDTHALER, M., LIN, C., 
SOCCI, N. D., HERMIDA, L., FULCI, V., CHIARETTI, S., FOA, R., 
SCHLIWKA, J., FUCHS, U., NOVOSEL, A., MULLER, R. U., SCHERMER, 
B., BISSELS, U., INMAN, J., PHAN, Q., CHIEN, M., WEIR, D. B., CHOKSI, 
R., DE VITA, G., FREZZETTI, D., TROMPETER, H. I., HORNUNG, V., 
TENG, G., HARTMANN, G., PALKOVITS, M., DI LAURO, R., WERNET, P., 
MACINO, G., ROGLER, C. E., NAGLE, J. W., JU, J., PAPAVASILIOU, F. N., 
BENZING, T., LICHTER, P., TAM, W., BROWNSTEIN, M. J., BOSIO, A., 
BORKHARDT, A., RUSSO, J. J., SANDER, C., ZAVOLAN, M. & TUSCHL, T. 
2007. A mammalian microRNA expression atlas based on small RNA library 
sequencing. Cell, 129, 1401-14. 
LEBRETON, A., TOMECKI, R., DZIEMBOWSKI, A. & SERAPHIN, B. 2008. 
Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature, 456, 993-6. 
 114 
LEE, R. C., FEINBAUM, R. L. & AMBROS, V. 1993. The C. elegans heterochronic 
gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 
75, 843-54. 
LEE, Y. S., SHIBATA, Y., MALHOTRA, A. & DUTTA, A. 2009. A novel class of 
small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev, 23, 2639-49. 
LI, Y., LUO, J., ZHOU, H., LIAO, J. Y., MA, L. M., CHEN, Y. Q. & QU, L. H. 2008. 
Stress-induced tRNA-derived RNAs: a novel class of small RNAs in the primitive 
eukaryote Giardia lamblia. Nucleic Acids Res, 36, 6048-55. 
LI, Z., ENDER, C., MEISTER, G., MOORE, P. S., CHANG, Y. & JOHN, B. 2012. 
Extensive terminal and asymmetric processing of small RNAs from rRNAs, 
snoRNAs, snRNAs, and tRNAs. Nucleic Acids Res, 40, 6787-99. 
LIU, Q., GREIMANN, J. C. & LIMA, C. D. 2006. Reconstitution, activities, and 
structure of the eukaryotic RNA exosome. Cell, 127, 1223-37. 
LORENTZEN, E., BASQUIN, J., TOMECKI, R., DZIEMBOWSKI, A. & CONTI, E. 
2008. Structure of the active subunit of the yeast exosome core, Rrp44: diverse 
modes of substrate recruitment in the RNase II nuclease family. Mol Cell, 29, 
717-28. 
LOWE, T. M. & EDDY, S. R. 1997. tRNAscan-SE: a program for improved detection of 
transfer RNA genes in genomic sequence. Nucleic Acids Res, 25, 955-64. 
MARTIN, G., GRUBER, A. R., KELLER, W. & ZAVOLAN, M. 2012. Genome-wide 
analysis of pre-mRNA 3' end processing reveals a decisive role of human 
cleavage factor I in the regulation of 3' UTR length. Cell Rep, 1, 753-63. 
MATSUMOTO, K., AOKI, K., DOHMAE, N., TAKIO, K. & TSUJIMOTO, M. 2000. 
CIRP2, a major cytoplasmic RNA-binding protein in Xenopus oocytes. Nucleic 
Acids Res, 28, 4689-97. 
MAYR, C. & BARTEL, D. P. 2009. Widespread shortening of 3'UTRs by alternative 
cleavage and polyadenylation activates oncogenes in cancer cells. Cell, 138, 673-
84. 
MITCHELL, P., PETFALSKI, E., SHEVCHENKO, A., MANN, M. & TOLLERVEY, 
D. 1997. The exosome: a conserved eukaryotic RNA processing complex 
containing multiple 3'-->5' exoribonucleases. Cell, 91, 457-66. 
NELSON, P. T., HATZIGEORGIOU, A. G. & MOURELATOS, Z. 2004. 
miRNP:mRNA association in polyribosomes in a human neuronal cell line. RNA, 
10, 387-94. 
NEUMANN, B., WALTER, T., HERICHE, J. K., BULKESCHER, J., ERFLE, H., 
CONRAD, C., ROGERS, P., POSER, I., HELD, M., LIEBEL, U., CETIN, C., 
SIECKMANN, F., PAU, G., KABBE, R., WUNSCHE, A., SATAGOPAM, V., 
SCHMITZ, M. H., CHAPUIS, C., GERLICH, D. W., SCHNEIDER, R., EILS, 
R., HUBER, W., PETERS, J. M., HYMAN, A. A., DURBIN, R., PEPPERKOK, 
R. & ELLENBERG, J. 2010. Phenotypic profiling of the human genome by time-
lapse microscopy reveals cell division genes. Nature, 464, 721-7. 
PERLMAN, M. 1986. Perlman syndrome: familial renal dysplasia with Wilms tumor, 
fetal gigantism, and multiple congenital anomalies. Am J Med Genet, 25, 793-5. 
 115 
QUINLAN, A. R. & HALL, I. M. 2010. BEDTools: a flexible suite of utilities for 
comparing genomic features. Bioinformatics, 26, 841-2. 
ROSENBLOOM, K. R., DRESZER, T. R., LONG, J. C., MALLADI, V. S., SLOAN, C. 
A., RANEY, B. J., CLINE, M. S., KAROLCHIK, D., BARBER, G. P., 
CLAWSON, H., DIEKHANS, M., FUJITA, P. A., GOLDMAN, M., GRAVELL, 
R. C., HARTE, R. A., HINRICHS, A. S., KIRKUP, V. M., KUHN, R. M., 
LEARNED, K., MADDREN, M., MEYER, L. R., POHL, A., RHEAD, B., 
WONG, M. C., ZWEIG, A. S., HAUSSLER, D. & KENT, W. J. 2012. ENCODE 
whole-genome data in the UCSC Genome Browser: update 2012. Nucleic Acids 
Res, 40, D912-7. 
SAXENA, S. K., RYBAK, S. M., DAVEY, R. T., JR., YOULE, R. J. & ACKERMAN, 
E. J. 1992. Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A 
superfamily. J Biol Chem, 267, 21982-6. 
SCHNEIDER, C., ANDERSON, J. T. & TOLLERVEY, D. 2007. The exosome subunit 
Rrp44 plays a direct role in RNA substrate recognition. Mol Cell, 27, 324-31. 
SCHNEIDER, C., LEUNG, E., BROWN, J. & TOLLERVEY, D. 2009. The N-terminal 
PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and 
tethers Rrp44 to the yeast core exosome. Nucleic Acids Res, 37, 1127-40. 
STAALS, R. H., BRONKHORST, A. W., SCHILDERS, G., SLOMOVIC, S., 
SCHUSTER, G., HECK, A. J., RAIJMAKERS, R. & PRUIJN, G. J. 2010. Dis3-
like 1: a novel exoribonuclease associated with the human exosome. EMBO J, 29, 
2358-67. 
TAKAKU, H., MINAGAWA, A., TAKAGI, M. & NASHIMOTO, M. 2003. A candidate 
prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease. 
Nucleic Acids Res, 31, 2272-8. 
THOMPSON, D. M., LU, C., GREEN, P. J. & PARKER, R. 2008. tRNA cleavage is a 
conserved response to oxidative stress in eukaryotes. RNA, 14, 2095-103. 
THOMPSON, D. M. & PARKER, R. 2009. The RNase Rny1p cleaves tRNAs and 
promotes cell death during oxidative stress in Saccharomyces cerevisiae. J Cell 
Biol, 185, 43-50. 
TOMECKI, R., KRISTIANSEN, M. S., LYKKE-ANDERSEN, S., CHLEBOWSKI, A., 
LARSEN, K. M., SZCZESNY, R. J., DRAZKOWSKA, K., PASTULA, A., 
ANDERSEN, J. S., STEPIEN, P. P., DZIEMBOWSKI, A. & JENSEN, T. H. 
2010. The human core exosome interacts with differentially localized processive 
RNases: hDIS3 and hDIS3L. EMBO J, 29, 2342-57. 
ULE, J., JENSEN, K., MELE, A. & DARNELL, R. B. 2005. CLIP: a method for 
identifying protein-RNA interaction sites in living cells. Methods, 37, 376-86. 
VANACOVA, S. & STEFL, R. 2007. The exosome and RNA quality control in the 
nucleus. EMBO Rep, 8, 651-7. 
VARKONYI-GASIC, E., WU, R., WOOD, M., WALTON, E. F. & HELLENS, R. P. 
2007. Protocol: a highly sensitive RT-PCR method for detection and 
quantification of microRNAs. Plant Methods, 3, 12. 
 116 
VOLAREVIC, S. & THOMAS, G. 2001. Role of S6 phosphorylation and S6 kinase in 
cell growth. Prog Nucleic Acid Res Mol Biol, 65, 101-27. 
WANG, Y., JURANEK, S., LI, H., SHENG, G., TUSCHL, T. & PATEL, D. J. 2008. 
Structure of an argonaute silencing complex with a seed-containing guide DNA 
and target RNA duplex. Nature, 456, 921-6. 
WANG, Z., TOLLERVEY, J., BRIESE, M., TURNER, D. & ULE, J. 2009. CLIP: 
construction of cDNA libraries for high-throughput sequencing from RNAs cross-
linked to proteins in vivo. Methods, 48, 287-93. 
WIGHTMAN, B., HA, I. & RUVKUN, G. 1993. Posttranscriptional regulation of the 
heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. 
elegans. Cell, 75, 855-62. 
XUE, Z., YUAN, H., GUO, J. & LIU, Y. 2012. Reconstitution of an Argonaute-
dependent small RNA biogenesis pathway reveals a handover mechanism 
involving the RNA exosome and the exonuclease QIP. Mol Cell, 46, 299-310. 
YAMASAKI, S., IVANOV, P., HU, G. F. & ANDERSON, P. 2009. Angiogenin cleaves 
tRNA and promotes stress-induced translational repression. J Cell Biol, 185, 35-
42.
 117 
Chapter 5:  Ewing sarcoma breakpoint region 1 protein binds G-rich 
RNAs and prevents transcription-associated genome instability 
Shivendra Kishore1,3,4, Biter Bilen1,4, Christophe Kunz2, Nitish Mittal1, Severin Berger1,  
Friedel Wenzel2, Georges Martin1, Erik van Nimwegen1, Primo Schär2, Mihaela 
Zavolan1,* 
1Biozentrum, University of Basel, Klingelbergstrasse 50-70, 4056 Basel, Switzerland 
2Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, 
Switzerland 
3Present address: Centogene AG, Schillingallee 68, 18057 Rostock, Germany 
4Equal contribution 
*Corresponding author (Email: mihaela.zavolan@unibas.ch, Phone: +41 612671577, Fax: 
+41 612671585) 
Running title: EWS binding, transcription, and genome instability 
Keywords: transcription-associated stress; RNA-binding; genome instability; Rloop; 
Ewing sarcoma; FET family; RNA polymerase II elongation; RNAPII; intron retention; 
DNA double strand break 
5.1 SUMMARY 
RNA-binding proteins (RBPs) are not only involved in RNA processing but also 
in the maintenance of genome stability by modulating RNA-DNA interactions. In this 
context, we studied the Ewing’s sarcoma breakpoint region 1 (EWS/EWSR1) protein, 
whose RNA-binding domain is lost when diagnostic chromosomal translocations occur in 
Ewing sarcoma. With in vivo crosslinking and high-throughput sequencing, we found 
that EWS binds G-rich RNAs that originate from intrinsically fragile genomic regions 
such as sub-telomeres, introns including those from its own chromosomal translocation-
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prone region, and predicted R-loops. EWS appears to promote the RNA polymerase II 
elongation through these loci, which also increases intron retention. EWS depletion 
increases the instability of its own locus and the frequency of spontaneous DNA double 
strand breaks (DSBs), but does not affect the level of induced DNA damage. These 
results highlight the importance of EWS in relieving transcription-associated stress and 
may link its loss to Ewing sarcoma tumorigenicity. 
5.2 HIGHLIGHTS 
• EWS binds G-rich RNAs from intrinsically fragile regions 
• RNA polymerase II elongation is promoted at the loci of EWS’ RNA targets 
• EWS depletion increases the level of stochastic but not induced DNA damage 
• EWS relieves transcription-associated stress 
5.3 INTRODUCTION 
R-loops are DNA-RNA hybrid structures that form between guanine (G)-rich 
nascent RNA and the template DNA strand leaving the non-template strand in a single 
stranded conformation. They play a role in many biological processes such as 
immunoglobulin class switching, telomere homeostasis, and protection of CpG island 
promoters from methylation (reviewed in (Wahba and Koshland, 2013)). However, their 
formation was linked to genomic instability mostly through the stalling of RNA 
polymerase II (RNAPII), which leads to collisions between the transcription and DNA 
replication machineries and DNA breaks. These in turn lead to mutations and 
chromosomal rearrangements (reviewed in (Aguilera and García-Muse, 2012)), whose 
accumulation predisposes to ageing and cancer. Various mechanisms have evolved to 
counteract such deleterious effects of R-loops. Co-transcriptional assembly of 
ribonucleoprotein complexes prevents the accumulation of naked nascent RNA and 
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thereby the accumulation of R-loops in eukaryotes (reviewed in (Kim and Jinks-
Robertson, 2012)). Consistently, mutations in RNAPII subunits and perturbation of RNA 
processing lead to an increase in the frequency and length of R-loops (Wahba et al., 2011, 
Li and Manley, 2005, Stirling et al., 2012, Domínguez-Sánchez et al., 2011). Moreover, a 
high-throughput genetic screen revealed that many RBPs, particularly those that are 
involved in splicing and RNA processing, reduce R-loop formation and thereby the level 
of DNA damage. This indicates that RBPs have a substantial impact on the maintenance 
of genome stability (Paulsen et al., 2009). 
EWS is a ubiquitously expressed nuclear RBP and was initially identified as part 
of a fusion protein in Ewing sarcoma, a rare but malignant bone and soft tissue tumor. 
The fusion protein is the result of a chromosomal translocation that juxtaposes the EWS 
gene to a transcription factor (TF) gene with the concomitant loss of the RNA-binding 
domain of EWS (Delattre et al., 1992). Similarly, recurrent translocations are observed in 
distinct types of sarcomas and leukemias involving EWS’ paralogs fused in sarcoma 
(FUS) and TATA-box binding protein-associated factor 15 (TAF15) (reviewed in 
(Kovar, 2011)), which together with EWS form the FET (FUS-EWS-TAF15) family of 
genes. The function of the wildtype EWS is not well understood. In vitro, the protein 
binds uridine(U)- and guanine(G)-rich RNAs (Ohno et al., 1994). In vivo, it interacts 
directly with components of RNAPII and with splicing factors (reviewed in (Kovar, 
2011)). Consistently, EWS was found to regulate alternative splicing of genes involved in 
genotoxic stress signaling (Paronetto et al., 2011, Sanchez et al., 2008), which in turn 
would predict an indirect role of EWS in DNA damage response (DDR). The knockout of 
EWS impairs B-lymphocyte maturation and meiosis in mice (Li et al., 2007) and its 
knockdown leads to chromosome segregation defects during mitosis in zebrafish (Azuma 
et al., 2007). These findings suggest that EWS and specifically, its RNA-binding activity, 
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plays a role in the maintenance of genomic integrity, and that the loss of EWS’ RNA 
binding domain contributes to the pathogenesis of Ewing sarcoma. 
To investigate this hypothesis we identified the transcriptome-wide targets of 
EWS with an in vivo crosslinking method. We showed that EWS binds G-rich RNAs that 
originate from intrinsically fragile genomic regions such as sub-telomeres and the introns 
of the FET family members where cancer-related translocations occur. Overall, EWS 
predominantly bound intronic RNAs, and the EWS-targeted regions had a propensity to 
form R-loops. The rate of RNAPII elongation appeared to be higher in introns that are 
bound by EWS compared to R-loop forming introns, and, consistently, depletion of EWS 
lead to decreased intron retention. Furthermore, EWS depletion increased the frequency 
of DNA double-strand breaks (DSBs) in untreated cells but did not affect the level of 
induced DSBs. Finally, depletion of EWS resulted in breaks at the EWS locus, breaks 
that occurred precisely in the region that is prone to genomic rearrangements and from 
which EWS-bound RNA fragments originate. Altogether, these results suggest that EWS’ 
activity in binding G-rich RNAs may play a role in the prevention of transcription-
associated genotoxic stress at intrinsically fragile genomic loci. The loss of this protective 
activity could, in turn, contribute to the development of Ewing sarcoma. 
5.4 RESULTS 
5.4.1 EWS targets G-rich intronic RNAs in vivo 
To identify in vivo targets of endogenous EWS we carried out photo-reactive 
nucleoside-enhanced crosslinking and immuno-precipitation (PAR-CLIP) (Hafner et al., 
2010, Kishore et al., 2011) in human embryonic kidney 293 (HEK293) cells.  While 
EWS specific antibody recognized a ~80kDa protein, immuno-precipitation of EWS with 
the associated RNAs revealed two bands at ~90kDa (EWS A) and ~120kDa (EWS B) 
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(Figure 1A). Deep sequencing libraries generated from these bands yielded 21,274,257 
and 32,468,723 reads respectively, which we mapped to the reference human genome and 
to the known transcripts with CLIPZ server (Khorshid et al., 2011). More than 80% of the 
uniquely mapping reads originated from protein coding and long non-coding RNA genes, 
repeats, or unannotated regions. We therefore determined EWS binding sites in RNAs 
from these functional categories with a method that takes advantage of crosslink-induced 
mutations (Jaskiewicz et al., 2012). Illustrative patterns of read coverage in the 
translocation prone loci of the FET genes are shown in Figure 1B. EWS bound relatively 
broad regions, but the read coverage from the two samples was very similar. To further 
assess the similarity of the samples, we computed the distances between crosslinked 
positions in EWS A and the closest crosslinked positions in EWS B. For comparison, we 
also computed the distances between the crosslinked positions in EWS A and the closest 
positions where another nuclear protein, Hu antigen R (HuR), crosslinked. We found that 
the top crosslinking positions identified from the EWS A sample were located closer to 
the crosslinked positions inferred from the EWS B sample than they were to positions 
that crosslinked to HuR, with very high significance (Figure 1C; Kolmogorov-Smirnov 
test p-value=0, statistic=0.81); half of the top crosslinked positions inferred from the 
EWS A sample were located less than 10 nucleotides (nts) away from a top crosslinked 
position from the EWS B sample. Hence, to obtain the genome-wide binding sites of 
EWS, we combined the reads from these two samples and defined a unique set of targets 
for further analysis (Jaskiewicz et al., 2012). 
To determine the in vivo sequence specificity of EWS, we submitted 10,000 top-
scoring EWS target regions to the MEME motif discovery tool (Bailey, 2002a). We 
obtained a significant G-rich motif that occurred 8 nts upstream of the crosslinked 
position in almost all crosslinked regions (Figure 1D; e-value=2.8e-644). This indicates 
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that, similar to what was observed in vitro (Ohno et al., 1994), EWS binds G-rich 
sequences in vivo. Scanning an extended set of regions with the FIMO motif search tool 
(Grant et al., 2011) we observed a modest inverse relation between the log-likelihood of 
the motif and the crosslink score of the region. The motif likelihood dropped slightly 
after the top 20,000 crosslinks and we therefore used only these positions for further 
analysis.  
We mapped the crosslinking positions onto gene structures defined by 
representative RefSeq transcripts (Meyer et al., 2013) to determine the positional 
preference of EWS within gene bodies. We found that EWS preferentially binds introns 
and 3’ untranslated regions (UTRs) (Figure 1E inset); among 1,143 target transcripts, 698 
(61%) were crosslinked at least once in introns, 298 (26%) in 3’ untranslated regions 
(UTRs), and 35-220 (<20%) in other sub-regions. While most transcripts harbored only a 
few of the top crosslinking positions (median count of 3) (Figure 1E), 62 (5%) transcripts 
were extensively crosslinked at >50 positions, most of which were located in introns. 
These results suggest that EWS mainly targets intronic regions of transcripts. Functional 
annotation of EWS target transcripts based on the KEGG pathway gene sets (Kanehisa et 
al., 2014) revealed that EWS targets components of signaling pathways that are involved 
in splicing, metabolism, immune response and cancers (Figure 1F). 
5.4.2 EWS promotes RNAPII elongation 
To better understand the role of EWS in intronic regions, we asked whether the 
protein has a more fine-grained positional preference. Indeed, we found that EWS tends 
to target initial introns. This positional preference was stronger for EWS than for GU-rich 
element binding heterogeneous nuclear ribonucleoproteins (hnRNPs) such as hnRNPH, 
hnRNPM, hnRNPF, hnRNPA2B1, hnRNPU, and hnRNPA1 whose binding specificity 
 123 
was studied by Huelga et al. (Huelga et al., 2012) (Figure 2A); in particular, EWS bound 
initial introns of 325 transcripts and second introns of 120 transcripts, which gives a 2.7-
fold ratio. Furthermore, EWS binding was enriched downstream of transcription start 
sites (TSSs) in the initial introns; 81 (25%) initial introns were bound in the 5’-most 10% 
of their length, which is 2.5-fold higher than that would be expected if the coverage of the 
initial intron were uniform (Figure 2B; Kolmogorov-Smirnov test 
p−value=5.383182e−11, statistic=0.19). These results suggest that EWS preferentially 
targets transcripts downstream of TSSs. 
The sequence composition of EWS-bound regions and their location within 
transcripts is reminiscent of R-loops (Ginno et al., 2012). To investigate the hypothesis 
that EWS targets RNAs that are prone to form R-loops, we analyzed a dataset of genome-
wide R-loop predictions from Ginno et al. (Ginno et al., 2012). We found that 508 (49%) 
of the 1,043 transcripts bound by EWS at genic regions also formed R-loops (Figure 2C 
inset; Fisher’s exact test p-value= 4.4e-35, odds-ratio=2.3) and the positions where EWS 
crosslinked within these 508 co-targeted transcripts were closer to R-loops than expected 
by chance (Figure 2C; Kolmogorov-Smirnov test p−value=5.775462e−18, statistic=0.28). 
Even more specifically, 60 (41%) of the 148 transcripts that were bound by EWS 
downstream of TSSs - that is, in the 5’ UTRs or in the first 10% of initial introns - also 
formed R-loops precisely in this region. These results suggest that the RNAs that are 
targeted by EWS are prone to form R-loops with the template DNA. 
To gain insight into the role of EWS binding at R-loop-forming regions, we 
analyzed the rate of RNAPII elongation in these regions. From chromatin immuno-
precipitation and sequencing (ChIP-seq) data obtained from HEK293 cells by the 
ENCODE consortium (Rosenbloom et al., 2013), we determined the read density of 
RNAPII in introns, normalized by the read density in the respective gene locus. We then 
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analyzed the RNAPII occupancy in the following mutually exclusive categories of 
introns: introns exclusively bound by EWS, introns that are only predicted to form R-
loops, introns that are both predicted to form R-loops and bound EWS and all other 
introns of crosslinked genes that are expressed in HEK293 cells. Consistent with a slow 
rate of RNAPII elongation through these regions, R-loop-forming introns had the highest 
read densities (Figure 2D). In contrast, the introns that were exclusively bound by EWS 
had much lower densities of RNAPII compared to those that form R-loops (Figure 2D, 
Kolmogorov-Smirnov test p-value=1.657989e−50, statistic=0.32). The introns that are 
predicted to form R-loops but were also bound by EWS showed an intermediate level of 
RNAPII density (Kolmogorov-Smirnov test p-value=1.086846e−08, statistic=0.2). These 
results suggest that EWS binding promotes RNAPII elongation along pre-mRNAs and 
counteracts R-loop formation at specific regions. 
The rate of RNAPII elongation affects the recognition of splicing signals and 
thereby alternative splicing (reviewed in (Dujardin et al., 2013). One of the models that 
was proposed to explain the coupling between transcription and splicing is the “kinetic 
model”, which postulates that a slow elongating RNAPII allows more time for the 
recognition of weak splice signals, reducing the frequency of intron retention. 
Consistently, a recent genome-wide study of co-transcriptional splicing in fly found that 
intron retention is reduced in cells that express a slow-elongating RNAPII mutant 
(Khodor et al., 2011). To test whether the apparent role of EWS in promoting RNAPII 
elongation is reflected in intron retention in EWS target genes, we analyzed the 
polyadenylated transcriptome obtained from HeLa cells that we transfected with either 
EWS or control small interfering RNAs (siRNAs). We obtained 30-60 million sequence 
reads, which we mapped to the reference human genome and to known transcripts with 
the CLIPZ server (Khorshid et al., 2011). The EWS mRNA levels were approximately 4-
 125 
fold reduced in the EWS siRNA-treated sample compared to the control indicating that 
the knockdown was efficient. We found that the EWS knockdown preferentially reduced 
the retention of EWS target introns: ~70% of the 699 introns that were only bound by 
EWS, compared to ~60% of the 235 that were also predicted to form R-loops and to 
~50% of the 2,758 that were only predicted to form R-loops had a reduced level of 
retention in EWS compared to control siRNA-treated cells (Figure 2E; Kolmogorov-
Smirnov test in comparing the first two categories of introns with the latter p-
value=1.138928e−16, statistic=0.18 and p-value=0.000179687, statistic=0.14, 
respectively). These results suggest that, consistent with a role in promoting RNAPII 
elongation, EWS leads to increased retention of its target introns. 
5.4.3 EWS acts in the prevention of transcription-associated stress 
Since co-transcriptional formation of R-loops has been associated with 
chromosomal instability, we sought to determine whether EWS protects against DNA 
damage. Phosphorylation of histone 2A variant X (H2AX) is an early event in the DDR 
(Rogakou et al., 1998) and H2AX has been shown to localize preferentially at 
endogenous DNA stress sites such as sub-telomeres and transcriptionally active loci in 
rapidly dividing cells (Seo et al., 2012). Re-analyzing H2AX ChIP-seq data obtained 
from Jurkat T cells by Seo et al. (Seo et al., 2012), we found that the loci of the RNA 
targets of EWS are strikingly similar to those bound by H2AX. EWS associated with 
RNAs originating from sub-telomeric regions, where H2AX also preferentially binds 
(Figure 3A; Kolmogorov-Smirnov test in comparing the distribution of EWS binding 
regions relative to a uniform distribution p-value=0, statistic=0.24); 52% (10,443) of 
19,964 crosslinked positions on the assembled human chromosomes were located within 
the first or last 5% of the chromosomes’ lengths. EWS and H2AX co-targeting was 
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evident also at the level of individual genes (Figure 3B inset; Fisher’s exact test p-
value=9.1e-39, odds-ratio=4.6) and even at the level of binding regions; within the 140 
co-targeted gene loci, EWS crosslinks occurred significantly closer to the H2AX peaks 
relative to what would be expected if the H2AX loci were randomly distributed within 
the genes (Figure 3B; Kolmogorov-Smirnov test p−value=5.775462e−18, statistic=0.28). 
These results suggest that EWS targets RNAs that are transcribed from regions that are 
prone to genomic instability. 
Phosphorylated H2AX (γH2AX) and p53-binding protein 1 (53BP1) mark sites 
where the non-homologous end joining (NHEJ) system engages to repair DSBs 
(Nakamura et al., 2006). To further determine whether EWS depletion increases the 
frequency of DNA DSBs, we examined by immunofluorescence the frequency of γH2AX 
and 53BP1 co-staining nuclear foci upon short hairpin RNA (shRNA) mediated 
knockdown of EWS. Transfection of EWS shRNA markedly reduced EWS protein levels 
compared to control shRNA in both HeLa and osteosarcoma (U2OS) cells. We found that 
depletion of EWS significantly increased the frequency of γH2AX/53BP1 co-foci in both 
HeLa and U2OS cells (Figure 3C; Kruskal-Wallis test p-value<0.0001), similar to the 
treatment with camptothecin (CPT), a DNA damaging agent that acts as a topoisomerase 
1 poison to cause transcriptional arrest and replication fork collapse (Liu et al., 2000). We 
observed a median number of 1, 7.5, 13, and 22 γH2AX/53BP1 co-foci in HeLa cells 
treated with control shRNA, EWS shRNA, sublethal-dose of CPT, and high-dose of CPT, 
respectively and 0, 5, 23.5 γH2AX/53BP1 co-foci in U2OS cells treated with control 
shRNA, EWS shRNA, and high-dose of CPT, respectively. EWS shRNA did not 
significantly increase the number of foci in cells in which DNA damage was induced 
with a high-dose of CPT: a median number of 23 compared to 22 foci were observed in 
HeLa cells and 27.5 compared to 23.5 foci in U2OS cells that were treated with EWS 
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shRNA and control shRNA, respectively (Figure 3C; Kruskal-Wallis test p-value=non-
significant (ns)). Thus, while the knockdown of EWS has a significant effect on the 
steady state levels of γH2AX/53BP1 co-foci in HeLa and U2OS cells, it does not affect 
the frequency of CPT-induced foci, suggesting that EWS functions in the prevention of 
DNA DSBs. 
The binding of EWS precisely within the chromosomal translocation-prone 
regions of transcripts from the FET genes is consistent with EWS being necessary for the 
maintenance of genomic integrity. To further test this hypothesis, we carried out 
fluorescence in situ hybridization (FISH) with EWS break-apart probes which flank the 
EWS breakpoint region between intron 7 and intron 10 in EWS and control shRNA 
transfected HeLa cells. EWS depletion lead to a significant 3-fold increase in the 
frequency of cells with one or more split signals (Figure 3D; Fisher’s exact test p-value < 
0.0001); compared to 20 split signals in control shRNA-treated cells, we observed 
approximately 60 split signals in EWS shRNA-treated cells. This result suggests that 
depletion of EWS creates an environment that is permissive for chromosomal 
translocations in its own genomic locus, in the region where EWS binds its own RNA. 
Finally, to more generally evaluate the propensity of EWS-bound transcripts to originate 
in translocation prone-loci, we analyzed the fusion transcripts from the ChimerDB 
knowledgebase (Kim et al., 2010). From 841 genes that are involved in fusions and are 
expressed in HEK293 cells, 124 (12%) were also targeted by EWS (Figure 3E; Fisher’s 
exact test p-value=2.4e-09, odds-ratio=1.9. This suggests that EWS is important for the 
maintenance of genomic integrity genome-wide. 
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5.5 DISCUSSION 
In addition to DNA damaging agents that induce genomic instability, single 
stranded DNA intermediates that predispose to chromosome fragility occur during 
normal processes such as replication and transcription. Not surprisingly, a variety of 
surveillance mechanisms, which act in DNA damage prevention, signaling and repair, 
have evolved to maintain the stability of genome. While the processes of DNA damage 
response and repair are relatively well studied, the mechanisms of DNA damage 
avoidance only recently began to be uncovered. A recent siRNA screen for factors that 
influence the frequency of γH2AX foci revealed that RNA binding proteins play an 
important role in the maintenance of genome stability by preventing the co-
transcriptional formation of stable RNA-DNA structures (Paulsen et al., 2009). Our study 
suggests that EWS is part of this preventive mechanism. Namely, EWS promotes 
RNAPII elongation, thereby relieving transcription-associated stress at intrinsically 
fragile genomic regions. That the landmark chromosomal translocations in Ewing 
sarcoma are accompanied by the loss of EWS’ RNA-binding domain raises the intriguing 
hypothesis that reduced EWS expression may trigger a vicious circle that leads to 
genomic instability and chromosomal translocations. 
In vitro, EWS was reported to bind G- and U-runs (Ohno et al., 1994). In our 
study, we determined the transcriptome-wide targets of EWS using PAR-CLIP (Hafner et 
al., 2010) and showed that it associates with G-rich sequences in vivo as well. Although 
crosslinking and immuno-precipitation is becoming a standard method to determine 
targets of RBPs in vivo, the protocols are quite involved and prone to biases at various 
levels (Kishore et al., 2011, Sugimoto et al., 2012), which may explain why CLIP studies 
of FET family proteins yielded somewhat divergent results. For instance, no G-rich motif 
emerged from a previous PAR-CLIP study of FET proteins, including EWS (Hoell et al., 
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2011). However, this could be due to the depletion of G-containing binding sites through 
T1 RNase digestion (Hoell et al., 2011, Kishore et al., 2011), because the same study 
identified an AU-rich stem-loop as the preferred binding motif of the FUS protein, while 
other CLIP studies of FUS found instead GU-rich elements (Lagier-Tourenne et al., 
2012, Rogelj et al., 2012). Our results, obtained with mild T1 RNase digestion, are 
consistent with both the previous in vitro data on EWS and the in vivo data from multiple 
CLIP studies of the related FUS protein, and indicate that EWS indeed binds G-rich 
elements in vivo. 
The location - downstream of TSSs - and composition - G-rich - of in vivo bound 
EWS targets are very reminiscent of regions that are prone to form R-loops (Ginno et al., 
2012, Roy and Lieber, 2009), structures that impede RNAPII elongation during 
transcription (reviewed in (Aguilera and García-Muse, 2012)). While EWS binds 
transcripts that are predicted to form R-loops, our analysis of RNAPII ChIP-seq data and 
mRNA-seq data indicates that EWS counteracts the effect of R-loops. Namely, EWS 
promotes RNAPII elongation and intron retention. Recent reports provide extensive 
evidence that the lack of coordination between RNA processing steps leads to the 
formation of R-loop structures and transcription-associated deleterious effects on the 
genome (reviewed in (Montecucco and Biamonti, 2013)). The fact that EWS depletion 
alters the steady state levels of DNA DSBs but does not affect the frequency of DSBs that 
occur in response to the topoisomerase inhibitor CPT suggests that EWS binding has a 
role in the prevention rather than the repair of breaks. These results point to a direct link 
between EWS and the prevention of transcription-associated genomic instability. 
The effect of EWS on intron retention is consistent with previously reported links 
between EWS and alternative splicing (Paronetto et al., 2011, Sanchez et al., 2008). EWS 
was found to interact directly with splicing regulatory proteins (reviewed in (Kovar, 
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2011)) and we here found that it binds preferentially transcripts of splicing factors. 
Finally, the relationship that we uncovered between the level of EWS and the level of 
intron retention is consistent with the kinetic model of coupling between RNAPII 
elongation and splicing (reviewed in (Dujardin et al., 2013)).  
Other FET family members appear to share EWS’ functions. For example, in vivo 
crosslinking studies of FUS also indicated binding at the rearrangement-prone loci of 
FET genes (Lagier-Tourenne et al., 2012, Rogelj et al., 2012). Interestingly, a recent 
study found that the FUS protein regulates the phosphorylation of RNAPII at serine 2 and 
thereby the rate of RNAPII elongation (Schwartz et al., 2012). In the RNAPII pull-downs 
presented in this study EWS was the second most abundant protein, but its interaction 
with RNAPII was not investigated further. Our data suggests however, that EWS 
promotes RNAPII elongation in regions that are prone to R-loop formation and 
transcription-associated stress, an activity that is probably common to all FET family 
members and perhaps other RBPs. 
Ewing sarcoma is a rare tumor whose very distinctive characteristic is the 
presence of chromosomal translocation-induced fusion proteins. In about 85% of Ewing 
sarcoma cases the EWS locus is translocated to the FLI1 (friend leukemia virus 
integration 1) locus, which leads to the production of an EWS-FLI1 fusion transcription 
factor that lacks the RNA binding domain of EWS (Ohno et al., 1994). How these 
translocations take place is unclear. However, our FISH analysis suggests that limiting 
levels of EWS lead to DNA breaks in its own translocation-prone genomic locus, which 
could in turn lead to chromosomal translocations. This translocation per se may not lead 
to tumorigenicity, which requires additionally that cells escape senescence and apoptosis 
and proliferate with an increased rate (Hanahan and Weinberg, 2011). However, these 
features may be acquired as a result of the expression of EWS fusion proteins (reviewed 
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in (Riggi et al., 2007)) or of DNA DSBs at other loci where the EWS RNA-binding 
activity is lost. Genome-wide translocation sequencing (Chiarle et al., 2011, Klein et al., 
2011) following EWS knockdown could be an initial approach to identify such recurrent 
translocation-prone regions. Collectively, our analysis points to a direct role of EWS’ 
RNA-binding activity in promoting RNAPII elongation and relief of transcription-
associated stress. The fact that this activity is lost in Ewing sarcoma suggests a novel 
mechanism contributing to the pathogenesis of Ewing sarcoma. 
5.6 EXPERIMENTAL PROCEDURES 
We used custom Perl (version 5.8.1) and R (version 2.15.1) scripts and BEDTools 
packages (version 2.17.0) (Quinlan and Hall, 2010) for in silico analysis and IGV 
(version 2.2) (Thorvaldsdóttir et al., 2012) for visualization of features. Detailed 
experimental and analysis methods can be found in the Extended Procedures. 
5.6.1 PAR-CLIP experiment and analysis 
PAR-CLIP of EWS in HEK293 cells was performed as described in (Hafner et 
al., 2010) and sequencing libraries were analyzed as described in (Jaskiewicz et al., 
2012). 
5.6.2 mRNA-seq experiment and analysis 
The Illumina directional mRNA-seq protocol with minor modifications was 
applied to samples extracted from control or EWS siRNA transfected HeLa cells and 
untreated HEK293 cells. 
5.6.3 H2AX ChIP-seq analysis 
H2AX immunoprecipitation (SRR074195 and SRR074196) and input DNA 
(SRR074203) samples obtained from Jurkat T cells by Seo et al. (Seo et al., 2012) were 
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downloaded from www.ncbi.nlm.nih.gov/sra and analyzed as described in (Arnold et al., 
2012a) with small modifications. 
5.6.4 Immunofluorescence 
HeLa and U2OS cells transfected with control or EWS shRNA constructs on glass 
coverslips were enriched by puromycin selection, fixed in ice-cold methanol, stained with 
antibodies and imaged with a Leica DMI 4000 microscope. 
5.6.5 Fluorescent In Situ Hybridization (FISH) 
The status of EWS locus was evaluated with the Poseidon Repeat Free EWS 
(22q12) break-apart probes (KBI-10708; KREATECH Diagnostics, Netherlands) in 
HeLa cells transfected with control or EWS shRNA constructs. Hybridizations, washing 
and evaluation were done according to the manufacturer’s instructions.  
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accession number GSE54689. 
5.8 ACKNOWLEDGMENTS 
We thank Manuel Stucki (University of Zürich) for his assistance in the 
evaluation of the 53BP1 foci, S. Piscuoglio, M. Kovac, K. Heinimann and lab members 
(Department of Biomedicine, University of Basel), and Zavolan lab members for helpful 
discussions. Work in the Zavolan laboratory was partly supported by SystemsX, the 
systems biology initiative in Switzerland. S.K. was the recipient of the EMBO long-term 
fellowship 184-2009, and B.B. of a Werner-Siemens Stiftung fellowship at Biozentrum. 
 133 
 
Figure 1. PAR-CLIP reveals that EWS targets intronic G-rich RNAs in vivo. A. The 
EWS antibody recognizes a ~80 kDa protein in western blot (WB) from HEK293 cells. 
Boxed ~90 kDa (A) and ~120kDa (B) bands in CLIP show the regions from which 
samples were prepared for sequencing. B.  Genome browser screenshots of the coverage 
of FET gene loci by CLIP reads. Range of raw read counts are indicated on each 
respective track. (kb: kilobase) C. Cumulative distribution of the relative distance from 
each of the top 10,000 crosslink in EWS A sample to the closest crosslink among the top 
10,000 crosslinks in EWS B and HuR samples. D. Frequency of the sequence motif 
identified as over-represented in EWS crosslinked sites as a function of position relative 
to the crosslink, which is indicated by the vertical dashed line at 0. E. Cumulative 
distribution of the number of crosslinks in various transcript regions, sketched at the top 
of the panel (UGS:  upstream of gene start, DGE: downstream of gene end). Inset shows 
number of transcripts with crosslinks in different types of regions. F. KEGG pathways 
enriched in EWS target transcripts. P-values are calculated from Fisher’s exact test taking 
the genes expressed in HEK293 as the universe. Vertical dashed line represents p-
value=0.01. 
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Figure 2. EWS associates with R-loops and promotes RNAPII elongation. A. Targeting 
of initial introns by EWS and GU-rich element-binding RBPs. B. Cumulative distribution 
of median displacements of EWS crosslinks from starts of introns. The dashed line 
indicates no positional bias within introns. Introns are ranked from transcript start. Inset 
shows the number of transcripts crosslinked in individual introns. C. Cumulative 
distribution of the median distance between an EWS crosslink and the closest R-loop 
within individual genes in the EWS and R–loop co-targeted gene loci. The background 
distribution was computed by randomizing the positions of R-loops within the co-
targeted gene loci. Inset shows Venn diagram of co-targeting of genes expressed in 
HEK293 cells. D. Cumulative distribution of relative RNAPII ChIP-seq read densities in 
introns compared to the entire gene bodies in HEK293 cells. E. Cumulative distribution 
of normalized intron expression change between EWS and control siRNA-treated cells in 
HeLa cells. Normalized intron expression was computed as ratio of read densities in the 
intron and in the exons of the corresponding gene. 
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Figure 3. EWS binds RNAs derived from intrinsically fragile genomic sites and prevents 
transcription-associated stress. A. Cumulative distribution of the relative distance of EWS 
crosslinks and H2AX ChIP-seq peaks from chromosome starts. Dashed line corresponds 
to no positional bias.  B. Cumulative distribution of the median distance between an EWS 
crosslink and the closest H2AX peak within individual genes in the EWS and H2AX co-
targeted gene loci. The background distribution was computed by randomizing the 
positions of H2AX peaks within the co-targeted gene loci. Inset shows Venn diagram of 
co-targeting of genes expressed in HEK293.  C. Representative immunofluorescence 
images and quantification of spontaneously formed nuclear γH2AX/53BP1 co-foci in 
HeLa and U2OS cells expressing EWS or control shRNA. CPT indicates camptothecin 
treatment. DNA was stained with DAPI. Box plots summarize the number of 
γH2AX/53BP1 co-foci per cell. ****: p < 0.0001 in the Kruskal-Wallis test; ns: not 
significant. D. Representative FISH images and the quantification of EWS break-apart 
probe signals showing intact (D < 1 ø) or split (D > 1 ø) patterns in the EWS locus in 
HeLa cells expressing EWS or control shRNA. ****: p < 0.0001 in Fisher’s exact test. E. 
Venn diagram showing the overlap of EWS target genes with genes from ChimerDB. 
Only genes that are expressed in HEK293 cells were considered in this analysis. 
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5.9 EXTENDED PROCEDURES 
5.9.1 Cell culture  
HEK293 and HeLa cells were routinely cultured in DMEM medium 
supplemented with 10% FCS in the presence of pennicillin and streptomycin antibiotics 
until they reached 80-90% confluence. 
5.9.2 PAR-CLIP experiment 
HEK293 cells were grown on 15-cm cell culture plates. Approximately 30 plates, 
with cells at ~80% confluence were used. 4-thiouridine (Sigma) was added to the cells to 
a final concentration of 100 µM and cells were incubated for 12 hours before 
crosslinking. PAR-CLIP was carried out as described previously (Hafner et al., 2010, 
Kishore et al., 2011). The sc-48404 antibody (Santa Cruz Biotechnology) coupled to 
protein-G Dynabeads (Invitrogen) was used for immuno-precipitation. The RNA was 
partially digested with endonuclease T1 (Ambion) and then with micrococcal nuclease 
(MNase, from New England Biolabs) as previously described (Jaskiewicz et al., 2012). 
The RNA complexed to the protein was radiolabeled; the complexes were separated on 
SDS-PAGE gel followed by transfer onto nitrocellulose membranes to reduce the 
background of free RNAs (Konig et al., 2011). The two bands (90kDa and 120kDa) 
containing EWS were separately isolated and the protein was digested with proteinase K. 
The recovered RNA was ligated first to preadenylated 3’ adaptor (5’ 
TCGTATGCCGTCTTCTGCTTG 3’) then size fractionated (20-50 nts) on denaturing 
acrylamide gels and ligated to 5’ adaptor (5’ 
GUUCAGAGUUCUACAGUCCGACGAUC 3’). The ligation mixture was once again 
size fractionated on denaturing acrylamide gels to remove unligated inserts along with 
free adaptors. The recovered RNA was reverse transcribed with Superscript III 
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(Invitrogen) reverse transcriptase using reverse complementary sequence of 3’ adaptor as 
primer and treated with RNase H. The cDNA resulting from reverse transcription was 
PCR amplified (typically 14-16 cycles) using forward primer (5' 
AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 3’) and 
reverse primer (5' CAAGCAGAAGACGGCATACGA 3’). The PCR products were 
extracted from agarose gels with a Qiaex II Gel extraction kit (Qiagen). Libraries were 
then sequenced on an Illumina Genome Analyzer IIx instrument. 
5.9.3 mRNA-seq  
HeLa cells were grown in 6-well plates as described above. The siRNA-mediated 
EWS knockdown was done with siRNAs from Santa Cruz Biotechnology (sc-35347, a 
pool of 3 target-specific 19-25 nt siRNAs sc-35347A, sc-35347B and sc-35347C). 
Corresponding control siRNA-A (sc-37007) for control transfections was also obtained 
from the same manufacturer. siRNAs were transfected with RNAiMAX (Invitrogen) 
according to the  manufacturers protocol. Two experiments were performed. In one, the 
sample was harvested at 48 hours (replicate 1) after transfection and in the other at 72 
hours (replicate 2). In both cases, the samples were split into two. One aliquot was used 
for western blot assay to assess the down-regulation of EWS protein. The other aliquot 
was used for the preparation of an mRNA-seq sample. Poly(A)+ RNA was isolated 
directly from EWS and control siRNA treated HeLa cells with Dynabeads® mRNA 
DIRECT™ Kit from Invitrogen, following the manufacturer’s protocol. After isolation, 
the mRNA was chemically fragmented by incubating mRNA solution with twice the 
volume of alkaline hydrolysis buffer (50 mM Na-CO3, 1 mM EDTA, pH 9.2, prepared 
by mixing 1 ml 0.1 M Na2CO3 with 9 ml 0.1 M NaHCO3, adding EDTA to 1 mM, 
adjusting the pH to 9.2 and the volume to 20 ml with H2O) at 95°C for 5 minutes to 
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obtain fragments of approximately 200 nt. Fragmented mRNA was immediately purified 
with RNeasy MinElute Cleanup Kit (Qiagen) to stop the reaction and to remove small 
RNA fragments (<100 bases). Purified fragmented mRNA was then treated with 
phosphatase FastAP (Fermentas) at 37 °C for 30 minutes to remove 5’ and 3’ phosphate 
groups from the fragmented mRNA. Fragmented mRNA was further incubated with ATP 
and T4 polynucleotide kinase (Fermentas) at 37 °C for an hour to add phosphate at 5’ end 
of fragmented mRNA (to define 5’ and 3’ end of fragmented mRNA). After 
phosphorylation fragmented mRNA was purified using above-mentioned kit to remove 
all the free ATP from phosphorylation reaction. Following purification, ligation of 
preadenylated 3’ adaptor from Illumina (RA3, 5’ TGGAATTCTCGGGTGCCAAGG 3’) 
was performed with T4 RNA Ligase 2, truncated K227Q (New England Biolabs Inc) 
according to the Illumina protocol. Ligation was followed by another purification done as 
described above to remove un-ligated 3’ adaptors. The 5’ adaptor from Illumina (RA5, 5’ 
GUUCAGAGUUCUACAGUCCGACGAUC 3’) was ligated with T4 RNA ligase 
(Fermentas) according to the Illumina protocol followed by purification to remove un-
ligated 5’ adaptors. cDNA was synthesized using the sequence complementary to the 3’ 
adaptor with SuperScript III (Invitrogen) as per Illumina protocol. Libraries were 
amplified for 14 cycles of PCR using forward primer and reverse primer with barcodes 
from Illumina. Barcodes were introduced in each library at the PCR step for 
multiplexing. Libraries were sequenced for 50 cycles on an Illumina HiSeq 2000 deep 
sequencer. 
HEK293 cells were grown on 6-well plates. mRNA-seq sample preparation was 
carried out as described above for HeLa cells, except that for replicate 1, the adaptors that 
were used were those that were specified above for the PAR-CLIP sample preparation: 3’ 
adaptor (5’ TCGTATGCCGTCTTCTGCTTG 3’) and  5’ adaptor (5’ 
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GUUCAGAGUUCUACAGUCCGACGAUC 3’), and the primers for PCR amplification 
were: forward primer (5' 
AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 3’) and 
reverse primer (5' CAAGCAGAAGACGGCATACGA 3’). 
5.9.4 Immunofluorescence 
EWS shRNA constructs used were originally obtained from Origene (catalogue 
number TG313142, sequence shRNA-EWS_1 - GI352561: 
GAGCAGTTACTCTCAGCAGAACACCTATG) and contained the shEWS sequence 
cloned in a retroviral GFP vector. shEWS cassette was subsequently sub cloned into a 
retroviral pRS vector (Origene) without GFP using EcorI/HindIII site to eliminate 
interference of any GFP fluorescence. HeLa and U2OS cells grown on coverslips in 6-
well plates were then transfected with EWS shRNA construct or respective control 
(sequence TR30013 GCACTACCAGAGCTAACTCAGATAGTACT) in pRS vector 
containing a puromycin-resistance cassette using the jetPEI transfection reagent 
(Polyplus-transfection SA, France) according to the manufacturers protocol. Medium was 
exchanged 12 hours after transfection. Successfully transfected cells were then enriched 
by the addition of 1 µg/ml puromycin to the culture medium. Additionally, for continuous 
CPT treatments, CPT was added to a final concentration of 10 nM. Four days after 
transfection, the cells were washed twice with PBS and fixed for 30 min in ice-cold 
methanol at 4°C. All following steps were performed at room temperature. After washing 
twice with PBS, cells were blocked with blocking buffer (5% FCS in PBS) for 30 min. 
Antibodies against γH2AX (clone JBW301; upstate, USA) and 53BP1 (H-300; Santa 
Cruz Biotechnology, USA) were hybridized in blocking buffer at dilutions of 1:1000 and 
1:500, respectively. After one hour cells were washed three times with PBS for 5 min, 
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and secondary antibodies (A11017 and A11012; Invitrogen, USA) hybridized in blocking 
buffer for 30 min. After washing 3 times with PBS for 5 min, coverslips were mounted 
using vectashield, containing DAPI (1 µg/ml). γH2AX and 53BP1 were evaluated and 
counted with a Leica DMI 4000 microscope. Statistical analysis of triplicate experiments 
was done using the Prism5 software (GraphPad, USA). 
5.9.5 FISH 
HeLa cells were grown and transfected with control or EWS shRNA constructs as 
mentioned above. Four days after transfection coverslips were washed twice with PBS 
and incubated in 2x SSC (pH 7.0) for 30 minutes at 37°C. Samples were then dehydrated 
by a series of two minutes incubations in 70%, 85% and 100% ice-cold ethanol and 
subsequently air dried. To avoid over-denaturation in the subsequent steps, samples were 
“aged” overnight at 4°C. Hybridization of the Poseidon Repeat Free EWSR1 (22q12) 
Break probe (KBI-10708; KREATECH Diagnostics, Netherlands) and subsequent steps 
were performed according to the manufacturer’s instructions. Briefly, coverslips were 
covered with 10 µl of the probe, sealed with Fixogum, denatured at 80°C for 5 minutes 
and hybridized over night at 37°C in a humidified chamber. Post-hybridization washes 
included one time 2xSSC/0.1% Igepal for 2 minutes at room temperature, one time 0.4x 
SSC/0.3% Igepal for 2 minutes at 72°C and one time 2xSSC/0.1% Igepal for 2 minutes at 
room temperature, the latter two steps being performed without agitation. Samples were 
then dehydrated by a series of two minutes incubations in 70%, 85% and 100% ethanol, 
air dried and mounted using vectashield, containing DAPI (1 µg/ml). Intact and aberrant 
loci defined as red/green (yellow) fusion signals or split signals with a distance of more 
than one signal diameter, respectively, were evaluated and counted with a Leica DMI 
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4000 microscope. Statistical analysis of triplicate experiments was done using the Prism5 
software (GraphPad, USA). 
5.9.6 Read mapping 
We mapped the reads from PAR-CLIP and mRNA-seq libraries to the human 
genome (assembly version hg19) downloaded from the University of California at Santa 
Cruz (genome.cse.ucsc.edu) (Meyer et al., 2013) and transcriptome with CLIPZ server 
(Khorshid et al., 2011). 
5.9.7 Estimation of expressed RefSeq genes 
We used 2 biological replicates of mRNA-seq libraries obtained from HEK293 
cells for the estimation of expressed RefSeq genes. We used uniquely mapping >25 nts 
long reads, which were annotated as either “mRNA” or “none”, without a known 
annotation mapped, by CLIPZ server (Khorshid et al., 2011). We fitted a two-component 
Gaussian mixture model with unequal variance to the per-nucleotide read densities of the 
representative RefSeq transcripts with the mclust R package (Yeung et al., 2001). We 
used the set of genes belonging to the higher expression component of the mixture in the 
libraries as the set of “HEK293-expressed genes” and used for functional annotation. 
5.9.8 PAR-CLIP analysis 
We used reads that were uniquely mapped to the genome and annotated as 
“mRNA”, “repeat”, or “none”, without a known annotation mapped, by CLIPZ server 
(Khorshid et al., 2011) to calculate the genome-wide crosslink scores in two 90kDa and 
120kDa EWS, their combination, and HuR (Martin et al., 2012) (sequencing data 
accessible from the Gene Expression Omnibus (GEO) accession GSM714639) PAR-
CLIP libraries as previously described (Jaskiewicz et al., 2012). 
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5.9.9 H2AX ChIP-seq analysis 
We used two H2AX ChIP-seq samples (SRR074195 and SRR074196) and one 
input DNA sample (SRR074203) obtained from Jurkat T cells by Seo et al. (Seo et al., 
2012), downloaded from www.ncbi.nlm.nih.gov/sra to identify genome-wide H2AX 
binding loci with the method described Arnold et al. (Arnold et al., 2012b) but modeling 
the fluctuations on the  read-counts as a convolution of log-normal and Poisson sampling 
noise (Balwierz et al., 2009). Briefly, raw sequencing reads were quality-filtered and 
adaptors were removed. Alignments to the human genome assembly hg19 were obtained 
with bowtie (Langmead, 2010) version 0.12.7 and parameters -v 2 -a -B 1 --quiet --best --
strata -m 100. Further analysis was performed with aligned reads. Read lengths were 
estimated by finding the distance d that maximizes the cross-correlation between the 
numbers of reads starting at opposite DNA strands, and subsequently each read was 
represented by its estimated center position. i.e. shifted by half of the estimated read 
length. Read counts associated with a given genomic location were obtained by summing 
over all read centers within the region, weighing each read with the inverse of the number 
of loci to which the read mapped equally well. To detect H2AX binding peaks we 
compared read density in sliding windows of size 500 nt for immuno-precipitation 
samples (foreground) with the read density in 2,000 nt regions, centered at the same 
position, for the input DNA sample (background). We assumed that the differences in log 
read-densities within the windows derive from a mixture of background (a convolution of 
log-normal and Poisson sampling noise) and enriched regions (represented as a uniform 
distribution over the range spanned by the data). We fitted the parameters of this mixture 
model with expectation maximization, i.e. using maximum likelihood. Finally, we 
calculated a z-value for each window, corresponding to the number of estimated standard 
deviations that the log read-density is enriched relative to the background distribution. 
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The histogram of z-values showed a distinct shoulder at high z-scores and 8,298 regions 
with z-value > 4 were selected as H2AX binding peaks.  
5.9.10 Functional annotation 
We used the RefSeq gene track from University of California at Santa Cruz 
genome browser (genome.cse.ucsc.edu) (Kuhn et al., 2009) to map EWS and HuR 
crosslinks, and H2AX peaks, R-loops, and GU-rich RBP binding sites over genes. We 
selected a representative RefSeq transcript from long-noncoding RNAs and mRNAs. The 
selection of representative transcripts of single-locus genes was based on several criteria 
such as biotype (mRNA > non-coding RNA), RefSeq gene status (Reviewed > Validated 
> Inferred > Provisional > Predicted), length of genomic locus, and total length of the 
exons (with a higher precedence for the longer transcript locus and total exon-length). 
The 2,500 nt long regions upstream of representative transcripts were defined as UGS 
regions (Upstream of Gene Start) regions and the 2,500 nt-long regions downstream of 
the representative transcripts were defined as DGE (Downstream of Gene End) regions. 
Intra-genic regions were classified as 5’ UTR, CDS, and 3’ UTR on the basis of the 
representative transcript annotation. Finally genomic crosslinks or regions were 
functionally annotated with the following precedence rules: 3’ UTR > 5’ UTR > CDS > 
intron > DGE > UGS. Region annotations were prioritized based on the longer of the 
intersecting regions. 
5.9.11 Motif discovery and search 
Non-overlapping representative crosslink centered regions (41-nt-long regions 
centered on the crosslink) from combined EWS PAR-CLIP sample were used for the 
motif analysis with the MEME program (Bailey, 2002b). We used the same number of 
regions with the same lengths from the sequences flanking these sites that did not contain 
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any crosslinked positions to compute a Markov model of order 1 which we used as 
background. Additional parameters were: -dna -bfile -mod zoops -nmotifs 1 -minw 5 -
maxw 12. We used the position weight matrix obtained from the motif analysis as 
described above as well as the same background model to compute the motif likelihoods 
for an extended set of 41-nt-long CCRs with FIMO (Grant et al., 2011) and defined a cut-
off for high-affinity EWS binding sites. 
5.9.12 Gene set enrichment analysis 
We used the KEGG Pathways dataset (Kanehisa et al., 2014) and checked their 
association with EWS crosslinks using Fisher’s exact test. 
5.9.13 GU-rich RNA binding data 
Processed files for the genomic binding regions of heterogeneous nuclear 
ribonucleoproteins (hnRNPs) such as hnRNPH, hnRNPM, hnRNPF, hnRNPA2B1, 
hnRNPU, and hnRNPA1 by Huelga et al. (Huelga et al., 2012) was obtained from 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34993. These predictions were 
done on the hg18 version of the human genome assembly therefore we converted the 
coordinates to hg19 coordinates using liftover utility from UCSC (Hinrichs et al., 2006). 
5.9.14 R-loop data  
We obtained R-loop predictions data from Ginno et al. (Ginno et al., 2012) and 
extracted strand specific G-skewed regions. These predictions were done on the hg18 
version of the human genome assembly and we therefore converted the coordinates to 
hg19 coordinates using liftover utility from UCSC (Hinrichs et al., 2006). 
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5.9.15 Fusion genes analysis 
The genes corresponding to head and tail partners of fusion transcripts inferred 
from mRNA-seq data were downloaded from ChimerDB (Version 2.0) (Kim et al., 
2010). 
5.9.16 EWS association analysis 
Association of EWS crosslinks with H2AX peaks, R-loops, and ChimerDB fusion 
genes was drawn based on the genes with which these features were annotated with 
HEK293 expressed transcript regions. The distance between a crosslink and H2AX peaks 
or R-loops on the co-targeted gene loci were further determined and used in statistical 
tests. 
5.9.17 RNAPII ChIP-seq data and analysis 
RNAPII ChIP-seq data obtained from HEK293 cells by ENCODE  
(ftp://hgdownload.cse.ucsc.edu/goldenPath/currentGenomes/Homo_sapiens/encodeDCC/
wgEncodeSydhTfbs/wgEncodeSydhTfbsHek293Pol2StdAlnRep3.bam) (Rosenbloom et 
al., 2013) were used in the analysis of RNAPII elongation rate. Reads were mapped onto 
introns of genes expressed in HEK293 and containing at least one EWS crosslink and 
only those introns with more than one read were used in the statistical significance 
analysis. 
5.9.18 Intron retention analysis 
We used 2 replicates of EWS and control siRNA treated mRNA-seq samples 
obtained from HeLa cell lines for intron retention analysis. Reads were mapped onto 
introns of genes expressed in HEK293 and containing at least one EWS crosslink and 
only those introns with more than one read were used in the statistical significance 
analysis. 
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Chapter 6:  Discussion 
In this thesis, we aimed to identify the targets and understand the function of three 
RNA-binding proteins that up to this point were only poorly characterized. An important 
approach towards this goal was the analysis of high-throughput, particularly next 
generation sequencing data. A second important aspect was the integration of multiple 
experimental data sets that were available in the public domain. 
We presented in the 2nd chapter an experimental approach, AGO CLIP, for the 
identification of in vivo targets of Argonaute proteins, and two probabilistic methods for 
the analysis of the resulting data. The only step that is specific for Argonaute however is 
the immunoprecipitation with the specific antibody, so the method can be generally 
applied to other RNA-binding proteins. In AGO CLIP, cells are initially grown in the 
presence of a photo-reactive nucleoside and subjected to UV radiation. This step is not 
absolutely necessary, but it allows very precise pinpointing of the crosslink sites due to 
the introduction of crosslink-diagnostic, T-to-C mutations during reverse transcription. 
After crosslinking of proteins to their target RNAs, cells are lysed and RNA-protein 
complexes are pulled down with an antibody. To fragment the RNAs for sequencing, the 
extracts are treated with nucleases, labeled with radioactive phosphate, run on a 
radiograph for size selection and then the protein is digested and the RNA purified. 
Finally, adaptor-ligated RNA species are reverse transcribed, amplified and sent to deep 
sequencing. The computational analysis then begins by removing the adaptors and 
aligning the short reads to the reference genome assembly. Reads are then functionally 
annotated, and finally statistical analysis is performed to identify high affinity binding 
sites of proteins on the target RNAs. We presented two probabilistic methods that we 
developed for this purpose; one is based on the enrichment of sequence reads with respect 
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to a background library (e.g. an RNAseq sample obtained from the same cell line), that 
can be applied to any CLIPed protein, and the other based on crosslink-diagnostic 
mutations. Noting that at bona fide crosslinked positions the mutation frequency is 
neither too low nor too high (in the latter case it would rather indicate polymorphisms), 
the method rests on the question of whether or not a genomic position retains the 
empirically estimated crosslinking rate estimated based on most of the data. Of course, a 
main advantage of the latter method is it does not need an independent background 
sample. An RNAseq library could still be utilized however to reduce false positives 
originating from de facto polymorphic sites observed with a comparable frequency to the 
estimated crosslinking rates. Existing SNP (single nucleotide polymorphism) data could 
also be used for the same purpose (Jaskiewicz et al., 2012). Although we developed this 
method to take advantage to the T-to-C mutations that are quite frequent in PAR-CLIP, 
work in our group established that crosslink-diagnostic mutations are introduced in the 
254 nm-based crosslinking that does not use photo-reactive nucleosides. Thus, our 
method can be applied to CLIP data in general (Kishore et al., 2011). 
In Chapter 3, we studied PAPD5, a non-canonical poly(A) polymerase whose 
homolog in yeast has been shown to have nucleotidyltransferase activity and to function 
in RNA surveillance pathway. Finding the targets of PAPD5 required a non-trivial 
amount of effort because, presumably due to the rapid processing of PAPD5 targets by 
the exosome complex, the CLIP replicates had a high variance. We applied very stringent 
methods and identified rRNA as the main substrates of the protein. An independent study 
recently arrived at the same conclusion (Shcherbik et al., 2010).  
In Chapter 4, we studied DIS3L2, one of the three human homologs of the core 
exosome exonuclease Dis3 that is involved in the degradation of its targets in yeast. 
DIS3L2 is the least characterized of the three homologs; like PAPD5, DIS3L2 is also 
 153 
involved in RNA surveillance and thus target identification is again hampered by the very 
rapid degradation of the targets and the variation between the replicates experiments. 
However, the most strongly reproducible result was the enrichment of tRNA fragments in 
the DIS3L2 PAR-CLIP samples. Thus, we were able to identify tRNAs as the main in 
vivo substrates of DIS3L2, and experimental work in the laboratory of our collaborators 
confirmed this computational prediction. Additionally, by analyzing Ago2-CLIP data 
obtained in our laboratory, we found clues that the fragments that DIS3L2 generates from 
tRNAs are loaded into the RNA silencing complex and may function in gene regulation. 
The last PAR-CLIP data set analyzed in this thesis corresponded to a protein of a 
very different nature, EWSR1. EWSR1 is very well known from the fusions that it forms 
with transcription factors. They occur in very specific pathologies, namely the Ewing’s 
sarcoma. The function of the normal protein was addressed by much fewer studies. It has 
been determined for example that EWSR1 is essential for mitotic integrity as well as for 
meiosis (Azuma et al., 2007, Li et al., 2007) and the protein has been implicated in 
alternative splicing of genes involved in DNA repair induced upon genotoxis stress 
(Paronetto et al., 2011). Analysis of EWSR1 PAR-CLIP data generated in our lab showed 
that EWSR1 binds its own pre-mRNA exactly at positions where fusions are usually 
generated. Additional analyses of the sequence and positional binding specificity of 
EWSR1 along pre-mRNAs lead us to hypothesize that EWSR1 binds preferentially on 
RNAs originating from instability-prone DNA regions; we found a strong enrichment of 
EWSR1 at subtelomeric regions, which are known hotspots of genomic rearrangement. 
Furthermore, we found a very significant correspondence between the regions where 
EWSR1 binds and the regions where H2AX, a histone variant that associates with 
double-stranded DNA breaks binds. These results implicate EWSR1 in the prevention of 
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double-strand breaks at genomic regions that are intrinsically unstable; however the exact 
mechanism still needs to be determined.  
In summary, being experimentally tedious and complex, when integrated with 
proper computational analysis, CLIP methods are powerful in the identification of one 
important component of post-transcriptional gene regulation, targets of RNA-binding 
proteins. More sophisticated methods still need to be developed for combinatorial 
modeling of the RNA-protein and regulatory RNA networks. 
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